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SUMMARY
Functional Analysis of the Herpes Simplex Virus Structural 
Polypeptide, Vmw65
The aim of this project was to study the role of Vmw65, a 
virion tegument polypeptide, which is important not only as 
a structural protein, but also as the trans-inducing factor 
(TIF) of HSV immediate-early (IE) gene transcription.
To elucidate the role of Vmw65 in the assembly of infectious
virions, the HSV-2 mutant, ts2203, derived from the multiple
mutant, tsl3, was characterised. Previous work strongly
suggested that tsl3 has a temperature sensitive (ts) lesion
within the Vmw65 gene, since Vmw65 produced by tsl3 failed
to react with the monoclonal antibody, MA1044, directed
against this polypeptide. In contrast, the wild type (WT)
+
HG52 HSV-2 Vmw65, or the gene product synthesised by ts 
revertants of tsl3, which retained the defect within the 
alkaline exonuclease gene, was immunoprecipitated by the 
antibody (H.M. Moss and J.W. Palfreyman, personal 
communication). Preliminary studies on tsl3 indicated that 
the virus has a late defect and therefore it was likely that 
the lesion affected the structural function of Vmw65. To 
obtain a mutant with a single ts lesion, a cloned fragment, 
Bglll i, containing the tsl3 Vmw65 gene, was recombined into
WT HSV-2 strain HG52, and the mutant, ts2203, isolated. \ The X
/ ! (
ability of the plasmid pMCl, which contains the HSV-1 Vmw65 
gene, to rescue ts2203 supported the idea that ts2203 had a 
lesion within Vmw65. Results from marker rescue experiments 
using HSV-2 HG52 cloned DNA fragments, together with
iii .
information from cross-hybridisation studies with HSV-1 pMCl
and subfragments of HSV-2 Bglll i, suggested that the
mutation was present at the 5 ’ end of the coding sequences.
+
The isolation of ts revertants which formed plaques at the
NPT with the same efficiency as WT virus confirmed that this
mutant had a single ts lesion.
Polypeptide analysis of virus-infected cell extracts showed
that ts2203 synthesised at both the PT and the NPT, a Vmw65
which had an altered electrophoretic mobility on SDS
+
polyacrylamide gels. Two of five ts revertants of ts2203 
also specified a polypeptide with this property whilst the 
remainder induced Vmw65 which had a similar mobility to WT 
virus. Thi£ information suggests that the ts lesion in the 
Vmw65 gene is responsible for the alteration in the 
electrophoretic mobility of Vmw65 encoded by ts2203. Since 
ts2203 Bglll i cloned DNA retained the ability to stimulate 
IE transcription to the same extent as WT HG52 Bglll i_, the 
lesion in ts2203 must only affect the structural function of 
Vmw65.
To determine which stage of virion assembly was affected by 
the lesion, thin section preparations of ts2203- or WT 
HG52-infected cells grown at the PT and NPT were examined 
under the electron microscope. Similar numbers of capsids 
were present in the nuclei of cells infected by either virus 
at the NPT, suggesting that ts2203 did not have a defect in 
the assembly of capsids. At this temperature, however, WT 
virus produced low numbers of dense cored capsids, making it 
difficult to ascertain whether there was any difference in
iv.
the number of DNA-containing capsids in the mutant-infected
cells compared with those cells infected with WT virus.
Analysis of viral DNA synthesised at the NPT revealed that
most of the viral DNA was endless, supporting the electron
microscopic observations that both viruses packaged DNA
inefficiently at this temperature. These results together
with the finding that cells infected with HG52 at the NPT
contained very few enveloped particles, presumably because
little of the replicated concatemeric viral DNA was cleaved
and encapsidated, meant that it was impossible to determine
whether the ts2203 defect was affecting packaging of viral
DNA or envelopment of DNA-containing capsids. To overcome
this problem, the Bglll i fragment of tsl3 was recombined
into another* HSV-2 strain, HVD25766, which grows well at the
NPT and, in contrast to strain HG52, produces large amounts
of cell-released enveloped virus. The resulting HVD mutant,
ts2204, was compared with WT HVD for the ability to
encapsidate virus DNA at the PT and NPT, and initial results
indicated that the mutant had a packaging defect. However, a 
+
ts virus, produced by recombining cloned HG52 Bglll i into 
ts2204 DNA, also failed to package significant amounts of 
viral DNA at the NPT. It was, therefore, concluded that 
ts2204 had more than one ts mutation. ^
A second HVD mutant with a ts lesion in Vmw65, ts2205,
+ +
isolated in the same way as ts2204, and a ts virus, ts 2205 
(MR-2), produced by recombining cloned HG52 Bglll i into 
ts2205 DNA, were examined for the ability to package viral
V .
+
DNA. In these experiments ts 2205 (MR-2) behaved as WT HVD,
indicating that ts2205, unlike ts2204, was not a multiple ts
mutant. Ts2205, however, failed to package significant
amounts of DNA either at the NPT, or on temperature
shiftdown from the NPT to the PT in the absence of further
protein synthesis. That is, ts2205 appears to have a
non-reversible ts defect in encapsidation of viral DNA.
This was confirmed by electron microscopic analysis of thin
+
section preparations of ts2205-, ts 2205 (MR-2)- and
+
HVD-infected cells. WT HVD and ts 2205 (MR-2) virus
produced large quantities of dense-cored capsids and
enveloped virus particles at the PT and NPT, whereas in
ts2205-infected cells, only partially-cored and empty
capsids were*evident following incubation at the NPT, or on
a temperature shiftdown to the PT in the presence of
cycloheximide to prevent any further protein synthesis.
Polypeptide analysis of virus-infected cell extracts showed
that ts2205 retained the altered electrophoretic mobility of
ts2203 Vmw65 at the PT and at the NPT, whilst WT HVD and 
+
ts 2205 (MR-2) synthesised a Vmw65 with a mobility similar 
to that of WT HG52. The evidence suggests, therefore, that 
Vmw65 is required for encapsidation of viral DNA.
Further experiments were concerned with the analysis of the 
functional domains of HSV-1 Vmw65 gene. This was determined 
by site-specific mutagenesis of the plasmid pMCl, which 
contains HSV-1 Vmw65 gene. Mutations were obtained by the 
insertion of a 6 base pair (bp) Xbal oligonucleotide linker
vi .
(5’-TCTAGA-3') into HaelII-digested linear plasmid DNA. The 
mutated plasmids were compared with pMCl for the ability to 
stimulate thymidine kinase (TK) activity in a transient 
expression assay in which cloned TK coding sequences were 
placed under IE control. In this way, regions of the gene 
affected by the insertion of two amino acids could be 
directly located. The results indicated that a small 
central domain of between 50 and 200bp was required for 
transcriptional activity of Vmw65, since plasmids with a 
6bp insertion in this region failed to stimulate expression 
of an IE-TK gene chimaera.
Interestingly, the insertion of a termination codon 59bp
upstream from the normal transcriptional termination codon
did not affect the ability of Vmw65 to stimulate IE gene
nonsense codon^__ 
expression. However, a similar  ^ insertion at a
distance of 240bp upstream from the normal termination site
disrupted the integrity of the polypeptide such that the
transcriptional stimulatory ability was lost.
Using ts2203, the structural domains of the Vmw65
polypeptide could also be located from the mutagenised pMCl
plasmids. The failure of a construct to produce significant 
+
numbers of ts progeny virus when cotransfected with ts2203 
into cells indicated that the insertional mutation in pMCl 
was present in the region of Vmw65 essential for its 
structural function. The results of these experiments 
suggested that the central region of the polypeptide, 
important for transcriptional activity, may also be required 
for assembly of virus particles.
vii . 
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CHAPTER 1
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AIMS OF THE PROJECT
Very little is known about the assembly of the herpesvirus 
particle and the role of individual structural polypeptides, 
especially the components of the virus tegument. It is 
therefore interesting that a tegument protein, Vmw65, has 
recently been identified as a transcriptional trans-inducer 
of HSV IE genes (Campbell et al., 1984). In view of this 
information, and the availability of the HSV-2 multiple 
mutant tsl3, thought to have a ts lesion in the HSV-2 gene 
equivalent to HSV-1 Vmw65 (Moss et al., 1979)^ this project 
was undertaken:
(1) to determine the structural role of Vmw65 by 
recombihing the tsl3 mutation in the Vmw65 gene into WT 
HG52 DNA, and analysing the resulting mutant containing V7" 
a single ts lesion,
(2) to make a preliminary study of functional domains in 
the HSV-1 protein.
These aspects of the project are described in Chapters 3 and 
4 respectively.
The following Chapter (1) is an introduction to the biology 
of herpes simplex virus, with particular emphasis on the 
assembly of the virus particle and encapsidation of virus 
DNA.
CLASSIFICATION AND PROPERTIES OF HERPESVIRUSES
Herpesviruses are a heterogeneous group of viruses 
which have been isolated from a wide range of 
vertebrates and invertebrates (for a comprehensive list 
refer to Roizman, 1982). The herpesvirion is composed 
of a double-stranded (ds), deoxyribonucleic acid (DNA) 
genome enclosed within an icosahedral capsid, which is 
surrounded by a lipid envelope (Wildy et al, 1960; 
Epstein, 1962; Roizman and Furlong, 1974)(Figure 1). 
Characteristically, herpesviruses replicate in the cell 
nucleus, and acquire their envelope by budding through 
the nuclear membrane (Morgan et al, 1954; Wildy et al, 
1960).
Although there is wide diversity both in the biological 
characteristics of herpesviruses and in the composition 
of the viral genome (Figure 2), a hierarchical system 
determined by the biological characteristics of 
herpesviruses has been devised. This scheme divides 
the herpesvirus family into three subfamilies on the 
basis of host range, duration of the lytic cycle, 
cytopathology and the properties of latent infection 
(Roizman et al, 1981; Matthews, 1982).
Subfamily Alphaherpesvirinae
Herpes simplex virus type 1 (HSV-1), a human pathogen, 
is the prototype for this group. Members of this 
subfamily are rapidly multiplying cytotoxic viruses
Figure 1
The Structural Components of the HSV Virion 
A section through a herpesvirion particle (Perdue et 
al., 1976).
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A schematic representation of the known genome 
structures of the herpesviruses
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in experimental animals 
which have a variable host range both in vivo^and in
vitro. The reproductive cycle is short, usually 24
hours (h) or less, and latency generally occurs in the
ganglia (Stevens and Cook, 1971, 1973).
Other alphaherpesvirinae include pseudorabies virus 
(PRV), which infects pigs (Gustafsohn, 1970), and 
varicella zoster virus (VZV) which infects man. The 
primary infection of VZV, which is normally a childhood 
disease, is known as chicken pox or varicella, whilst 
the recurrent disease, known as shingles, generally 
occurs in the elderly (Weller et al, 1958; Richards et 
al. , 1979) and in immunocompromised people.
Subfamily Betaherpesvirinae
This group comprises the cytomegaloviruses (CMV) which 
can be isolated from a wide variety of mammals 
including man (Human CMV, HCMV). The host range of 
these viruses is narrow and the growth cycle slow.
Lytic foci are produced in cell culture, and latency 
can be established in a variety of tissues, including 
the secretory glands, lymphoreticular cells and the 
kidneys. HCMV normally causes asymptomatic infections 
in immunocompetent adults. However, it is an important 
cause of infection, particularly in immunocompromised 
adults, for example, organ transplant patients and in 
particular, kidney transplant patients (Alford and 
Britt, 1985). This virus is also responsible for 
certain congenital deformities in babies.
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1•3 Subfamily Gammaherpesvirinae
These are the lymphocyte associated viruses and include 
the human herpesvirus, Epstein Barr Virus (EBV). This 
virus is the causative agent of infectious 
mononucleosis, and has been strongly implicated in 
Burkitt1s lymphoma and nasopharyngeal carcinoma (Henle 
et al., 1968, 1973; DeThe et al., 1978; Raab-Traub et 
al., 1983). Other viruses in this group are 
herpesvirus saimiri (HVS) which infects primates, and 
Marek’s disease virus (MDV) which infects chickens.
The reproductive cycle of the gammaherpesviruses varies 
in length, and the host range is generally limited. In 
vitro t'hey can replicate in lymphoblastoid cells, but 
some members of this group undergo lytic infections in 
cell types such as the T or B lympocytes. For example, 
EBV is specific for B lymphocytes (Koide et al♦, 1981). 
Frequently, infection in lymphocytes is arrested, and 
no virus is produced.
Latent virus is normally present in lymphoid tissue.
1.4 Herpes Simplex Virus Types 1 and 2
These viruses have similar serological and biological 
properties, as well as very similar genome structures. 
Both HSV-1 and HSV-2 infect man, but in general have 
different sites of infection.
HSV-1 is mainly responsible for lesions about the mouth 
and lips, but can also infect the eye, causing a 
disease known as keratoconjunctivitis, a major 
infective cause of blindness in the western world 
(Whitley, 1985). On rare occasions, encephalitis can 
result from HSV-1 infection (Olson et al., 1967; Hammer 
et al., 1980). HSV-1 is normally spread by direct 
contact or by droplets from an infected person.
HSV-2 is usually transmitted venereally and causes 
genital lesions. This can produce a severe and often 
fatal disease in neonates, which acquire their 
infections during birth from genital lesions of the 
mother!
HSV-2 can also infect other regions of the body, for 
example, the eye and mouth, although these infections 
are uncommon. Likewise, HSV-1 can also cause genital 
lesions, but these infections are generally less severe 
than cases where HSV-2 is the causative agent (Corey et 
al., 1983).
HSV CELL TRANSFORMATION AND ONCOGENESIS 
Seroepidemiological research during the past 30 years 
has implicated HSV-2 in the aetiology of cervical 
carcinoma. HSV-2 is normally transmitted venereally 
and readily infects the cervix and vulva; antibody 
titres of the virus are generally higher in women with 
pre—invasive carcinoma or cervical cancer than in 
matched control women (Nahmias et al., 1980).
-6-
Attempts to show that HSV-2 is a tumour virus have 
concentrated on examining the ability of the virus to 
transform cells in vitro. Initial work, using virus 
under conditions in which lytic infection was 
suppressed (Duff and Rapp, 1971; Darai and Munk, 1973; 
Macnab, 1974) failed to detect viral DNA sequences or 
proteins consistently associated with the transformed 
phenotype. Subsequent studies, using defined fragments 
of HSV DNA, identified two transforming regions of 
the HSV-2 genome, the Bglll n region (0.58-0.63mu) 
(Reyes et al., 1979; Galloway and McDougall, 1981; 
Galloway et al., 1984; Jones et al., 1986), and the 
Bglll c fragment (0.41-0.58mu) (Jariwalla et al., 1980, 
1983) a*nd one region of HSV-1, Xbal f (0.30-0. 45mu ) 
(Camacho and Spear, 1978; Reyes et al., 1979).
Although HSV-transformed cells are generally oncogenic 
when transplanted into the syngeneic host animal, HSV 
DNA is progressively lost from the transformed cells 
during passaging in vitro (Minson et al., 1976;
Galloway and McDougall, 1983; Cameron et al., 1985).
In addition, no viral oncogenes of HSV have been 
identified (Galloway and McDougall, 1983; Macnab et 
al., 1985b). This has led to a revival of the "hit and 
run" hypothesis (Skinner, 1976; Minson et al., 1976) 
since the continuous expression of an HSV DNA sequence 
does not appsar to be required for the maintenance of 
cellular transformation (Galloway and McDougall, 1983).
-7-
Transformation by HSV-2 is, therefore, a complex 
process. There is considerable evidence that HSV can 
act as a mutagen causing:
1. Gene amplification (Lavi, 1981; Brandt et al., 
1987).
2. Chromosomal re-arrangements (Hampar and Ellison, 
1961; O'Neill and Rapp, 1971).
3. The demonstration of mutants at a specific cell 
locus, for example, the HGPT locus (Schlehofer and 
Zur Hausen, 1982), or alternatively,
r
4. The enhancement of expression of certain cellular 
genes (either by mutation or by altered regulation 
eg. demethylation (Macnab et al., 1985a).
HSV DNA has been detected in some cervical tumours 
(Park et al., 1983) and generally these sequences span 
regions which correspond to those identified in in 
vitro transformation studies. However, it should be 
noted that HSV DNA sequences are present in only a 
small percentage of cervical carcinomas (Park et al., 
1983; Galloway and McDougall, 1983; Macnab et al., 
1985b), whilst human papilloma virus (HPV) DNA can be 
detected in up to 80% of cervical carcinomas examined 
(Macnab et al., 1986).
HSV LATENCY
The establishment of a latent infection by HSV was 
first postulated by Goodpasture (1929), who also put 
forward the hypothesis that the latent virus resided in 
the neurons of the sensory ganglia. It was, however, 
not until 1971 that Stevens and Cook (1971) first 
demonstrated that virus could be isolated from spinal 
ganglia explants of mice which were latently infected 
with HSV-1. Shortly afterwards it was shown that HSV-1 
could be recovered from explants of trigeminal ganglia 
of humans (Bastian et al., 1972; Baringer and 
Swoveland, 1973), and since then HSV-2 has been 
reactivated from sacral ganglia explants cultured in 
vitro (Baringer, 1974). Latent virus can be 
reactivated by a variety of stimuli such as sunlight, 
the common cold, or menstruation, and the available 
evidence suggests that the latent virus is harboured in 
the neuronal cells of the sensory ganglia (Cook et al., 
1974; McLennan and Darby, 1980).
Although it has been shown that TK viruses and several 
ts mutants of HSV-1 fail to establish latent infections 
in various animal models (Lofgren et al., 1977; Field 
and Wildy, 1978; Watson et al., 1980; Price and Kahn, 
1981), the virus gene(s) that are directly required for 
■the initiation and maintenance of the latent state have 
not yet been identified with any certainty. Recently, 
a mutation, which is thought to affect reactivation of 
latent virus, has been identified in the HSV—1 stiain
17 mutant ts>I. The gene in which the lesion lies, 
however, has not been located (Cook et al., 1986).
In both the mouse model and in humans, the physical 
state of the latent viral DNA appears to be in the form 
of "endless" DNA molecules (Rock and Fraser, 1983,
1985; Efstathiou et al., 1986). It has not yet been 
determined whether the viral DNA exists in an 
extrachromosomal state or is integrated into the host 
cell genome. It is also uncertain how much of the 
latent virus genome is transcribed, but recent evidence 
suggests that very little of the virus DNA is 
transcribed. Interestingly, an anti-sense mRNA to 
VmwllO'has been identified in cells harbouring latent 
HSV in the mouse model (Stevens et al., 1987).
VIRION STRUCTURE
The herpesvirion is composed of four major structural 
components: the core, capsid, tegument and envelope 
(Wildy et al., 1960; Roizman and Furlong, 1974) Figure 
1. }
The core is thought to consist of viral DNA tightly 
spooled in the form of a toroid around a cylindrical 
mass which is probably composed of protein (Furlong et 
al., 1972). Since the core is centrally located within 
the capsid, it has been proposed that it is maintained 
in this position by interaction with inner capsid
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material known as the pericore although the presence of 
the pericore has not been demonstrated in HSV (Roizman 
and Furlong, 1974). Electron microscope studies on MDV
and CMV suggest that the core is attached at its poles
to the capsid (Nazerian, 1974; Haguenau and 
Michelson-Fiske, 1975).
The icosahedral shaped capsid is approximately lOOnm in
diameter and is calculated to be composed of 150
hexameric and 12 pentameric units (Wildy et al., 1960).
EM examination of partially disrupted capsids suggests
that the hexamers may be linked by intercapsomeric
fibrils (Palmer et al. , 1975; Vernon et al., 1974).
*
The amorphous layer between the capsid and envelope is 
known as the tegument or matrix (Morgan et al., 19 68; 
Wildy et al., 1960; Schwartz and Roizman, 1969). Its 
thickness is genetically determined (McCombs et al.,
1971) and varies considerably between the different 
herpesviruses (McCombs et al., 1971), but it is not 
particularly distinct in HSV (Nii et al., 1968; McCombs 
et al., 1971). The tegument may play a role in 
envelopment of the virus (Vernon et al., 1982).
The herpesvirus envelope surrounds the virion 
(Darlington and Moss, 1968) and adheres closely to the 
capsid (Nii et al♦, 1968; Nii 1971). It consists of a 
trilaminar membrane and has spikes of about 8nm in
-11-
length projecting from its surface (Wildy et al.,
1960).
4 .1 Structural Polypeptides of HSV
Most work has concentrated on HSV-1, but other 
herpesviruses have a similar number, and range of 
sizes, of structural polypeptides (Spear and Roizman, 
1972; Gibson and Roizman, 1972; Heine et al., 1974; 
Perdue et al., 1975, 1976; Cohen et al., 1980).
Approximately 30 structural polypeptides have been 
identified in HSV-1 and HSV-2 purified virions (Marsden 
et al., 1976; Heine et al., 1974; Cassai et al., 1975), 
and 7 different polypeptides have been identified in 
HSV-1 capsids which contain DNA (Gibson and Roizman, 
1972; Cohen et al., 1980) (Figure 3). Of these, Vmw55 
(VP19C) was shown to be located in an internal position 
and to have DNA-binding properties (Braun et al., 
1984a), suggesting that it may be a core or pericore 
protein.
The core has also been shown to contain the polyamine, 
spermine (Gibson and Roizman, 1971), which is thought 
to bind to the narrow groove of DNA and neutralise 
phosphate charges.
The ICP35 family of immunologically related proteins 
(p40, NC3) (Cohen et al., 1980; Heilman et al., 1979;
Figure 3
The map location of genes encoding
A. Major glycoproteins: gB, gC, gD, gE, gG, gH,
B. Components of the capsid and tegument
C. Map location of HSV-1 syncytial (syn) loci:
Syn 1, syn 2; syn 3; syn 4; syn 5.
References are given in the text.
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Gibson and Roizman 1972) includes VP21, which is a 
minor unprocessed form, and VP22a (p40) which is a low 
MW processed form of the polypeptide (Braun et al., 
1984b). Recent work with immune-gold electron 
microscope techniques has indicated that this form of 
the protein is located on the surface of empty but not 
full capsids (F J Rixon, personal communication). The 
function of p40 is uncertain but it has been termed an 
"assembly" protein since its presence on the capsid is 
a transient one during maturation (Gibson and Roizman,
1972). It does not appear to be necessary for 
maintenance of the capsid and therefore cannot be 
termed a capsid structural polypeptide.
t
This leaves four polypeptides which are most likely to 
be true components of the capsid. The major capsid 
protein, Vmwl55 (ICP5,NC1), coats the capsid and is 
thought to be the major constituent of the hexamers.
The other minor capsid proteins may be associated with 
the intercapsomeric fibrils, with the hexamers or 
alternatively they may be present at the exterior 
surface of the pericore (Vernon et al., 1981).
4.2 HSV Tegument Polypeptides
Polypeptides which remain associated with the capsid 
when the virus is de-enveloped, but which are absent 
from capsids isolated from infected cell nuclei, are
-13-
classified as tegument proteins (Roizman and Furlong, 
1974; Lemaster and Roizman, 1980). This definition, 
however, does not allow the inclusion of 
nonglycosylated polypeptides which are closely 
associated with the envelope and are solubilised by 
detergent (Spear, 1980; Johnson et al., 1984).
Although a large number of structural polypeptides have 
been identified as components of the tegument, their 
precise function has not yet been determined. A major 
component of the tegument is the high MW protein, 
Vmw273, which may have a role in uncoating of the viral 
genome and in envelopment (V G Preston, personal 
communication). Another major constituent is Vmw65, 
which has been identified both as an essential 
structural polypeptide of the virion (Moss et al., 
1979), and as the virion component responsible for 
trans-activation of immediate-early (IE) gene 
transcription (Campbell et al., 1984) [Section 7.5.3]. 
The HSV Us9 gene also specifies a tegument polypeptide 
of 10,000MW (McGeoch et al., 1985) which can be 
precipitated from NP40 extracts of HSV-1 virions using 
an oligopeptide antiserum (Frame et al., 1986b). This 
phosphoprotein is located around the perimeters of the 
capsid and probably becomes associated with capsids 
soon after their assembly (Frame et al., 1986b).
It has been proposed that HSV encodes at least one 
protein kinase species (Lemaster and Roizman 1980;
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Purves et al., 1986), and that this is located in the
tegument. However, although a gene homologous to
eukaryotic protein kinase genes has been identified in 
the Us, Us 3 (McGeoch and Davidson, 1986), it remains
unclear as to whether the enzyme isolated by Lemaster 
and Roizman (1980) is virus- or host-specified (Stevely 
et al., 1985).
4.3 HSV Envelope Glycoproteins
It should be noted that the polyamine spermidine is 
present in the HSV envelope (Gibson and Roizman, 1971), 
but the major constituents of the envelope are the 
virus glycoproteins. These polypeptides are important 
determinants of pathogenicity, and mediate the entry of 
virus into the host cell and the spread of the virus
between cells. The precise role of individual
glycoproteins in these processes is not well 
understood.
Seven major HSV-1 glycoproteins (Figure 3) with 
homologues in HSV-2 have been identified in the virus 
envelope and their functions are summarised in Table 1. 
In addition, one minor glycoprotein: has
recently been discovered through analysis of the HSV-1 
DNA sequence (McGeoch et al., 1985), but it is not yet 
known whether these polypeptides are components of the 
virus envelope.
Table 1
Functions of the Major HSV Glycoproteins
+ Function demonstrated; positive role
- Negative role
  Role unknown at present, or uncertain
References
gB Sarmiento et al., 1979; Little et al., 1981
gC Friedmann et al., 1984; Smiley and Friedmann 1985
gD Noble et al., 1983; Para et al., 1985
gE Baucke and Spear 1979; Para et al., 1980, 1982
gG Roizman et al., 1985; McGeoch et al., 1985, 1986;
Frame et al., 1986; Richman et al., 1986
gH Buckmaster et al., 1984; Gompels and Minson, 1986
gl Johnson and Feenstra (1987)
HSV Glycoproteins
Table 1
Function gB gc gD gE g G gn gi
Neutralisation 
without complement
+ + + + + +
Adsorption + + + +
Penetration + +
Cell fusion (syn) + +
Fc receptor - - - * - - *
C3b receptor - gc-i - - - - -
Virus exit +
*gE/gI may' form a functional complex (M.C.Frame, personal 
communication).
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The map location of genes encoding major components of 
the virus capsid, tegument and envelope are given in 
Figure 3.
5. GENOME STRUCTURE OF HSV
Detailed analysis of the DNA of HSV-1 and HSV-2 has
shown that a very close relationship exists between
these viruses. The genomes of both HSV-1 and HSV-2 are
linear, ds DNA molecules (Becker et al., 1968; Graham
6
et al♦, 1972) with a mw of 95-100 x 10 , representing 
approximately 155kbp (Kieff et al., 1971). A striking 
feature of HSV DNA is its very high guanosine and 
cytosine (G+C) content : 67% overall for HSV-1 and 69% 
for HSV-2 (Goodheart et al., 1968), although the 
distribution of G+C % residues is not uniform. For 
example, within the DNA sequence encoding the 
immediate-early (IE) polypeptide Vmwl75 there is an 
especially high G+C content of 81.5% (McGeoch et al., 
1986a).
The HSV genome (Figure 2) is composed of a long unique 
(Ul ) and a short unique (Us) segment, each bounded by 
inverted repeat sequences (Sheldrick and Berthelot, 
1974). At each terminus there is a direct repeat known 
as the a sequence, which is present in an inverted 
orientation at the L-S junction (Grafstrom et al.,
1974, 1975; Sheldrick and Berthelot, 1974; Wadsworth et 
al., 1975; Davison and Wilkie, 1981). As a consequence 
of this genome structure, the IJf^ and Ug components
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invert relative to the repeat sequences, producing a
population of virus genomes containing equimolar
amounts of four isomeric forms, referred to as P
(prototype), Is (Us inversion), II (UL inversion) and IcT
(U /U inversion) (Sheldrick and Berthelot, 1974;S L
Hayward et al., 1975; Clements et al., 1976; Delius and 
Clements, 1976) (Figure 4).
All the isomeric forms can replicate and produce viable 
progeny (Jenkins and Roizman, 1986). However, the 
ability to invert is not essential for virus growth, 
and non-inverting viable populations of HSV have been 
isolated (Preston et al., 1978; Davison and Wilkie,
1981; P*offenberger et al., 1983; Poffenberger and 
Roizman, 1985; Jenkins and Roizman, 1986).
A cis-acting signal for inversion has been identified 
within the a sequence of HSV. Evidence for this was 
derived from the observation that the insertion of an a 
sequence into UL caused additional inversions, and, 
consequently, the generation of novel genomic termini 
(Mocarski et al., 1980; Mocarski and Roizman, 1981; 
Smiley et al., 1981). Inversion of the fragment did 
not occur if it was flanked by a sequences present in 
the same orientation (Smiley et al., 1981), or if the a 
sequences on either side were heterotypic (Davison and 
Wilkie, 1983a)(See also Section 1.10.1).
Figure 4
Genome isomers of HSV
P = prototype orientation (details are given in Figure 
2)
lg = inversion of long region (Us)
3^  = inversion of short region (l^ )
IgL = inversion of short and long regions (Ug and UL )
/\ V/ /\
w cT r
c
CO
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5.1 Gene Layout in HSV
The complete DNA sequence of the HSV genome is now
available (McGeoch, 1985; McGeoch et al, 1985, 1986a.,
1986b., 1987, D. McGeoch, personal communication ) and
is estimated to be 152260 bp. The largest contiguous
published HSV sequence is the U region which is almost
s
13kbp long, and contains 12 genes (McGeoch et al.,
1985; Rixon and McGeoch, 1985). The polypeptide coding 
sequences are compactly arranged and comprise 79% of 
the sequence.
All the Us genes have separate promoters, but several 
share 3'termination sites, and one pair, Us 10 and Usll, 
have overlapping coding sequences in different reading 
frames. The promoter sequences of Us10 are also 
present within coding sequences of Usll (Rixon and 
McGeoch, 1984; McGeoch et al., 1985). Whilst none of 
these gene arrangements are restricted to , 
overlapping coding sequences are rare.
The overall (G+C%) content of U s is 64.3% (McGeoch et
al., 1985), which is considerably lower than that of
the adjacent TI^  /IRg sequence, which has an especially
high (G+C) content of 79.5% (McGeoch et al., 1986a).
The TR /IR region is 6.6kbp in length and encodes a 
s s
single gene, IE175. The a sequence is present at the 
3' end of this gene, and at the 5 ? end there is an 
origin of replication, termed orig, plus promoter
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sequences which are shared by the genes, IE68 and IE12, 
whose coding sequences are contained entirely within Us 
(Murchie and McGeoch, 1982; McGeoch et al., 1985,
1986a).
The presence of short, tandemly repeated sequences is a 
widespread feature of herpesvirus genomes (McGeoch , 
1985). Repeats of 12-54bp in length have been detected 
in the non-coding sequences of HSV-1 strain 17 (Murchie 
and McGeoch, 1982; Davison and Wilkie, 1981; Rixon et 
al., 1984; Perry et al., 1986; Chou and Roizman, 1986), 
and their copy number can vary considerably between 
different virus plaque isolates. Other short tandem 
repeats* have been located in the polypeptide coding
u s io
sequences of genes, for example, Us7^and U gll (Rixon 
and McGeoch, 1984; McGeoch et al., 1985).
5.2 Relatedness of HSV-1 and HSV-2
Hybridisation experiments by Kieff et al (1972) showed 
that there was a close relationship between the genomes 
of HSV-1 and HSV-2 since about 50% of the DNA sequences 
had strong homology. Subsequent electron microscope 
analysis of hybrid molecules of DNA (Kudler et al.,
1983) and cross-hybridisation studies (Davison and 
Wilkie, 1983b) revealed that the homologous regions of 
HSV-1 and HSV-2 were distributed throughout the genome. 
This conclusion was supported by genetic studies which 
showed that recombination (Timbury and Subak-Sharpe,
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1973; Halliburton et al. , 1977; Morse et al., 1977; 
Preston et al., 1978), and complementation (Timbury and 
Subak-Sharpe, 1973; Esparza et al., 1976; Schaffer et 
ajL. , 1978) between the serotypes can occur. Cross-over 
sites in the recombinants were detected across the 
whole of the genome.
The colinearity of HSV-1 and HSV-2 has also been 
confirmed through the sequence analysis of large 
regions of HSV DNA. Although the sequence data on 
HSV-2 is limited, the sequence spanning most of the 
HSV-2 Ug has been determined (Whitton and Clements, 
1984; McGeoch et al., 1987). A comparison of HSV-1 and 
HSV-2 U*s regions confirmed that they possessed 
equivalent genes, and that homology at the amino acid 
level is distributed throughout Ug . One noteable 
exception, however, is the gene Us4.
In HSV-1, U s4 encodes a glycoprotein, designated gG-1, 
with a MW of 25,000 (McGeoch et al., 1985; Frame et 
al., 1986a; Richman et al., 1986). In HSV-2, near the 
N-terminus, the Us4 coding sequence has an extra 1,460 
residues (McGeoch et al., 1987), and this gene 
specifies a 72,000 MW polypeptide. The finding that an 
oligopeptide antiserum raised against the HSV-2 gG 
amino acid sequences near to the C terminus (which are 
homologous to the HSV-1 sequence with the exception of 
a single amino acid), could immunoprecipitate gG-1,
-20-
confirmed that the HSV-2 Ug4-encoded polypeptide, 
designated gG-2, was the HSV-2 counterpart to gG-1 
(McGeoch et al., 1987).
5.3 Evolution of HSV-1 and HSV-2
The sequence analysis of the HSV-1 and HSV-2 genomes 
has enabled their divergent evolution to be studied. 
Within the Us sequence many single nucleotide 
differences have arisen between the viruses, presumably 
through point mutations occurring after divergence of 
HSV-1 and HSV-2 from a common ancestor (McGeoch et al., 
1987). These base pair changes are more extensive in 
non-coding than coding sequences. In coding regions 
the redundant third codon position has diverged most, 
whilst the second codon position is the more conserved 
(McGeoch et al., 1987). Nevertheless, many amino acid
alterations are tolerated in the U sequence, and this
s
characteristic is also apparent in genes located 
outside Ejg , for example, the HSV thymidine kinase (TK) 
gene (Swain and Galloway, 1983).
differences
Duplication and deletion between HSV-1 and
HSV-2 genomes have also been identified. Some of these 
differences have occurred in reiterated sequences,
resulting in different copy numbers of the repeated 
elements. Others have been found in non-reiterated 
sequences. One particularly interesting example, 
mentioned earlier, is gene 4 of HSV-2. The N
terminal region of this gene shares amino acid homology 
with PRV gX (McGeoch et al., 1987), and it may, 
therefore, represent an ancient alphaherpesvirus gene, 
present before divergence of PRV and HSV. It is 
proposed that the HSV-1 4 gene lost amino acid 
sequences after divergence of HSV-1 and HSV-2. Another 
remarkable feature of HSV-2 is that it has homology
at the amino acid level to gD of both HSV-1 and HSV-2, 
again at the N terminal region, indicating that gene 
duplication has occurred during the evolution of HSV.
HSV LYTIC CYCLE
The early stages of HSV infection can be divided into 
three distinct phases: attachment of the virion to the
cell, penetration of the cell, and uncoating of the 
viral genome.
Attachment
Attachment of HSV to the cell surface occurs very
rapidly after addition of the virus inoculum to the
cells (Hochberg and Becker, 1968) and can take place at
o o
temperatures ranging from 4 to 40 (Farnham and 
Newton, 1959). The action of heparin, a negatively 
charged polysaccharide which prevents the adsorption of 
virus to cells and causes the release of virus already 
attached to the cell surface suggests that initially the 
virus is bound to the cell by weak electrostatic forces 
(Hochberg and Becker, 1968). The subsequent
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reduction in cell surface protein mobility indicates 
that there is an increase in the strength of binding 
(Rosenthal et al. , 1984). This restriction in mobility 
is thought to be due to the cross-linking of cellular 
receptor proteins and cytoskeletal elements, and is 
similar to the effects of attachment of multivalent 
ligands to cell surface receptors (Gall and Edelman, 
1981; Henis and Elson, 1981). However, this is a 
temporary feature and protein mobility returns to 
normal upon viral penetration of the cell.
Several virus glycoproteins have been implicated in
attachment of the virus to the cell. A study using
*■ .
virosomes, lipid vesicles enriched with HSV-1 
glycoproteins, which bind to cells and may fuse with 
them, showed that gB and gD were important for this 
process (Johnson et al., 1984). When virosomes were 
depleted of gB or gD, there was a reduction in the 
number of virosomes binding to cells. Subsequent work 
by Fuller and Spear (1985) using a virion adsorption 
assay demonstrated that HSV-1 adsorption to cells was 
inhibited by antibodies to both gD and gC, or by the 
addition of high concentrations of the Fc portion of 
immunoglobulin G (IgG). This suggested that gD, gC and 
possibly gl (Johnson and Feenstra, 1987; M. Frame, 
personal communication) which is an Fc receptor protein 
complexing to gE (Baucke and Spear, 1979), participate 
in viral adsorption (Fuller and Spear, 1985).
Although gD is one of the major targets for virus
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neutralising antibodies (Para et al., 1985), strongly
neutralising anti-gD antibodies had little effect on 
adsorption even at high concentrations (Fuller and 
Spear, 1985). This implies that whilst viral 
neutralisation may prevent adsorption of virions to 
cells, it normally affects a later stage of infection, 
possibly virus penetration.
6.2 Penetration of the Cell Membrane
Penetration is a temperature dependent event (Farnham 
and Newton, 1959), during which the virus is thought to 
enter the cell by fusion of the virus envelope with the 
cellular plasma membrane (Morgan et al., 1968; Abodeely 
et al.,* 1970) rather than by viral phagoctyosis or 
viropexis (Dales and Silverberg, 1969). The results of 
Para et al. (1980) which demonstrated the movement of 
Fc binding receptors from the viral envelope to the 
cell membrane in the presence of clycoheximide supports 
the fusion model of virus entry, as does genetic 
evidence from HSV-1 mutants which are ts for production 
of gB. These viruses do not contain mature forms of gB 
in the virus envelope when grown at the NPT (Manservigi 
et al., 1977; Sarmiento et al., 1979; Little et al.,
1981), and although the virions produced at this 
temperature can bind to cells they are unable to 
penetrate the cell membrane. Exposure of virus-cell 
complexes to a fusion promoter, polyethylene glycol 
(PEG), enhanced infection at the NPT, suggesting that
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the envelope glycoprotein, gB, is essential for 
infection, and that penetration occurs by fusion of 
virus with the cell membrane (Sarmiento et al., 1979, 
Little et al., 1981).
The importance of gB has been examined further by means 
of tsB5, an HSV-1 mutant with a syn mutation, 
responsible for syncytial plaque morphology of this 
virus, and a ts lesion in the gene encoding gB (Haffey 
and Spear, 1980). The finding that tsB5 also has an 
accelerated rate of entry into the host cell in 
comparison with the WT HSV-1 KOS virus (DeLuca et al.,
1982) supported the idea that gB played a role in virus 
entry. * From the analysis of tsB5-KOS5 recombinants 
DeLuca et al. (1982) demonstrated that the DNA
sequences responsible for rate of entry of adsorbed 
virus were located between the syn and ts loci on the 
genome of tsB5, and that the three functions were 
encoded within the gene specifying gB (Figure 3). They 
may, therefore, represent functional domains of the gB 
gene. Subsequent work on tsl204, an HSV-1 mutant which 
has a ts lesion in a non-glycosylated polypeptide with 
a MW of 65,000, suggested that this gene product may 
also be involved in virus penetration, since this virus 
adsorbed to cells at the NPT, but failed to penetrate 
the cell membrane (Addison et al., 1984).
6.3 Uncoating of the Viral Genome
Early work indicated that degradation of the virus
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capsid occurred in the cytoplasm in the perinuclear 
region (Morgan et al., 1968; Miyamoto and Morgan,
1971), and that the viral DNA was rapidly transported 
to the nucleus (Hochberg and Becker, 1968; Hummeler et 
al., 1969; Miyamoto and Morgan, 1971).
Hochberg and Becker (1968) found that transport of the 
viral DNA from cytoplasm to nucleus was unaffected by 
RNA or protein synthesis inhibitors, suggesting that 
the virus utilises pre-existing cellular enzymes or 
virion proteins to release the viral DNA from the 
capsid. Miyamoto and Morgan (1971) on the other hand, 
found that treatment of cells with protein synthesis 
inhibitors prior to infection did have an effect, and 
concluded that protein synthesis was required for 
transport of viral DNA from the capsid to the cell 
nucleus. This contradiction has not yet been resolved.
Vernon et al. (1974) noted in electron microscopic 
studies that preparations of flattened capsid sheets 
had lost their pentamers, and Dargan (1986) has 
suggested that this might allow the exit of viral DNA 
from the capsid. An HSV-1 ts mutant, tsB7, which fails 
to uncoat at the NPT was used to analyse the uncoating 
process. At the NPT full virus capsids accumulated 
outside the nucleus next to the nuclear pore structures 
(Knipe et al., 1981; Batterson et al., 1983). On a 
temperature shift from the NPT to the PT, the viral DNA
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was released from the capsids. The proximity of 
capsids to the nuclear pores suggests that the viral 
DNA is actively transported through the nuclear pores 
into the nucleus.
6.4 The Effect of Virus Infection on the Host Cell 
Macromolecular Metabolism
In a productive lytic infection by HSV, the synthesis 
of host cell macromolecules is inhibited; the 
synthesis of both 45s and 4s rRNA, as well as the 
subsequent processing of 45s rRNA to 28s and 18s rRNA 
is severely reduced (Wagner and Roizman, 1969). Host 
tRNA synthesis, however, is unaffected. Although 
synthesis of most cellular genes transcribed by 
cellular polymerase II declines during virus infection, 
a few are transcriptionally "upregulated" (La Thangue 
et al., 1984; Kemp et al., 1986).
Stenberg and Pizer (1982) studied the inhibition of 
cellular gene transcription in an HSV infection of an 
adenovirus-transformed cell line, and proposed that HSV 
IE genes were responsible for the decrease in host RNA 
synthesis. This reduction in host RNA, together with 
the inhibition of cellular protein synthesis in the 
infected cell, then contributes to the decline in the 
synthesis of cellular DNA. However, even at late times 
infection, some cellular DNA synthesis can still be 
detected (Roizman and Roane, 1964).
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The inhibition of host polypeptide synthesis is a 
multistep process (Nishioka and Silverstein, 1977, 
1978b) and can be divided into two phases termed 
"early" and "delayed" shut off.
"Early" shut-off begins soon after infection, and is 
mediated by one or more structural components of the 
virion (Fenwick and Walker, 1978; Nishioka and 
Silverstein, 1978; Fenwick et al., 1979).
Disaggregation of host polyribosomes is responsible for 
the early suppression of cellular protein synthesis 
(Sydiskis and Roizman, 1966, 1967; Silverstein and 
Engelhardt, 1979). The polyribosomes are subsequently
t
reassembled, and the majority of mRNAs associated with 
these ribosomes are virus coded (Stringer et al.,
1977). In addition, inactivation of mRNAs (Fenwick and 
McMenamin, 1984) by degradation (Nishioka and 
Sliverstein, 1977, 1978a., 1978b; Inglis, 1982) also 
contributes to early shut-off of host protein 
synthesis. Whether or not the same structural protein 
is responsible for both processes is not known.
The rate of early shut-off of cellular protein 
synthesis mediated by HSV-2 is faster than that of 
HSV-1, although some strains of HSV-2, including HG52, 
are relatively poor at this function (Pereira et al., 
1977; Fenwick and Clarke, 1982; Fenwick and McMenamin, 
1984; Schek and Bachenheimer, 1985). This difference
between the two types of viruses has enabled the early
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host shut-off function to be located on the virus 
genome by analysis of HSV-l/HSV-2 recombinants. The 
locus was mapped within 0.52-0.59mu (Fenwick et al., 
1979). The host shut-off function has proved to be a 
non-essential property for virus growth in tissue 
culture since non-lethal mutants of HSV-1 with defects 
in the virion-associated suppression of protein 
synthesis have been isolated. These mutants are 
deficient in the ability to degrade mRNA (Stromm and 
Frenkel, 1987). It is not known, however, if these 
mutants are impaired in the ability to disaggregate 
ribosomes.
♦
Complete inhibition of host polypeptide synthesis 
(delayed shut-off) requires the expression of an early 
or late viral gene (Honess and Roizman, 1975b; Hill et 
al., 1983; Read and Frenkel, 1983; Schek and 
Bachenheimer, 1985). Since inhibition of protein 
synthesis is greater than might be accounted for by the 
effect of RNA metabolism, there may be additional 
factors required for full suppression. Fenwick and 
Walker (1979) have reported that a 48,000MW protein 
associated with ribosomes, was phosphorated during 
virion infection, and that the process required virus 
gene expression. Subsequently, Kennedy et al. (1981)
showed that the S6 protein of the small ribosomal 
subunit was phosphorylated, but it is not known whether 
this is the same protein described by Fenwick and
Walker (1979). It is intriguing to speculate that this 
modification to a ribosomal protein may affect 
translation of host proteins.
HSV TRANSCRIPTION 
Introduction
HSV transcription occurs in the infected cell nucleus 
(Wagner and Roizman, 1969) and is thought to be carried 
out by a cellular RNA polymerase II (polll), since at 
all stages of the lytic cycle HSV transcription is 
sensitive to inhibition by oC-amanitin (Alwine et al. , 
1974; Ben Ze'ev et al., 1976; Costanzo et al., 1977). 
The fact that the first viral gene transcripts, the 
immediate early (IE) mRNAs, are made in the absence of 
viral protein synthesis (Honess and Roizman, 1974,
1975; Clements et al., 1977; Watson et aJL. , 1979), 
together with the observation that naked viral DNA is 
infectious (Graham et al., 1973), strongly suggests 
that the very early stages of transcription are 
probably carried out by an unmodified host polll. It 
is possible, though unlikely, that modification of the 
host polll takes place later in infection (Ben Ze’ev et 
al., 1976), or that a new RNA polymerase might be 
synthesised.
Transcript Processing
Cellular and viral genes share a number of properties
1. Polyadenylation at the mRNA 3' termini which is
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dependent on the consensus signal 'AATAAA'
(Bachenheimer and Roizman, 1972; Silverstein et al., 
1976; Proudfoot and Brownlee, 1976; Cole and 
Santangelo, 1983).
2. A 'G-T'-rich sequence (Consenus YGTGTTYY-3') 
approximately 30bp downstream from the poly-A signal, 
which is necessary for the efficient formation of 3' 
termini of gene transcripts (Taya et al., 1982; 
McLauchlan et al., 1985; Whitton et al, 1983; Cole and 
Stacey, 1985).
3. The 'TATA-box' homology located close to the 5' 
end of most eukaryotic genes (Gannon et al., 1979), and 
all the HSV genes so far sequenced (McGeoch et al., 
1985, 1*986). This is important for the efficient and 
accurate initiation of transcription.
4. A 51 terminus mRNA 'cap', consisting of 7-methyl 
guanosine triphosphate residues (7MeG), added by a
5'-5' linkage. The cap structure is important for 
efficient translation (Shatkin, 1976) and may protect 
the mRNA against phosphatase and nuclease action (Moss 
et al. , 1977). Methylation of internal adenine 
residues (6MeA) also takes place in both viral and 
cellular mRNA although late viral mRNAs are reported to 
be deficient in 6MeA (Bartkoski and Roizman, 1976; Moss 
et al., 1977).
7.2 Splicing
HSV has very few spliced genes. These include IE68 and
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IE12 genes (Watson et al., 1981; Watson and 
Vaude-Woude, 1982; Rixon and Clements, 1982; Murchie 
and McGeoch, 1982) (Figure 5) which have single introns 
in the 5' noncoding sequences. In contrast, IE110 
contains two introns located in the coding sequences of 
the gene (Watson et al., 1979; Perry et al., 1986). 
There is also a spliced late viral transcript of 2.7kb 
(at approximately 0.2mu) which has a particularly large 
intron of 4kb (Costa et al., 1985).
7.3 Temporal Regulation of HSV Transcription
In a normal lytic cycle, HSV transcription is a 
temporally regulated process which can be separated 
into th'ree stages known as the IE, early (E) and late 
(L) phases, alternatively the oC, p and phases 
(Swanstrom and Wagner, 1974; Honess and Roizman, 1974, 
1975; Clements et al., 1977; Jones and Roizman, 1979). 
On the basis of inhibitor and kinetic studies a 
"cascade model" of gene regulation was proposed by 
Honess and Roizman (1974, 1975), however, more recent 
work has demonstrated that the process and control of 
sequential HSV gene regulation is far more complex than 
was originally envisaged.
7.4 Nomenclature of IE Genes and IE Polypeptides 
Several different nomenclatures have been proposed for 
the IE genes and their protein products (see also 
Figure 5). However, in this thesis they will be
Figure 5
The map locations of HSV-1 IE mRNA transcripts
IE genes are termed IE110, IE63, IE175, IE68 and IE12 
or alternatively the nomenclature is IE1, 2, 3, 4 and 5 
respectively.
The sizes of protein products by SDS-PAGE and 
sequencing are:
IE gene_____SDS-PAGE( mwx-iQ Q Qfl_______ Sequencing Data(mw)
110 11*0 78,452
63 63 55,376
175 175 132,835
68 68 46,522
12 12 9,792
References are given in the text.
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referred to solely in terms of their sizes on SDS-PAGE. 
Thus, for example, the gene IE175, and its protein 
product, Vmwl75.
7.5 Immediate Early Genes
The IE genes are defined as those which are transcribed 
very early in a normal lytic infection, and in the 
absence of de novo viral protein synthesis as 
demonstrated by the addition of inhibitors such as 
cycloheximide or anisomycin from the time of infection 
(Honess and Roizman, 1974; Clements et al., 1977; Jones 
and Roizman, 1979; Harris Hamilton and Bachenheimer,
1985).
t
The IE genes are located within or close to the repeat 
sequences of HSV (Figure 5). The IE polypeptides range 
in predicted size from 12,000 to 175,000 MW as 
estimated by electrophoresis on SDS-polyacrylamide gels 
and this correlates roughly with the predicted MW as 
determined by DNA sequencing of the IE genes. This 
information is summarised in Figure 5 (Clements et al., 
1979; Watson et al., 1979, 1981; Watson and 
Vande-Woude, 1982; Whitton et al♦, 1983; McGeoch et 
al., 1985, 1986; Perry et al., 1986). Apart from 
Vmwl2, all the IE polypeptides are phosphorylated and 
bind to DNA (Marsden et al., 1976; Pereira et al.,
1977; Hay and Hay, 1980).
-33-
IE175 is present as two copies on the genome (Rixon et 
ad, 1982; McGeoch et al., 1986a.), and the gene product 
(Vmwl75) is essential for the transcription of early 
and late genes. The DNA binding properties of Vmwl75 
were lost on extensive purification of this 
polypeptide, but could be restored by the addition of 
uninfected cell extracts, indicating that direct 
binding of Vmwl75 to DNA was unlikely (Freeman and 
Powell, 1982). In further work, Vwml75 which had been 
only partially purified, was found to form a complex 
with DNA at sequences upstream of the gD promoter and 
in pBR322 (Faber and Wilcox, 1986; Beard et al., 1986). 
This work has led to the description of a consensus 
sequence for Vmwl75-DNA binding (5' ATCGTCNNNYCGRC-3': 
N=any base; Y=pyrimidine R=purine)(Faber and Wilcox, 
1986). Recently, Muller (1987) showed that extracts of 
HSV-1 infected cells contain proteins which form a 
complex with DNA fragments that contain the IE175 cap 
site and sequences fitting the consensus. Furthermore, 
Vmwl75 is a component of this complex. However,
Kristie and Roizman (1986b.) have demonstrated the 
binding of Vmwl75 to different DNA sequences in IE 
promoters, and at upstream sequences in IE175. The 
reason for these differences is unclear at the present 
time.
IE110, like IE175, is a diploid gene, but is not
essential for virus growth in tissue culture (Stow and
-34-
Stow, 1986). VmwllO and the products of the unique 
genes IE63 and IE12, Vmw63 and Vmwl2, have been 
implicated in the trans-activation of early and late 
genes (O'Hare and Hayward, 1985a., 1985b.; Sacks et 
al., 1985; Everett, 1986). However, IE12, as well as 
IE68, is a non-essential gene (Post and Roizman, 1981; 
Sears et al♦, 1985; Longnecker and Roizman, 1986) in cells
7.5.1 IE Promoters and Regulation
The basal level of transcription from IE gene promoters 
is detectable even in the absence of trans-activation. 
Using a recombinant plasmid where the coding sequence 
of a gene with an easily assayed product is placed 
under H*E control, the basal levels of transcription 
have been studied by cell transformation assays and in 
transient expression assay systems. The virus TK and 
the bacterial plasmid chloramphenicol acetyl 
transferase genes have been particularly useful in this 
work (Wigler et al., 1977; Kit et al., 1978; Post et 
al., 1981; Mackem and Roizman, 1982a.; Cordingley et 
al., 1983). Analysis of IE gene promoter and
regulatory regions has thus been carried out by 
deletions of the promoter sequences, revealing a number 
of different upstream sequence elements (Figure 6). In 
the case of the IE175 gene, the TATA box homology is 
present at approximately 30bp from the mRNA start site.
A proximal promoter region which contains Spl binding 
sites is located between -38 and -108bp (Jones and 
Tjian, 1985) and within this region is an element whose
Figure 6
The upstream noncoding promoter sequences of immediate 
early, early and late genes 
Details are given in the text 
From Johnson and Everett (1986b).
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deletion abolishes transcription of the IE gene 
(Cordingley et al., 1983). Enhancer-like sequences 
have been identified in IE175, so termed because they 
can function in either orientation at a distance of up 
to l,300bp from the promoter, and because they exhibit 
some host specifity (Cordingley et al., 1983; Preston 
and Tannahill, 1984; Lang et a_l. , 1984; Bzik and 
Preston, 1986). In addition, there is a regulatory 
element with a conserved ’AT'-rich sequence (consensus 
TAATGARATTC, where R is a purine) present far upstream 
of all HSV-1 and HSV-2 IE genes (Mackem and Roizman, 
1982a, 1982b; Cordingley et al., 1983; Whitton et al., 
1983; Whitton and Clements, 1984). This region is 
responsive to trans-activation of IE transcription.
7.5.2 Negative Regulation of IE Gene Expression
All IE polypeptides are made very early in infection 
and their synthesis declines at early and late times 
(Honess and Roizman, 1974, 1975; Clements et al.,
1977). Initially it was proposed that early gene 
products were responsible for the "switch-off" of IE 
synthesis (Honess and Roizman, 1974), and this theory 
was supported by Read and Frenkel (1983) who identified 
a structural protein which both inhibited host protein 
synthesis and affected IE mRNA stability. However, 
studies on tsK, which is an HSV—1 mutant which has a ts 
lesion in IE175 gene (Preston, 1979a, 1979b), suggested 
that IE synthesis was autoregulated at the level of
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transcription. When tsK-infected cells were 
transferred from the PT to the NPT in the presence of 
cycloheximide, early and late mRNA synthesis declined, 
and IE transcripts were overproduced, implying that 
functional Vmwl75 plays a role in the suppression of IE 
mRNA synthesis (Preston, 1979a; Dixon and Schaffer, 
1980; Watson and Clements, 1980).
DeLuca and Schaffer (1985) also demonstrated Vmwl75 
involvement in IE gene regulation with a transient 
expression assay system where low levels of Vmwl75 were 
found to stimulate expression from the IE68/12 
promoter, whilst at high concentrations of Vmwl75, 
negative regulation of transcription was detected. The 
effect of Vmwl75 on transcription from an IE175-CAT 
gene construct was studied by 0 1 Hare and Hayward 
(1985b), and the polypeptide was shown to have a 
consistently negative effect. These workers also 
demonstrated that the stimulation induced in the 
IE175-CAT plasmid by VmwllO (another IE polypeptide), 
could be inhibited by the addition of Vmwl75, and 
proposed that this was due to the dominant negative 
regulation by Vmwl75 over VmwllO-stimulation of the 
plasmid construct. However, this result may also be 
explained as the negative regulation of IE110 by Vmwl75 
(O'Hare and Hayward, 1985b).
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The autoregulation of IE175 could be mediated by the 
binding of Vmwl75 to negatively regulating sequences at 
the IE175 mRNA cap site, as suggested in recent work by 
Muller (1987), or alternatively by the removal, 
inhibition or inactivation of a cellular factor 
essential for activation of the IE promoter, in which 
case an apparent "down-regulation" of IE175 
transcription would result. It should also be noted 
that whilst VmwllO has only been implicated in a 
stimulatory role, IE polypeptides apart from Vmwl75 may 
be involved in some way in the repression of IE gene 
expression.
Sacks et al (1985) have shown that viruses which 
contain ts mutants within IE63 overproduce IE 
polypeptides at the NPT, and it is possible that a late 
gene product required for IE gene regulation is not 
synthesised at the NPT by these viruses. This suggests 
that Vmw63 may be involved, indirectly, in the 
regulation of IE gene transcription.
7.5.3 Trans-activation of IE Genes
Trans-activation of IE genes was first demonstrated by 
Post et al (1981). These workers converted the early 
gene for TK into an IE-regulated gene by inserting 
IE175 promoter sequences upstream of the TK coding 
sequence. Transfection of TK or IE-TK constructs into 
LTK cells resulted in the expression of TK at similar
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basal levels. On superinfection of the transformed 
cells with a TK virus, expression of normal TK was 
stimulated 2-3 fold by 6-8h pi. However, expression of 
IE-TK was enhanced within 2-3h pi, and by 6-8h pi 
expression was 5-10 fold greater than the basal level.
Further experiments demonstrated that stimulation of 
IE-TK by superinfecting virus was unaffected by the 
presence of cycloheximide, and this suggested, 
therefore, that a component affecting IE 
trans-activation was present in the HSV particle (Post
et al♦, 1981). This phenomenon has been demonstrated
in vitro using a transient expression assay system 
(Mackem and Roizman, 1982b; Cordingley et al., 1983; 
Preston et al., 1984), and the virion component has 
since been identified as a 65,000 MW structural 
polypeptide, located in the virus tegument (Campbell et 
al., 1984).
The process of IE gene trans-activation is thought to 
be required by the virus as a means of increasing the 
efficiency of the round of virus infection and
replication. Thus, this represents an important field 
of study, and it has been the basis of much of the work
in this thesis. The subject of IE trans-activation and
the studies resulting from the work of Post et al 
(1981) will, therefore, be discussed in more detail in 
Section 4.
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7 •6 Early Gene Transcription and Regulation
Early genes are transcribed after the IE genes and in 
the presence of inhibitors of viral DNA synthesis, such 
as cytosine arabinoside (araC) or phosphonoacetic acid 
(PAA) (Honess and Roizman, 1974, 1975), but require the 
presence of functional IE polypeptides for their 
transcription (Swanstrom and Wagner, 1974; Swanstrom et 
al., 1975; Clements et al., 1977; Harris-Hamilton and 
Bachenheimer, 1985). The early class of polypeptides 
includes many enzymes, and also some structural 
proteins, for example, gD (Watson et al., 1983).
Early gene transcripts can be detected in HSV-1
o
infecte'd BHK cells, at 37 , from 2h pi, and increase in 
abundance until 6-8h pi. At this point the level of 
most early mRNAs declines, although some individual 
mRNAs continue to be synthesised until much later in 
infection (McLauchlan and Clements, 1982; Sharp et al., 
1983; Johnson and Spear, 1984; Harris-Hamilton and 
Bachenheimer, 1985).
7.6.1 Cis-actinq Regulatory Sequences of Early Genes
Early genes such as the viral TK exhibit a basal 
promoter activity which can be detected both in cells 
where the HSV TK gene is integrated into the host 
chromosom (Wigler et al., 1977; Maitland and McDougall, 
1977; Minson et al., 1978) and on the microinjection of 
Xenopus Laevis oocytes, where functional TK is produced
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(McKnight and Gavis, 1980; Cordingley and Preston, 
1981). Thus, it is possible to define the control 
elements responsible for constitutive transcription of 
a typical early gene such as TK. The results from the 
analysis of the TK gene have located at least three 
important regulatory domains in the 5 ’ noncoding 
sequences of this gene (McKnight et al., 1981; McKnight 
and Kingsbury, 1982). These domains were identified 
through the production of linker scanning (L-S) mutants 
(McKnight and Kingsbury, 1982). Mutations were 
engineered into the TK gene by the recombination of 5' 
and 3' deletion mutants of the gene, whose termini were 
separated by 10 nucleotide residues. The 10
t
nucleotides were substituted by linker sequences and 
clusters of base substitutions were therefore inserted 
across the gene.
Three promoter regulatory regions were identified by 
this means: (1) the proximal signal or TATA box
homology located between -16 and -37bp; (2) a distal
signal, dsl, at -47 to -79bp; (3), a distal signal 
dsll, located between -84 and -104bp upstream from the 
start of the coding sequences (McKnight, 1980, 1982). 
The distal signals each have a GC-rich hexanucleotide 
sequence (McKnight and Kingsbury, 1982; McKnight et 
al. , 1984) which are functionally related and operate 
in a mutually dependent manner (McKnight et al., 1981; 
McKnight, 1982). In addition, dsll contains an
-41-
inverted *CCAAT1 pentanucleotide, which, like the 
GC-sequences, is responsive to transcriptional 
stimulation by cellular transcription factors (see also 
Section 8.5).
7.6.2 Early Gene Trans-activation
A number of viral gene products have been identified as 
trans-activators of early gene transcription.
Vmwl75 is essential throughout infection for the 
transcription of both E and L genes, and the basis of 
this dependence has been investigated in several ways. 
It has been demonstrated that ts mutants of HSV-1, such 
as tsK,* which have a lesion in IE175, fail to process 
functional Vmwl75 at the NPT, or to transcribe E genes, 
but overproduce IE transcripts (Preston, 1979a, 1979b; 
Watson and Clements, 1980). On temperature shiftdown 
to the PT in the presence of cycloheximide, E gene 
transcription proceeds, whilst a shift back to the NPT 
causes E gene transcription to cease, and IE 
transcription to recommence (Preston, 1979a., 1979b; 
Watson and Clements, 1980).
Alternatively, stably transformed cell lines which 
constitutively express Vmwl75 have been produced.
These stimulate early gene expression from 
superinfecting virus in the presence of CHX (Davidson 
and Stow, 1985; Persson et al., 1985). In addition,
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early genes resident in transformed cells can be 
trans-activated by IE polypeptides expressed from a 
superinfecting virus (Leiden et al. , 1976;
Sandri-Goldin et al. , 1983).
Another approach to the study of E gene promoter 
trans-activation is the use of a transient expression 
assay system, by which the promoters of the early 
genes, gD (Everett, 1983, 1984a, 1984b), TK (O'Hare and 
Hayward, 1985a, 1985b; Gelman and Silverstein, 1985,
1986), and the major DNA binding protein (MDBP) of 
HSV-1 (Quinlan and Knipe, 1985) have been analysed. In 
all cases, expression of the early genes was stimulated 
by cotransfection with plasmids which expressed 
functional Vmwl75.
Transfection studies have also demonstrated that an 
independent role exists for VmwllO in the 
trans-activation of early genes (O'Hare and Hayward, 
1985a, 1985b; Everett, 1984a, 1985; Gelman and 
Silverstein, 1985; Quinlan and Knipe, 1985). The 
effect of this trans-activation varied considerably in 
different experiments, and this is thought to be due to 
differences between gene promoters, the various cell 
types and the assay systems which have been used 
(Everett, 1986).
Interestingly, the cotransfection of plasmids
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expressing Vmwl75 and VmwllO resulted in an enhancement 
of the trans-activation of early promoters to a level 
considerably greater than the sum of trans-activation 
by Vmwl75 or VmwllO alone (Everett, 1985, 1986; Gelman 
and Silverstein, 1985, 1986). In some cases, this 
stimulation appears to be augmented further by the 
addition of Vmwl2 (O'Hare and Hayward, 1985b).
Gelman and Silverstein (1986) have suggested that the 
synergistic effect of Vmwl75/Vmwll0 co-stimulation may 
be the result of an interaction between the two 
proteins to regulate early gene expression. The 
existence of a tight protein complex has been excluded, 
since antisera to Vmwl75 or VmwllO will only 
immunoprecipitate their respective proteins (Metzler 
and Wilcox, 1985), however, this does not rule out a 
weak association between these polypeptides. 
Alternatively, either or both IE proteins might modify 
the host polll, or interact with cellular transcription 
factors to stimulate E gene expression.
A number of workers have studied E gene promoter 
mutants, but have been unable to identify any specific 
promoter region which is essential for trans-activation 
(Everett, 1984b; Eisenberg et al., 1985). However, 
using L-S mutants of the TK promoter, Coen et al.,
(1986) have shown that the upstream TK sequences which 
are sensitive to base substitutions are those which are
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important for recognition by cellular transcription 
factors. Thus, the evidence suggests that 
trans-activation of E genes by IE gene products may 
occur through an interaction with cellular factors 
which recognise promoter elements.
7.7 Late Gene Transcription and Regulation
Late genes can be broadly defined as those whose 
expression is significantly reduced in the presence of 
inhibitors of viral DNA synthesis such as PAA and ara-C 
(Honess and Roizman, 1974, 1975; Swanstrom et al.,
1975; Clements et al. , 1977). Two groups of late genes 
have been identified within this general description; 
these dre known as leaky-late ( ,  oryS^ ) and true late 
( ^ o r  ^ ) genes (Holland et al., 1980; Johnson and 
Everett, 1986a.).
, gene transcripts are easily detectable prior to 
DNA synthesis, whereas mRNAs are present only in 
very small amounts early in infection, at about 5% of 
the levels detectable after viral DNA synthesis 
(Holland et al., 1980; Johnson and Everett, 1986b.; 
Johnson et al♦, 1986).
Recent work on the promoter regions of a true late
gene, U 11, which encodes a polypeptide Vmw21 (Rixon 
s
and McGeoch, 1984; Johnson and Everett, 1986a., 1986b.;
Johnson et al., 1986) has shown that late genes do not
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possess any detectable upstream sequences which are 
responsible for the late pattern of regulation (Johnson 
and Everett, 1986b). In these experiments, the 
plasmid-borne U^ll gene promoter was first shown to be 
regulated as a late gene in a transient expression 
assay in the presence of origin of replication (orig ) 
sequences (Johnson and Everett, 1986a). Deletion 
analysis of the promoter sequences then showed that all 
the required DNA sequence elements were located within 
31bp of the mRNA cap site, that is, the cap site and 
TATA box homology alone (Johnson and Everett, 1986b) 
(Figure 6). These results were confirmed by the 
observation that the early gene gD, was converted to a 
gene with late-regulation by the removal of promoter 
sequences upstream from the TATA box (Johnson and 
Everett, 1986b).
In addition, Homa et al (1986) have shown that the late 
gene, gC, has similar structural requirements to Ugll, 
suggesting that late genes are characterised by the 
absence of promoter elements upstream from the TATA 
box. These findings support the theory that late genes 
have weak promoters, and that viral DNA replication 
enhances the copy number of the genes, as has been 
proposed for SV40 late gene regulation (Rio et al.,
1980; Tjian, 1981; Keller and Alwine, 1984). However, 
if this were solely the case, the expression of E genes 
would also be expected to increase dramatically on
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viral DNA replication. This anomaly may be explained 
by:
1. A requirement by early genes for a transcription 
factor which is present in the cell in rate 
limiting amounts, or which is unstable at late 
times in infection.
2. An E mRNA instability at late times.
3. The negative regulation of E gene transcription at 
late times in infection.
Studies on late gene expression using transient assay 
systems have shown that Vmwl75 and VmwllO play an 
important role in late gene trans-activation 
(Mavromara-Nazos et al., 1986b; DeLuca and Schaffer, 
1985; Silver and Roizman, 1985). These experiments, 
together with the work of Johnson and Everett (1986b) 
implies that the TATA box and cap site alone may fulfil 
the requirement for trans-activation of late genes by 
Vmwl75 and VmwllO. Other gene products which have been 
implicated in the regulation of gene expression include 
Vmw63, since ts mutants with lesions in this gene were 
found to make reduced amounts of L proteins at the NPT 
(Sacks et al., 1985), although there was no block to 
viral DNA synthesis in these mutants.
The HSV major DNA binding protein (ICP8) (Powell and 
Purifoy, 1976, 1977; Knipe et al., 1982) has been shown 
to repress expression of the late gene gC, in the
absence of DNA replication (Godowski and Knipe, 1985). 
Mutants of HSV-1 with a ts lesion in ICP8 made 
increased amounts of gC at the NPT compared with WT 
virus which was treated with PAA. However, the amount 
of gC synthesised in the ts mutant-infected cells under 
these conditions was still approximately 10-fold less 
than that produced late in infection in WT virus cells 
in the absence of a viral DNA synthesis inhibitor 
(Godowski and Knipe, 1985).
CELLULAR TRANSCRIPTION FACTORS
The analysis of eukaryotic gene promoters has led to
the identification of a number of sequence elements
*
located upstream from the normal transcriptional start 
site which have important roles in the initiation of 
polll transcription.
The TATA box (Benoist and Chambon, 1981).
Promoter motifs, which may be gene specific, for 
example for the metallothionein metal response element 
(Karin et al., 1984) and the heat shock regulatory 
sequence (Pelham, 1982), or general, such as the GC 
hexanucleotide, or 'CCAAT'-box (Benoist et al., 1980; 
Efstratiadis et al., 1980).
Enhancers, which vary in their specificity (Banerji et 
al., 1981; Gruss et al., 1981; Moreau et al., 1981; 
Fromm and Berg, 1982).
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Recent studies on transcriptional control have focused 
on polypeptides which bind to DNA sequences.
8.1 The Identification of Cellular Factors
In vitro initiation of transcription by polll was first 
demonstrated with crude cell extracts (Manley et al., 
1980; Handa et al., 1981; Dignam et al., 1983), and the 
subsequent fractionation of these extracts resulted in 
the identification of a number of cellular 
transcription factors. Certain factors were found to 
be required for transcription of all genes tested 
(Matsui et al., 1980; Samuels et al., 1982) whilst 
others exhibited promoter specificity (Dynan and Tjian, 
1983a;*Sawadogo and Roeder, 1985b; Jones et al., 1985). 
Using dimethylsulphate methylation and DNasel 
protection studies (Dynan and Tjian, 1983b; Gidoni et 
al., 1985) several of these proteins were shown to bind 
specifically to discrete DNA sequences, such as the 
GC-hexanucleotide box.
8.2 Spl
Cellular transcription factor Spl was first identified 
in HeLa cells (Dynan and Tjian, 1983a), and found to be 
essential for SV40 early gene transcription. Its 
recognition sequence, 5'GGGCGG31, is present in the 
SV40 early gene promoter as six tandem repeats within 
three 21bp repeat sequences (Figure 7), and up to 5 Spl 
subunits can bind to these at any one time (Dynan and 
Tjian, 1983b., 1985; Gidoni et al., 1985).
Figure 7
Viral promoter elements and cellular transcription 
factors
A. SV40 Control region
ORI represents SV40 origin of replication sequences. 
Open rectangles represent ; (AT) the TATA-like element, 
and (GC), six 'GC' hexanucleotides (Spl binding sites). 
GC-boxes are underscored by horizontal arrows. Two 
open boxes represent 72bp repeats which contain 
cis-acting elements for enhancers and late promoter 
activity. The direction of mRNA transcription is 
represented by arrows. Open triangles represent a 
protomer of Spl. * The thickness of curved arrows from 
Spl represent different affinities of individual ’GC’ 
hexanucleotides for Spl binding.
B . HSV: cis-acting control elements in the TK 
promoter
These include the proximal region (TATA box), distal 
signal I (dsl) and distal signal II (dsll). 
Transcription is represented by an arrow. dsl and 
dsll contain a ’GC' hexanucleotide represented by 
an open box and inverted horizontal arrows. dsll 
also contains 'CCAAT' homology represented by an 
open ellipse. An Spl protomer is represented by an 
open triangle, and the number of arrows to the dsll 
'G C ' box represents greater affinity of binding to the 
dsll ’G C ' hexanucleotide. A protomer of CTF is 
represented by a closed triangle which is bound to a 
functional 'CCAAT'-box in dsll.
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Since its initial detection in the SV40 early gene
promoter the Spl recognition sequence has been
identified in a variety of other gene promoters. These
include, for example, the mouse hypoxanthine
phosporibosyl transferase (Melton et al., 1984), human
adenosine deaminase (Valerio et al., 1985) the HIV
terminal repeat (Ratner et al., 1985; Wain Hobson et
al♦, 1985; Jones et al., 1986) and the HSV IE and TK
promoters (see also Section 1.8.5) (Jones et al., 1985;
Jones and Tjian, 1985; Kadonaga et al., 1986). The
hexanucleotide core is present at all binding sites,
however further analysis has shown that binding of the
promoter to DNA is not dependent on the orientation of
the hexanucleotide (Everett et al., 1983; Gidoni et
al. , 1985), and the affinity of the Spl molecule is
affected by sequences adjacent to the GC core. A lObp
consensus sequence which is probably required for
competent binding of an Spl protomer, has therefore
been derived from the known Spl-binding sequences as
5 'GGGGCGGGGG31(Kadonaga et al. , 1986). Efficient
T AAT
binding of Spl to this sequence can increase the rate 
of gene transcription by 10 to 50 fold.
8.3 CCAAT Transcription Factor (CTF)/CCAAT Binding Protein 
( CBP)
Two similar proteins, CTF (Jones et al., 1985) and CBP 
(Graves et al., 1986) which bind to a domain specified 
by 5'CCAAT 3 ’, have been isolated from HeLa cells and
liver nuclei, respectively. It is not yet clear if
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these are the equivalent proteins of different cell 
systems, since whilst both bind to the 5'CCAAT 3' 
sequence, they differ in a number of properties. For 
example, CBP is heat stable in comparison with CTF 
(McKnight and Tjian, 1986), and can bind to altered 
CCAAT sequences. Furthermore, their DNase footprinting 
patterns in the HSV TK gene are slightly different.
They may, therefore, be two different gene products 
which are simply related in their ability to bind 
specific DNA sequences (McKnight and Tjian, 1986).
CTF has been compared with nuclear factor-1 (NF-1), a 
cellular polypeptide required for the initiation of 
adenovirus DNA replication (Nagata et al., 1982; Hay, 
1985). On purification, NF-1 and CTF (Rosenfeld and 
Kelly, 1986) appeared to be identical, and it is now 
thought that there may be a single protein factor with 
the ability to function both as a replication and 
transcription factor (Jones et al., 1987).
8.4 Upstream Stimulatory Factor (USF), TFIIB, TFIID, TFIIE 
At least three different protein factors, TFIIB, TFIID 
and TFIIE plus RNA polll have been shown to be required 
for initiation of transcription of the adenovirus major 
late (ML) promoter in vitro (Sawadogo and Roeder, 
1985a). A further protein, the upstream stimulatory 
factor (USF), has also been identified in uninfected
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HeLa cells, and this appears to increase transcription 
efficiency by simultaneous interaction with TFIID on 
the adenovirus ML promoter upstream sequences (Sawadogo 
and Roeder, 1985b).
8.5 The Action of Cellular Protein Factors on HSV Gene 
Transcription
Spl binds to at least eight different regions within 
the HSV TRg, and can stimulate transcription from 
IE175, IE68 and IE12 genes by up to twenty-five fold 
(Jones and Tjian, 1985; Jones et al., 1985), although 
the individual Spl sites in the IE175 promoter 
stimulate transcription to quite varying degrees. The 
IE175 upstream region also contains sequences which 
respond specifically to trans-activation by Vmw65 (Bzik 
and Preston, 1986). Vmw65, which does not bind 
directly to DNA (Marsden et al., 1987) is believed to 
affect transcriptional stimulation by means of a 
cellular protein-Vmw65 sequence-specific DNA binding 
complex, and this will be discussed in more detail in 
Section 4.
Cellular transcription factor binding sequences have 
also been identified in the HSV TK promoter. This 
early gene promoter is composed of 3 elements which 
affect transcription; the TATA box, and two distal 
elements, dsl and dsll (Figure 7), both of which have a 
single GC box which is inverted in dsl (McKnight et
al•, 1981; McKnight and Kingsbury, 1982; McKnight et
al., 1984). Both GC-rich hexanucleotides function as 
Spl binding sites (Jones et al., 1985), but dsl is much 
weaker than dsll (McKnight and Kingsbury, 1982). This 
difference in affinity for Spl may be explained by the 
change of a single nucleotide in dsl which disrupts the 
consensus outside the basic GC box: 5'GGGGCGGCGC3', 
whilst dsll maintains the consensus sequence (Kadonaga 
et al., 1986; Jones et al. , 1985).
In addition to the Spl site, dsll, unlike dsl, has 2 
possible, adjacent 'CCAAT'-boxes (Figure 7). One of 
these is in the usual orientation at -81 to -77bp 
upstreaVn, and contains a single base mismatch (CGAAT). 
However, the disruption of this element has little 
effect on TK promoter activity. The second site is a 
perfect 'CCAAT'-box (-82 to -86bp), but is in an 
inverted orientation (Graves et al., 1986). Mutation 
of this CCAAT-box results in a reduced efficiency of TK 
transcription both in vitro and in vivo (Jones et al., 
1985). Transcription of TK, therefore, may be 
dependent on Spl and CTF/CBP acting separately or in 
concert; however, it appears that independently 
neither factor may be entirely sufficient for efficient 
expression of TK (McKnight and Tjian, 1986).
VIRAL DNA SYNTHESIS
Semiconservative viral DNA synthesis takes place in the 
infected cell nucleus (Munk and Sauer, 1964; Roizman,
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o
1969). Replication of HSV-2 strain HG52 at 37 can be 
detected in BHK cells by 3h pi, reaching a maximal rate 
within 9-llh pi (Rixon, 1977), and similar results have 
been reported for HSV-1 strain <>C(Wilkie, 1973). Only 
a small proportion (<5%) of input HSV genomes are 
replicated, whereas 70-80% of parental PRV genomes 
participate in DNA synthesis (Jacob and Roizman, 1977; 
Ben-Porat et al., 1976a.). During replication nicks 
and gaps of unknown function which are present within 
the DNA are repaired (Wilkie, 1973; Frenkel and 
Roizman, 1972; Ben Porat et al., 1976b.). Viral DNA 
also contains short stretches of ribonucleotides 
(Biswal et a_l. , 1974), however, it is not known whether 
such ribonucleotides can act as primers for 
discontinuous synthesis of the DNA.
The precise details concerning viral DNA replication 
have not yet been fully elucidated. Electron 
microscope studies on viral DNA suggested that the 
linear genome circularises early in infection (Jean and 
Ben-Porat, 1976; Jacob and Roizman, 1977; Ben-Porat and 
Veach, 1980) and the restriction endonuclease analysis 
of a population of a non-inverting HSV-1 mutant with 
lacked an internal a sequence and most of the IR /IR
La. O
confirmed and extended these observations (Poffenberger 
et al., 1983; Poffenberger and Roizman, 1985). In 
these experiments, it was found that the viral genome 
circularised in the absence of viral protein synthesis,
-54-
indicating that a host enzyme or a virion protein was 
responsible for this process. In addition, the 
discovery that the circularisation process occurred 
very rapidly, together with the finding that a small 
proportion of virion genomes were circular, suggested 
that HSV genome termini are available for immediate 
ligation (Poffenberger and Roizman, 1985).
Although HSV DNA has terminally redundant ends 
(Grafstrom et al., 1974; Sheldrick and Berthelot, 1974; 
Wadsworth et al., 1975), sequence analysis of the 
termini and joint regions indicates that the DNA 
probably circularises by direct ligation of its termini 
(Davison and Wilkie, 1983) rather than by the base 
pairing of exposed complementary sequences as was 
originally proposed (Jacob and Roizman, 1977). The PRV 
genome, which has unique ends, is also thought to 
circularise by direct ligation of its termini.
9.1 The Mechanism of Viral DNA Synthesis
At early times in the virus reproductive cycle, 
"lariats" of DNA and genomes containing "eyes" or 
branches can be visualised under the electron 
microscope, and these are believed to represent 
replicative intermediates (Shlomai et al., 1976; 
Ben-Porat et al., 1976; Hirsch et al., 1977). In view 
of the observations that most viral genomes circularise
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early in infection, it is likely that initially, PRV 
and HSV replicate by a theta type mechanism (Figure 8). 
Late in infection, however, replicating PRV and HSV DNA 
form rapidly sedimenting "tangles" of DNA, indicative 
of high MW intermediates (Ben-Porat and Tokazewski, 
1977; Jacob et al., 1979). Restriction endonuclease 
analysis of this DNA revealed a low concentration of 
terminal fragments relative to the joint-spanning 
fragments (Ben-Porat and Rixon, 1979; Jacob et al., 
1979). This suggested that the replicated DNA was 
present as head-to-tail concatemers, and, on the basis 
of this information, Jacob et al (1979) proposed that 
at this stage, HSV replicates by a rolling-circle
t
mechanism, whereby head-to-tail concatemers of DNA are 
formed from the continuous synthesis of one strand and 
discontinuous synthesis of the other strand (Figure 8).
9.2 Viral Origins of Replication
Electron microscope analysis of replicating wild type 
HSV DNA suggested that DNA synthesis was initiated at 
multiple sites on the virus genome (Friedmann et al., 
1977). This approach, however, was unsuitable for 
determining the precise locations of the viral origins 
of replication. Indirect evidence for the presence of 
cis-acting sequences required for viral DNA replication 
was obtained from the analysis of defective genomes of 
both HSV and PRV (Frenkel et al., 1975, 1976; Rixon and
Ben-Porat, 1979; Graham et al., 1978; Locker and
Frenkel, 1979 ) .
Figure 8
The replicative forms of HSV
A. The rolling-circle mechanism
A DNA strand is displaced from nicked circular DNA 
and DNA is synthesised using the opposite strand 
as a template, forming a concatemer.
B. Early in replication viral DNA appears to 
replicate by a Theta (0 ) mechanism involving the 
continuous synthesis of one strand and 
discontinuous synthesis of the other strand.
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Defective virus particles are produced by the serial
passage of a virus stock at a high moi (Bronson et al.,
1973) and contain genomes consisting of tandem
reiterations of a portion of the parental genome. Two
classes of HSV defective DNA molecules have been
identified: Class 1 genomes consist of sequences
derived from U sand the entire short repeat (Vlazny and
Frenkel, 1981) whereas Class 2 genomes have sequences
from UL linked to sequences from a small part of the
short repeat (Schroder et al., 1975/1976; Kaerner et
al., 1979). It was deduced from these studies that
there were three origins of replication (ori) within
the HSV genome; two copies of oris, on® in each short 
*
repeat, and one copy of or^ present in .
Direct evidence for the presence of origins of 
replication within Class 1 and 2 defective molecules 
was obtained by Vlazny and Frenkel (1981) and Spaete 
and Frenkel (1982). These workers showed that tandemly 
reiterated DNA sequences in a head-to-tail arrangement 
were generated from defective monomer DNA molecules in 
cells cotransfected with helper virus DNA, which 
supplied trans-acting replication functions, and the 
defective DNA.
The precise map location of orig was achieved by 
screening cloned HSV DNA fragments for the ability to
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replicate in the presence of helper virus, using a 
transfection assay for replication (Stow, 1982;
Mocarski and Roizman, 1982b; Stow and McMonagle, 1983). 
A 90bp element, which contained all the cis-acting 
sequences essential for replication, was identified.
An almost perfect 45bp palindrome was found within this 
sequence (Murchie and McGeoch, 1982). Comparison of 
the HSV-2 strain HG52 DNA sequence between IE175, and 
IE genes 68 and 12 with that of the HSV-1 strain 17 
ori^ region revealed the presence of a strongly 
conserved sequence containing a tandem duplication 
(Whitton and Clements, 1984b). The ori^ of HSV-2 is 
137bp long and the homology to HSV-1 extends just 
beyond the limit of the HSV-1 90bp °ris region.
The identification of oriL sequences has proved to be a 
more difficult task because the essential sequences 
were deleted when fragments containing the putative 
ori^ were cloned into bacterial plasmids. HSV-1 ori 
sequences were determined from defective viral DNA 
(Gray and Kaerner, 1984) and also from virion DNA 
(Quinn and McGeoch, 1985). The problem of deletion was 
overcome by cloning the HSV DNA sequence into a yeast 
vector (Weller et al., 1985) and subsequent analysis of 
the cloned DNA identified a 144bp palindrome in which 
the central region of was highly homologous to the 
HSV-1 orig (Weller et al. , 1985).
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An HSV-2 was identified in an analogous position
on the genome to that of the HSV-1 ori (Spaete and
L
Frenkel, 1985) and cloned in an undeleted form into a 
bacterial vector by minimising the growth of 
recombination-deficient host bacteria (Lockshon and 
Galloway, 1986). This ori^ contains an AT-rich 136bp 
palindrome and has strong homology with the HSV-1 ori . 
The AT-rich palindrome is present in all the HSV 
origins of replication and is a feature shared with 
other origins of replication such as those of SV40, 
polyoma virus and VZV (Jay et al., 1976; Soeda et al.,
1979; Davison and Scott, 1985).
A seconcl feature common to the origins of replication
of HSV-1 and HSV-2, is their location at the 5' ends of
divergently transcribed genes. HSV-1 and HSV-2 orig is
flanked on one side by the gene encoding Vmwl75 and on
the other side by the IE genes specifying Vmwl2 or
Vmw68 (Stow and Davison, 1986), whilst the HSV-1 and
HSV-2 ori lies between the genes encoding the DNA 
L
polymerase and the major DNA binding protein (Quinn and 
McGeoch, 1985), which are essential for viral DNA 
replication. The significance of the positioning of 
ori0 and oriT is not known, but it is interesting to
S
note that VZV, which has sequences in the short repeat 
homologous to HSV-1 orig , does not have any sequences 
resembling HSV-1 ord^ between genes encoding the DNA
polymerase and major DNA binding protein (Stow and 
Davison, 1986 ) .
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10. MATURATION OF VIRAL DNA
Late in infection, the replicated DNA forms a large 
pool of concatemers from which viral DNA molecules are 
randomly withdrawn for cleavage and packaging.
Analyses of ts mutants of HSV and PRV have shown that 
cleavage of concatemeric viral DNA into monomeric units 
is closely linked to the encapsidation of full length 
viral genomes (Ladin et al., 1980, 1982; C.Addison, 
1986). In addition, sequence determination of the 
termini of virion and defective genomes has
site-specific (Mocarski and Roizman, 1982a; Vlazny et 
al., 1982; Deiss and Frenkel, 1986).
There is little information on the proteins involved in 
DNA maturation and, to date, most work has concentrated 
on determining the cis-acting sequences which are 
important for cleavage and packaging. Analysis of the 
structure of defective genomes of HSV-1 suggested that 
these cleavage and packaging signals were located at 
the end of the S terminus since this sequence was 
common to all defective DNA molecules (Frenkel et al., 
1976; Kaerner et al., 1979; Vlazny and Frenkel, 1981; 
Vlazny et al., 1982). Subsequently, transfection
studies, using plasmids containing the HSV-1 ori and
s
the a sequence, confirmed that the cleavage-packaging 
signal mapped within the a sequence, since only
replicated plasmids possessing this sequence were
demonstrated that the mecha of cleavage is
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packaged into capsids when transfected into cells 
together with helper virus DNA (Stow et al., 1983,
1986; Deiss and Frenkel, 1986).
10.1 The a Sequence
Sequence analyses of the joint and terminal restriction 
endonuclease fragments of various HSV-1 strains have 
shown that the a sequence is composed of unique (U) and 
directly repeated (DR) elements (Figure 9). A wide 
variation in the size of a sequences have been observed 
between different HSV strains and this is due to 
variation in the copy number of DR elements (Figure 9) 
(Davison and Wilkie, 1981; Mocarski and Roizman, 1981; 
Mocarstfi et al., 1985), whilst the HSV-2 a sequence 
appears to be a constant 251bp and no DR reiterations 
have been identified (Davison and Wilkie, 1981;
Mocarski et al., 1985). In spite of this difference, 
the HSV-1 a sequence is recognised in trans by HSV-2 
functions for cleavage, packaging and inversion 
(Mocarski and Roizman, 1982b; Spaete and Frenkel,
1985).
A single a sequence at the L-S junction has a direct 
repeat at each end known as DR1. Multiple a sequences 
at this junction, however, are only separated by a 
single DR element. TRS and TRL have a sequences ending 
in incomplete copies of DR1 such that direct ligation 
of HSV-1 termini reconstitutes a complete DR1 element 
between two a sequences, and this finding suggested
Figure 9
The a sequence of HSV-1
Unique (U^, U c) and directly repeated (DR1, DR2, DR4) 
regions are shown. The numbers of the repeats, DR2 and 
DR4 vary between different virus isolates.
References are given in the text.
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that the cleavage signal was located within DR1 
(Mocarski and Roizman, 1982a). Subsequent work 
revealed that although cleavage occurred within DR1, 
signals specifying this process were located elsewhere 
in the a sequence. Furthermore, the lack of homology 
between the DR1 elements of different HSV-1 strains, 
and also between HSV-1 and HSV-2 supported the idea 
that the recognition signal mapped outside DR1, 
probably within conserved regions of the a sequence, 
perhaps Ub and/or Uc (Davison and Wilkie, 1981).
Experiments by Varmuza and Smiley (1985) extended the
observations of Mocarski et al (1985). Various
subfragments of the a sequence were inserted into the
TK locus of HSV-1 and the resulting recombinant virus
was tested for the ability to produce novel termini.
The presence of such novel fragments was taken as
evidence that the inserted a sequence could promote
cleavage. A cloned fragment, Smal f, which lacked DR1
and part of Ub at one end, and contained only a partial
copy of DRl at the other end was found to behave as a
functional a sequence. This result provides strong
evidence that the cis-acting cleavage-packaging signals
map outside DRl (Varmuza and Smiley, 1985). When the
novel termini produced in the experiment were
sequenced, the cleavage sites were discovered to lie in
the HSV UT sequences adjacent to the inserted Smal f L
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sequence. Furthermore, the novel S and L termini were
created by two distinct cleavage events within
unrelated nucleotide sequences. Varmuza and Smiley
(1985) therefore proposed that in a standard HSV genome 
two distinct cleavage events normally occur 
fortuitously within DRl, and suggested that the 
cleavage-packaging signals mapped within the conserved 
regions of the HSV-1 and HSV-2 a sequence outside DRl.
This is supported by recent work in which plasmid
vectors containing deleted a sequences were tested for 
efficient cleavage and packaging (Deiss et al. , 1986). 
Deletions in the Ub or Uc regions abolished or severely 
reduced the ability of the plasmid to be propagated 
into detective virus stock. However, it was not 
possible from this data to determine whether the Ub and 
Uc signals act in concert as suggested by Varmuza and 
Smiley (1985) or separately (Deiss et al., 1986).
Whilst most viral genomes have a single a sequence at 
the termini and junctions, which are sufficient for 
cleavage and packaging to proceed (Deiss and Frenkel, 
1986), tandem reiterations of the a sequence arise 
within the genome, but only at the L terminal and joint 
sequences (Wagner and Summers, 1978). Mocarski and 
Roizman (1981) proposed that amplification of the a 
sequence resulted from multiple rounds of unequal 
recombination through DRl. However, subsequent work by 
Varmuza and Smiley (1985) excluded this mechanism.
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From an analysis of Smal f reiterations present at 
novel termini generated by the insertion of the Smal f 
(a subfragment of the a sequence) into the HSV-1 UL 
sequences, Varmuza and Smiley (1985) concluded that in 
the majority of cases, amplification of the a sequence 
occurred through rounds of cleavage and religation of 
the termini, that is, the cleavage-packaging system was 
responsible for a sequence duplication.
10.2 Cleavage and Packaging of Viral DNA
A number of models, incorporating the known details of 
viral DNA maturation, have been proposed to explain the 
mechanism by which concatemeric viral DNA is processed 
to unit* length genomes and packaged within the viral 
capsid.
In the "theft mechanism" (Varmuza and Smiley, 1985) 
(Figure 10) a packaging complex recognises cleavage 
signals located within the DRl element in the a 
sequence of a standard HSV genome, and makes a ds 
cleavage at an L-S junction, producing, at least in 
some cases, ends with a protruding 3 ’ nucleotide 
(Mocarski and Roizman, 1982a). This cleavage event 
creates two termini, one of which lacks an a sequence. 
The DNA carrying an a sequence is packaged into a 
preformed capsid until a second L-S junction in the 
same orientation (ie. at full genome's length) is 
encountered, and a second ds cleavage event then
Figure 10
"Theft" mechanism
ds cleavage at one of two cleavage sites at an L-S 
junction containing a single a sequence produces L and 
S termini, one of which lacks an a sequence. DNA 
fragments lacking an a sequence are discarded and 
degraded. Termini containing an a sequence are 
packaged (in this example the L terminus) until the
next L-S junction in the same orientation is reached
and an S terminal* cut is made.
Packaging signals - ▼ ▲
Cleavagerpackaging complex - 
from Varmuza and Smiley (1985).
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creates 2 termini as before (Figure 10). Thus, the 
termini of the packaged molecules all contain an a 
sequence. This mechanism, however, does not explain 
the asymmetric distribution of a sequences within HSV. 
To account for this feature of the HSV genome, a 
directional packaging model was proposed (Deiss et al., 
1986). In this "modified theft model" the packaging 
complex scans the viral concatemer and cleaves the DNA 
in the DR element, proximal to the first Uc sequence 
encountered, creating an L terminus with at least one a 
sequence (ba or ban ) and an S terminus lacking an a 
sequence (ca^_pr c). Packaging then proceeds in an 
L-to-S direction to a repeat junction where a second ds 
cleavage, proximal to the first Ub sequence of the 
junction, creates an S terminus with a single a 
sequence. In genomes where multiple a sequences are 
present, this process also creates an L terminus with 
at least one a sequence which may become packaged into 
a separate capsid. In this model, and the basic theft 
mechanism, only DNA which retains an a sequence at each 
end of the genome is packaged. The disadvantage of 
both models is that they predict the formation of DNA 
fragments which lack a sequences. Such termini, 
however, have not been identified in total nuclear DNA 
and it must be assumed that they are rapidly degraded.
As an alternative to the theft model, Varmuza and
Smiley (1985) proposed the staggered nick repair model
-65-
in which L and S termini are produced by single 
stranded nicks rather than by a double-strand cleavage. 
At an L-S junction containing a single a sequence, a 
cleavage-packaging complex bound to Ub, and another 
interacting with Uc, make single strand nicks at the 
future location of S and L termini, respectively. The 
nicked DNA then undergoes strand repair synthesis 
across the staggered cleavages. This process generates 
2 termini, each carrying an a sequence. These L and S 
termini can religate to form tandem a sequences, and 
such junctions, containing duplicate a sequences, can 
be cleaved by the coincident action of two single 
strand nicks from adjacent a sequences, producing a ds 
cleavag'e (Figure 11).
To take account of the findings of Mocarski and Roizman 
(1982a), it was proposed that the ends created by the 
break have a 3' nucleotide overhang.
In addition to the modified theft model, Deiss et al
(1986) have described a scheme known as the double 
strand-break and gap repair model, which is based on 
the mechanism proposed by Szostak et al (1983) for gene 
conversion. This model incorporates directional 
scanning and packaging of the viral genome, plus 
amplification of the a sequence (Szostak et al., 1983; 
Deiss e t a l ., 1986).
The packaging complex scans the genome and juxtaposes
Figure 11
Staggered nick repair mechanism proposed by Varmuza and
Smiley (1985)
L and S termini arise by
a. Staggered single strand nicks followed by repair 
synthesis.
b. an -alternative pathway in which tandemly 
reiterated copies of the a sequence are processed 
by co-operation of L and S recognition complexes 
in adjacent a sequences, resulting in a single ds 
break.
L (O) and S (#) recognition complexes bound to signals
in Ub and Uc respectively.
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two directly repeated single a sequences at the L-S 
junctions. The a sequence is then amplified by a gene 
conversion mechanism, and termini are formed by a ds 
break within DRl. In this model, no termini devoid of 
a sequences are produced, and therefore all the ends 
can be packaged. The ds-break and gap repair model 
accounts for the structure of defective genomes 
generated from plasmids containing an a sequence with a 
deletion in Ub, and an origin of replication, 
cotransfected into cells with helper virus DNA.
However, the simpler possibility that acquisition of a 
sequences by plasmid progeny occurred as a result of 
high frequency recombination between the helper viruses 
and pldsmid DNA cannot be discounted.
11. GENE PRODUCTS INVOLVED IN VIRAL DNA SYNTHESIS
Although the available evidence indicates that the 
majority of polypeptides involved in viral DNA 
replication are virus-coded, work on ts BHK cell cycle 
mutants has suggested that cellular proteins may also 
be required (Yanagi et al., 1978). Little work, 
however, has beeen done on this aspect. Various 
approaches have been used to identify viral 
polypeptides involved in DNA metabolism, and these 
include:
1. the search for virus-infected cell enzyme 
activities that have different biochemical properties 
from the uninfected cell enzyme and
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2. genetic analysis, in particular the isolation and 
characterisation of HSV ts mutants which fail to 
synthesise DNA at the NPT.
3. Recently, a plasmid replication assay has been 
used to identify seven genes required for viral DNA 
replication (Challberg, 1986).
Using this last technique, it was found that a 
combination of cloned HSV DNA fragments was able to 
supply all the functions required for amplification of 
a plasmid containing an HSV origin of replication, when 
transfected into cells. This assay implicated four Ul 
genes of unknown function, U. 5, U 8, U 9 and UT52,
■Li L L ^
encoding polypeptides with MWs of 99,000; 80,000;^4,000 
and 11^,000 respectively (Challberg and McGeoch, 
personal communication) (Figure 12). Since ts 
mutations which impair viral DNA synthesis at the NPT 
have been induced in each of these four genes (Matz et 
al., 1983; V.Preston, personal communication), they 
must be essential for viral DNA replication.
Viral polypeptides involved in DNA synthesis can be 
divided into two classes:
1. the gene products which are directly involved in 
DNA replication, for example, the major DNA binding 
protein (MDBP) and the DNA polymerase.
2. the enzymes which supply the precursors for viral 
DNA synthesis, for example, the ribonucleotide 
reductase and TK.
Figure 12
The map locations of genes for alkaline exonuclease 
(alk exo), TK, MDBP, DNA polymerase, ribonucleotide 
reductase large (RR1) and small (RR2) subunits, Vmw65 
DNA binding protein and dUTPase, which are involved in 
HSV DNA metabolism.
Also shown are the map positions of UL5, UL8, UL9 and U l 
HSV-1
52, and~~t nejdJNA fragments which can supply all 
replication functions in the plasmid amplification 
assay (Challberg, 1986).
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The map locations of genes involved in viral DNA 
metabolism, and the locations of the HSV-1 DNA 
fragments which supply all these functions (Challberg, 
1986) are given in Figure 12.
11-1 Polypeptides Which are Directly Involved in DNA 
Synthesis 
MDBP
The HSV-1 polypeptide is also referred to as ICP8 
(Conley et al., 1981), and has a MW of 128,347 (Quinn 
and McGeoch, 1985). The HSV-2 counterpart is known as 
ICSP11, and has a similar MW to the HSV-1 MDBP (Powell 
and Purifoy, 1976).
This polypeptide binds more strongly to single-stranded 
DNA than to ds DNA (Bayliss et al♦, 1975; Powell and 
Purifoy, 1976), and is thought to play a major role in 
viral DNA synthesis, probably by maintaining the viral 
DNA in an extended configuration, thereby reducing 
hairpin-loop formation (Ruyechan, 1983), and increasing 
the processivity of the DNA polymerase. Evidence that 
the MDBP is involved in viral DNA replication was first 
obtained from the observation that in vitro, synthesis 
of viral DNA was inhibited by monospecific antiserum to 
the MDBP (Powell et al., 1981). The failure of ts 
mutants, with lesions in the MDBP gene, to synthesise 
viral DNA at the NPT (Conley et al., 1981; Littler et 
al., 1983), confirmed that this polypeptide was 
essential for viral DNA replication.
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The presence of a ts lesion in the MDBP also caused the 
destabilisation of both the DNA polymerase and alkaline 
exonuclease at the NPT (Littler et al., 1983), 
suggesting that these three polypeptides are part of a 
replication complex.
DNA Polymerase
The viral DNA polymerase has a MW of 136,272 in HSV-1 
strain 17 (Quinn and McGeoch, 1985). Its main function 
is to extend the replicating DNA chain in the 5'->3' 
direction, but it also has a 3'->5' exonuclease 
proofreading activity (Weissbach et al., 1973; Knopf, 
1979). The viral DNA polymerase can be distinguished 
from th*e host enzyme on the basis of its requirement 
for high salt for maximal activity, its heat stability 
and its ability to use different DNA primers (Keir and 
Gold, 1963).
Evidence for the essential role of the DNA polymerase 
in viral DNA replication comes not only from the 
plasmid replication assay (Challberg, 1986), but also 
from the characterisation of HSV ts mutants which have 
lesions in this gene (Aron et al., 1975; Purifoy and 
Benyesh-Melnick, 1975; Hay and Subak-Sharpe, 1976; 
Purifoy and Powell, 1981), and also from the study of 
drugs which act on the viral DNA polymerase (Section
1.16.3).
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Vmw65 DNA Binding Protein
A number of polypeptides of varying sizes copurify with 
the DNA polymerase. Using immunoaffinity 
chromatography, Vaughan et al (1985) demonstrated that 
a Vmw65 DNA binding protein was consistently among 
these. This polypeptide is distinct from the Vmw65 
trans-inducing factor (Marsden et al., 1987), and may 
be an accessory protein required for efficient viral 
DNA synthesis (Knopf, 1979). The isolation of an HSV-1 
ts mutant with a lesion in this gene, which fails to 
synthesise viral DNA at the NPT, strongly suggests that 
this gene is essential for viral DNA replication (V 
Preston, personal communication).
t
Alkaline Exonuclease
The virus exonuclease has an alkaline pH optimum (Keir 
and Gold, 1963; Keir, 1968) and is composed of a single 
polypeptide species, Vmw85, which has a MW of 67,503, 
as determined by sequence analysis (McGeoch et al.,
1986). The purified enzyme also has an associated 
endonuclease activity (Hoffman and Cheng, 1978, 1979; 
Strobel Fidler and Francke, 1980).
The finding that the HSV-2 mutant, tsl3, which has a 
lesion in the alkaline exonuclease gene, makes reduced 
amounts of viral DNA at the NPT (Moss, 1986), indicated 
that this gene may have an essential role in DNA 
replication. However, Challberg (1986) found that this 
gene was not required for plasmid replication in his
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assay identifying genes required for viral DNA 
synthesis. This discrepancy has yet to be resolved.
11.2 Gene Products which Supply Precursors for DNA Synthesis 
Ribonucleotide Reductase
The HSV-encoded ribonucleotide reductase catalyses the
reduction of all four ribonucleotide diphosphates to
the corresponding deoxyribonucleotides (Averett et al. ,
1983) and can be distinguished from the cellular enzyme
activity by its insensitivity to inhibition by dTTP and
dATP, and in its lack of requirement for ATP or
magnesium salt for activity (Cohen, 1972; Ponce de Leon
et al., 1977; Huszar and Bacchetti, 1981).
*
Both the HSV-1 and HSV-2 ribonucleotide reductase are 
composed of two non-identical subunits, the large one 
consisting of a polypeptide of apparent MW 136,000 in 
HSV-1 and 138,000 in HSV-2, and the small one 
consisting of a polypeptide with an apparent MW of
38,000 in HSV-1 and 36,000 in HSV-2 (Dutia, 1983;
Huszar and Bacchetti, 1983; Reichard and Ehrenberg,
1983; Bacchetti et al., 1984; Preston et al., 1984).
Evidence that Vmwl36 and 38 form a complex was obtained 
from studies on the HSV-1 mutant, tsl207 which has a 
lesion in Vmwl36 (Preston et al., 1984), and induces a 
thermolabile ribonucleotide reductase activity (Dutia, 
1983). Monoclonal antibodies specific for Vmwl36 or 
Vmw38 bind to ribonucleotide reductase and precipitate
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both polypeptides from wild type virus-infected cells 
(Bacchetti et al., 1984; Preston et al. , 1984).
However, these two polypeptides were not coprecipitated 
from extracts prepared from tsl207-infected cells grown 
at the NPT, either by a monoclonal antibody specific 
for Vmwl36, or by an oligopeptide antiserum specific 
for Vmw38, even though both polypeptides were 
synthesised by tsl207 at this temperature.
This result indicates that the functional enzyme 
requires the association of Vmw38 with Vmwl36 (Frame et 
al., 1985).
TK *
The virus TK, or pyrimidine deoxyribonucleoside kinase,
phosphorylates either of the pyrimidine
deoxy
deoxyribonucleosides, thymidine or^cytidine, but 
thymidine is preferentially converted to dTMP and dTTP 
(Kit and Dubbs, 1963; Dubbs and Kit, 1964; Klemperer et 
al., 1967; Cooper, 1983; Jamieson et al., 1974).
The enzyme has a MW of 40,900 in HSV-1 and 38,000 in
HSV-2 (Wagner et al., 1981; Swain and Galloway, 1983)
and, in comparison to the host enzyme, is relatively
insensitive to thymidine triphosphate inhibition. It
also has a low pH optimum and a low Km compared with
o
the host TK, and is stable on heating at 40 (Klemperer 
et al., 1967 ).
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Virus-encoded dUTPase
The dUTPase catalyses the conversion of dUTP to dUMP 
and pyrophosphate. The cellular enzyme has two 
functions; it minimises the incorporation of dUTP into 
DNA by maintaining low levels of dUTP, and also 
supplies the cell with dUMP, the substrate for 
thymidylate synthetase (Ostrander and Cheng, 1980).
The precise role of the virus specified dUTPase is 
uncertain. Since HSV does not encode a thymidylate 
synthetase gene and viruses deficient in dUTPase 
activity grow as well as WT viruses in tissue culture 
(Preston and Fisher, 1984) the main function of this 
enzyme is probably to maintain low levels of dUTP to 
minimisfe incorporation of uracil into DNA by DNA 
polymerase.
Two further enzymes that may be involved in virus DNA 
metabolism have been found in HSV-infected cells.
These are:
1. a type I topoisomerase, which can relax supercoiled 
DNA by breaking and rejoining the backbone 
phosphodiester bonds of a single strand of the DNA 
(Muller et al., 1985). Although many DNA replication 
systems require a topoisomerase, it is not yet known 
whether HSV encodes a topoisomerase or if this enzyme 
is required for HSV DNA synthesis (Biswal et al., 1983; 
Leary and Francke, 1984).
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2. a uracil DNA glycosylase. This enzyme removes 
uracil bases present in replicating DNA (Caradonna and 
Cheng, 1981), and is important in reducing the number 
of mutations arising from deamination of cytosine 
residues. To date, little information is known about 
this enzyme which is present in HSV-infected cells.
12. CAPSID ASSEMBLY
HSV proteins are synthesised in the cytoplasm and some 
proteins, including the nucleocapsid polypeptides, 
migrate to the nucleus where the capsids are assembled 
(Morgan et al., 1954; Olshevsky et al♦, 1967).
Recent ‘evidence suggests that nucleocapsid assembly 
takes place at the nuclear matrix (Bibor-Hardy et al., 
1982a, 1982b, 1985; Ben-Ze'ev, et al., 1983). This 
structural component of the cell is thought to 
represent the skeletal framework of the nucleus and is 
defined as the insoluble material remaining after 
purified nuclei have been sequentially treated with 
nonionic detergent, low magnesium salt buffer, high 
salt buffer and finally digested with nucleases 
(Berezney and Coffey, 1974). Examination of the matrix 
under the electron microscope has shown that it 
consists of a residual peripheral lamina with nuclear 
pore complexes, nucleoli, and an internal fibrogranular 
network (Berezney and Coffey, 1974, 1977). It has been 
proposed that in uninfected cells the matrix is the 
active site for DNA replication and RNA processing,
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since newly synthesised DNA and unprocessed RNA are 
associated with this structure (Pardoll et al., 1980; 
Van Eekelen and Van Venrooji, 1982). In HSV-1 infected 
cells, a subset of both structural and non-structural 
viral proteins are present in matrix preparations and 
many capsids, most of which are empty, are attached to 
the fibrogranular network (Bibor-Hardy et al., 1982a, 
1982b, 1985). Similar results have been obtained with 
HSV-2 infected cells (Tsutsui et al., 1983). These 
findings, together with the observation that 
herpesvirus DNA co-purifies with the nuclear matrix 
(Ben-Porat et al., 1984, F.J.Rixon, personal 
communication), led Bibor-Hardy et al. (1985) to
proposd that the matrix is the site of both viral DNA 
synthesis and nucleocapsid assembly, and that these two 
processes may be linked. However, there remains the 
possibility that viral DNA and capsids become trapped 
within the matrix during the extraction procedure, and 
this has not yet been disproved.
The analysis of DNA positive, ts mutants of PRV which 
failed to produce capsids at the NPT (Ladin et al.,
1980, 1982) suggested that the accumulation of 
nucleocapsid proteins within the nucleus is linked to 
capsid assembly. In mutant virus-infected cells grown 
at the NPT, the major capsid proteins were found in the 
cytoplasmic fraction instead of the nuclear fraction.
To explain this finding, Ladin et al. (1982) put
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forward the proposal that the formation of capsids 
promotes the transport of structural proteins into the 
cell nucleus by creating a "sink", whereby the 
retention of capsid polypeptides within the nucleus 
favours the continued movement of structural 
polypeptides from cytoplasm to nucleus.
12.1 Viral DNA Encapsidation
There are two general methods for the packaging of 
virus DNA:
1. The DNA is inserted into a pre-formed capsid.
2. The capsid is assembled around the virus DNA.
The weight of evidence suggests that the capsid is 
assembled first, and that the viral DNA is inserted 
into it. A model for this mechanism was first proposed 
are rearranged to form a large cylindrical structure 
onto which the DNA is spooled. As the DNA is wound 
around the cylinder to form a densely staining toroid 
structure, the cylinder undergoes condensation (Perdue 
et al., 1976). This scheme is in agreement with the 
process described for HSV encapsidation by Furlong et 
al. (1972).
The model described by Perdue and co-workers is 
supported by work on DNA positive mutants of PRV and
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HSV which are ts for the ability to package virus DNA 
(Ladin et al., 1980; Preston et al. , 1983). At the NPT 
these mutants generally produce large numbers of 
partially-cored capsids which resemble the I capsid 
forms of EHV-1 as described by Perdue et al. (1975). 
When mutant virus-infected cells were transferred from 
the NPT to the PT in the presence of cycloheximide, an 
increase in the numbers of full capsids in the nucleus 
and enveloped virus in the cytoplasm, together with a 
concomitant decrease in the partially-cored (I) capsids 
was observed (Ladin et al., 1980; Preston et al.,
1983), suggesting that like the 'I' capsids of EHV-1, 
the partially-cored capsids are precursors to full 
capsids*. Analyses of the different forms of purified 
capsids isolated from PRV mutant virus-infected cells 
in "pulse-chase" experiments, confirmed that partially 
cored capsids were intermediates of full capsids (Ladin 
et al♦, 1980).
Pignatti and Cassai (1980) proposed an alternative 
theory for encapsidation, in which newly synthesised 
viral DNA, derived from a replication complex, is 
condensed and packaged into a nucleoprotein complex 
(NPC). They suggested that VP5, 12, 15.2, 19 and 24 
were required for initiation of encapsidation since 
these proteins were present in the NPC, which appeared 
in EM analysis to be present at one end of the genome. 
The addition of structural proteins to the NPC would 
lead to the formation of nucleocapsids. However, this
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theory is not generally accepted because the 
experimental evidence favours the previous model in 
which the DNA enters a preformed capsid. Furthermore, 
Pignatti and Cassai (1980) have not excluded the 
possibility that the NPCs represent disrupted 
nucleocapsids.
Viral DNA is cleaved as it is packaged; this 
relationship between capsid assembly and maturation of 
virus DNA has been demonstrated both by the 
characterisation of tjs mutants and by the study of 
defective viral genomes. DNA-positive ts mutants of 
PRV and HSV which fail to package DNA at the NPT do not 
cleave concatemeric virus DNA into unit length 
molecules (Ladin et al., 1980; Addison, 1986). On 
shift-down of mutant virus-infected cells from the NPT 
to the PT in the presence of cycloheximide, the DNA is 
cleaved and packaged, and full capsids are produced 
(Ladin et al., 1980; Preston et al.r 1983; Addison, 
1986). Deiss and Frenkel (1986) studied the cleavage 
and packaging of defective genomes of HSV-1 in the 
presence in helper virus. Their results show that the 
majority of DNA termini in the nuclear fraction of 
infected cells are present in encapsidated viral DNA, 
again linking cleavage with packaging of viral DNA.
12.2 Gene Products Involved in Viral DNA Encapsidation 
Several polypeptides have been implicated in the
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encapsidation of viral DNA. The best studied of these 
is the gene, U 26 encoding ICP35 (MW 40,000). This is
Li
present in multiple forms in the infected cell, the 
lower MW species of which have been termed VP22a 
(Gibson and Roizman, 1972), p40 (Heilman et al., 1981) 
and NC-3 (Cohen et al., 1980). The analogous 
polypeptides in PRV and CMV are referred to as the
35,000 MW structural protein (Ladin et al., 1982) and 
the 36,000 MW "assembly protein" (Irmiere and Gibson,
1985) respectively. Early work by Gibson and Roizman 
(1972) suggested that VP22a was involved in DNA 
encapsidation because this polypeptide was found in 
full but not empty capsids purified from infected cell 
nuclei* Subsequent work by Braun et al. (1984b)
localised ICP35 to the surface of full capsids.
Further evidence that ICP35 was required for DNA 
packaging was obtained from the characterisation of the 
HSV-1 mutant, tsl201. This virus, which has a lesion 
in the ICP35 gene, fails both to process ICP35 to its 
lower MW forms (Preston et al., 1983) and to package 
viral DNA at the NPT.
Interestingly, the empty capsids produced by tsl201 at 
the NPT have a larger internal core structure than 
those of packaging deficient ts mutants with lesions in 
other genes, for example tsl203 (Addison, 1986).
More recently, the distribution of ICP35 within virus-
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infected cells has been determined by immuno-electron 
microscopy. In contrast to earlier results, F.J.Rixon 
and V.Preston (personal communication) found that the 
polypeptide was localised on the surface of empty but 
not full capsids from WT- and tsl201-infected cells at 
the NPT. This result suggests that ICP35 is associated 
with empty capsids, and that following packaging this 
association is weakened, resulting in loss of the 
polypeptide from full nucleocapsids. This finding is 
in contradiction with the results obtained by Gibson 
and Roizman (1972) which suggested that ICP35 is 
present in full capsids. A possible explanation for 
these conflicting data is that the method of capsid 
purification used by Gibson and Roizman (1972) may have 
resulted in the isolation of a capsid population 
consisting of a mixture of dense-cored, DNA-containing 
capsids and partially cored capsids which lacked DNA. 
VP19c (ICP32, 1^41) has a MW of 50,000, and is an 
internal component of both full and empty capsids 
(Gibson and Roizman, 1972; Braun et al., 1984a). Since 
this polypeptide binds to DNA, it has been speculated 
that it has a role in DNA encapsidation or in the 
anchorage of newly packaged DNA within the capsid 
(Braun et al., 1984a). To date, however, there is no 
direct information about the function of this 
structural polypeptide.
Results from DNA binding experiments with HSV-infected
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cell extracts suggested that the UL 11 gene products, 
Vmw21 and 22 bound specifically to the 'a' sequence 
(Dalziel and Marsden, 1984; McGeoch et al., 1985). 
This data, together with earlier findings that a 
similar sized polypeptide was attached to the genomic 
termini of HSV-1 (Wu et al., 1979; Hyman, 1980), 
indicated that Vmw21 and 22 might be involved in the 
packaging of viral DNA (Dalziel and Marsden, 1984). 
However, recent work has shown that the U 11 gene 
products are not essential for virus growth in tissue 
culture (Umene, 1986; Brown and Harland, 1987; 
Longnecker and Roizman, 1986) and that they are 
localised within the nucleolus (Maclean et al., 1987). 
These results raise doubts as to whether 11 gene 
products are involved in nucleocapsid assembly.
13. HSV ENVELOPMENT AND EXIT FROM THE CELL
HSV nucleocapsids generally become enveloped by 
"budding" through the inner nuclear membrane of the 
cell (Darlington and Moss, 1968; Nii et al., 1968; 
Roizman and Furlong, 1974) at positions where the 
membrane is enriched for viral glycoproteins and lacks 
the normal complement of cellular proteins (Asher et 
al., 1969; Spear et al ♦ , 1970, Spear and Roizman,
1972). Envelopment is thought to be a rapid process 
since "budding" viruses are rarely seen in thin 
sections of virus-infected cells under the electron 
j-picroscope, however enveloped particles are frequently 
observed between the nuclear membranes.
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Although herpesvirus envelopment by "budding" has also 
been detected at cytoplasmic vacuoles (Nii, 1971; 
Seigneurin et al., 1977) and the Golgi complex 
membranes (Smith and de Harven, 1973), these are not 
considered to be the normal sites of envelopment. In 
addition, the occasional presence of enveloped capsids 
within the nuclei of cells infected with WT HSV-2 and 
some ts mutants of HSV-1 has prompted the suggestion 
that de novo synthesis of an HSV envelope can occur 
(Atkinson et al., 1978; Dargan and Subak-Sharpe, 1983). 
This idea, however, is not widely accepted.
From the analysis of proteins present in capsids and 
de-enveloped virions, Gibson and Roizman (1972) 
proposed that ICP35 plays a role in HSV envelopment.
In subsequent work on CMV, Gibson (1981) observed that 
tegument proteins surrounding the capsid of this virus 
had exposed hydrophobic groups, and suggested that 
these structural proteins promoted nucleocapsid 
envelopment by interacting with hydrophobic elements, 
possibly viral glycoproteins, located on the cellular 
nuclear lamella. To date, no evidence has been 
obtained directly implicating either HSV tegument 
polypeptides or glycoproteins in this process. 
Nevertheless, such an interaction is an attractive 
explanation for the process of HSV envelopment. 
Following envelopment, the virion is transported to the 
cell membrane where it is released into the
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extracellular space. Alternatively, virus is spread 
from cell to cell by fusion of adjacent cellular 
membranes.
There are two major theories for the transport and exit 
of HSV from the cell, of which the favoured mechanism 
is a modified version of the "reverse phagocytosis" 
hypothesis (Morgan et al., 1959). In this model 
envelopment occurs at the inner nuclear membrane and 
the virus particles are moved by transport vesicles from 
the rough endoplasmic reticulum to the Golgi complex, 
and from there to the cell surface (Johnson and Spear,
1982). This theory is supported by work with monensin, 
an ionophore which catalyses the exchange of sodium and 
potassium ions across biological membranes (Pressman, 
1976), disrupting the ion gradients between membranes 
in the Golgi complex and blocking the secretion of 
soluble proteins (Tartakoff and Vassali, 1978; Uchida 
et al., 1979). The addition of monensin to 
virus-infected cells inhibits the transport of membrane 
proteins between the Golgi complex and the plasma 
membrane (Johnson and Schlesinger, 1980) and also 
prevents the transport of enveloped virions to the cell 
surface. As a consequence, infectious virions 
accumulate within large cytoplasmic vacuoles in the 
cell (Johnson and Spear, 1982), strongly suggesting 
that movement of virus to the cell surface occurs via 
the Golgi apparatus.
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An alternative mechanism has been proposed by Schwartz 
and Roizman (1969) on the basis of electron- and 
light-microscope studies. They suggested that in 
virus-infected cells, a network of highly branched 
tubules is formed, connecting the perinuclear region 
with the extracellular space. These tubules are 
thought to facilitate the exit of enveloped virus 
particles from the cell.
Three virus glycoproteins, gD, gH (Gompels and Minson,
1986) and gE (Tognon et al., 1981) have been implicated 
in the process of virus egress; many antibodies to gD 
and gH are strongly neutralising in the absence of 
complement (Para et al., 1985; Buckmaster et al., 1984; 
Gompels and Minson, 1986), and also inhibit the fusion 
of cells infected by syncytial virus strains (Gompels 
and Minson, 1986). In addition, a monoclonal antibody 
to gH has been produced which inhibits plaque formation 
when added to the overlay of virus-infected cells 
(Buckmaster et al., 1984). Evidence that gH has a role 
in virus exit is supported by work on an HSV-1 mutant 
tsQ26, which has a ts lesion in gH (Weller et al.,
1983). This mutant grows normally at the NPT in terms 
of the yield of infectious virus from cells, but fails 
to form plaques, that is, virus exit from the infected 
cell does not occur.
14. HSV ENCODED POLYPEPTIDES
14.1 Number and Genomic Location of HSV-induced Polypeptides
The HSV-1 genome encodes 71 unique genes (D.McGeoch
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personal communication). At least 50 HSV-1 and HSV-2 
induced polypeptides have been detected by 
1-dimensional SDS-polyacrylamide gel electrophoresis 
(Honess and Roizman, 1973; Powell and Courtney, 1975). 
More recently, knowledge of the HSV-1 DNA sequence 
(McGeoch et al., 1985, 1986) has enabled gene products 
to be identified by means of antiserum raised against 
an oligopeptide specific for a small portion of the 
amino acid sequence of a gene (Palfreyman et al., 1983; 
Frame et al., 1986a, 1986b; Marsden et al., 1987).
14.2 Regulation of Synthesis of HSV-induced Polypeptides
Although the synthesis of HSV polypeptides is largely 
regulated at the level of mRNA transcription (Section 
1.7), there have been claims that control also occurs 
at the level of translation. Work by Inglis and Newton 
(1981) indicated that HSV-1 mRNAs are no more 
efficiently translated than cellular transcripts in a 
cell free translation system, suggesting that any 
virally-induced inhibition of cellular polypeptide 
synthesis must take place at the post-transcriptional 
level. Also, work by Johnson and Spear (1984) showed 
that gD transcription increased until late times, even 
when little of the gene product was translated, 
suggesting that control was at the translational rather 
than transcriptional stage. However, this work 
conflicts with results obtained by Johnson et al.,
(1986) who found that whilst synthesis of gD increased 
steadily until late times in infection, as detected by 
immunoprecipitation of the polypeptide, transcription
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of gD decreased after 5h pi.
15. POST-TRANSLATIONAL MODIFICATIONS OF VIRAL POLYPEPTIDES 
A variety of post-translational modifications of HSV 
polypeptides occur, the most common of which are 
phosphorylation, cleavage, glycosylation and 
sulphation.
15.1 Phosphorylation
16 HSV-1 and 18 HSV-2 phosphorylated polypeptides 
including all of the IE polypeptides with the exception 
of Vmwl2 (Hay and Hay, 1980) have been detected in 
virus-infected cells (Pereira et al., 1977; Marsden et 
al., 19^8). Wilcox et al. (1980) demonstrated that the 
phosphate groups cycled on and off some HSV induced
r
pjpteins, for example Vmwl75, and that the DNA binding 
properties of certain proteins was altered after they 
were phosphorylated. These workers also concluded that 
more than one pathway existed for protein 
phosphorylation since Vmwl75 was phosphorylated during 
pulse labeling, whilst Vmw63 and 68 were phosphorylated 
during the chase period (Wilcox et al., 1980).
In addition, a large number of structural polypeptides 
are phosphorylated, for example the tegument protein 
Vmw65 (H. Moss, personal communication).
15.2 Proteolytic Cleavage
An examination of gD in virus-infected cells showed 
that 25 amino acids were absent from the amino terminus 
of the polypeptide in comparison with the predicted
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sequence (Eisenberg et al., 1984). This amino acid 
sequence is highly hydrophobic and probably represents 
the signal peptide located at the amino-terminus of 
many transmembrane glycoproteins (Kreil, 1981;
Eisenberg et al., 1984) which is required for transfer 
of glycoprotein through the lipid membrane, and is 
cleaved during maturation. Similarly, HSV-2 gG was 
shown to be processed from a 120,000 MW precursor to a 
108,000 MW polypeptide (Balachandran and Hutt-Fletcher,
1985). In addition, it is speculated that the 
non-glycosylated polypeptide, ICP35, is cleaved (Braun 
et al., 1983, 1984b), although no definite evidence for 
this has yet been obtained.
t
At late times in infection a number of polypeptides 
including Vmwl75 and the large subunit of the 
ribonucleotide reductase (Vmwl36) undergo cleavage 
(McDonald, 1980). This process did not occur when 
virus-infected cells were treated with the protease 
inhibitor tosylphenylchloromethyl ketone (TPCK), 
suggesting that protein degradation was due to specific 
proteolytic cleavage. The significance of this remains 
unknown.
15.3 Glycosylation
The map location of the HSV-1 and HSV-2 genes encoding 
glycosylated polypeptides, and the function of the gene 
products is given in Section 1.4.3.
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Glycosylation of viral polypeptides is rapid, and can 
be detected 12-15min after the production of the 
precursor protein (Spear and Roizman, 1970). All HSV 
glycoproteins examined so far contain N-linked 
oligosaccharides, that is, linkages between N-acetyl 
glucosamine and asparagine residues (Eisenberg et al. , 
1979; Pizer et al. , 1980). 0-linked oligosaccharides 
between N-acetylglucosamine and serine or threonine 
have also been found in some HSV glycoproteins, for 
example, gB, gC, gD (Olofsson et al., 1981, 1983;
Wenske and Courtney, 1981; Johnson and Spear, 1983).
15.4 Sulphation
Inorganic sulphate is added to all the major 
glycoproteins of HSV-1 and HSV-2, and it is thought 
that in the majority of cases the inorganic sulphate is 
attached to the N-linked oligosaccharides (Hope et al., 
1982; Hope and Marsden, 1983).
In addition to these modifications poly ADP- 
ribosylation of Vmwl75 (Preston and Notarianni, 1983) 
and fatty acid acylation of gE (Johnson and Spear,
1983) have also been reported.
16. GENETICS OF HSV
16.1 Mutations in Essential Genes
16.1.1 Ts Mutants
Most of the conditional lethal mutants which have been 
isolated from HSV are ts, and these have been extremely
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useful in identifying the function of genes essential 
for virus growth in tissue culture. Since very few of 
the mutants characterised are from HSV-2, this section 
will concentrate largely on the analysis of HSV-1 
mutants.
Ts mutants with lesions in essential genes grow
o
normally at low temperatures (31-34 ) but not at higher
o
temperatures (usually within the range of 38-39.5 ). 
Although these lesions can arise spontaneously, most ts 
mutations have been induced by treatment of 
virus-infected cells with 5'-bromo-2 1-deoxyuridine 
(BUdR), by mutagenesis of virus with UV light, or by 
treatment of whole virus DNA or viral DNA fragments 
with nitrous acid, UV light or hydroxylamine (Timbury, 
1971; Brown et al., 1973; Schaffer et al., 1973;
Esparza et al., 1974; Manservigi, 1974; Chu et al., 
1979; Sandri-Goldin et al., 1981). Complementation 
analyses of HSV-1 ts-mutants have identified at least 
35 different cistrons (Schaffer et al♦, 1978; V.
Preston, personal communication) suggesting that at 
least half the genes encoded by HSV are essential for 
virus growth in tissue culture.
In HSV-2, the study of ts mutants has been limited and 
only 20 different complementation groups have been 
identified (Timbury et al., 1976; Schaffer et al.,
1978).
- g o -
16.1.2 Host Range Mutants
An alternative approach to the one used above for 
selecting mutations in essential genes has been to make 
host range mutants. This has been achieved by 
transforming tissue culture cells with cloned 
restriction endonuclease fragments from WT virus.
Mutant viruses containing an inactive essential gene 
will only grow on cell lines expressing the WT gene. 
Host range mutants with defects in Vmwl75 (Davidson and 
Stow, 1985; DeLuca et al. , 1985), gB (Cai et al., 1987) 
and the MDBP (Minson et al., 1978; Oberg and Schaffer,
1987) have been isolated and characterised.
16.2 Mutations in Nonessential Genes
Nonessential genes have been inactivated by insertions 
into the DNA; for example, the dUTPase gene (Preston 
and Fisher, 1984), or deletion of sequences, for 
example VmwllO (Stow and Stow, 1986).
A novel method to produce specific deletions in a virus
genome and thus identify nonessential genes has been
described by Post and Roizman (1981). This method is
composed of two steps: The selectable TK gene marker is
inserted into the target DNA sequence, and this
fragment is cotransfected into cells with TK viral
DNA. Recombinant virus, where the TK is inserted into
+
the target region, can be identified as TK progeny.
+
Cotransfection of this TK virus DNA with a plasmid
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containing a deletion in the target sequence will
klrc
result in TK virus progeny which carry^deletion. The 
isolation of such TK virus indicates that the target 
gene is nonessential in tissue culture (Hubenthal-Voss 
and Roizman, 1985; Longnecker and Roizman, 1986). 
Specific nonessential genes have also been identified 
by a selection process, for example gC (Holland et 
ad., 1983), where gC mutants were isolated from a 
mutagenised virus stock by means of resistance to 
anti-gC antibodies, and TK (Kit and Dubbs, 1963; Dubbs 
and Kit, 1964) where treatment of virus-infected cells 
with BUdR enabled the isolation of TK /BUdR resistant 
viruses.
t
From studies on dispensable genes it has become 
apparent that many genes are not required for growth in 
tissue culture. Evidence is emerging from studies of 
mutants with deletions in Us that all of these genes, 
with the possible exception of gD, are nonessential for 
virus growth in vitro (Longnecker and Roizman, 1986, 
1987; Mavromara-Nazos et al., 1986a; Umene, 1986;
Brown and Harland, 1987; Weber et al., 1987).
16.3 Drug Resistance Mutants
The virus TK will phosphorylate a variety of nucleoside 
analogues, converting them from inactive to active 
agents which normally interfere with viral DNA
replication by becoming incorporated into viral DNA and 
causing chain termination. Viruses exposed to these
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drugs acquire resistance by mutation in the TK or virus
polymerase genes. Many drug resistant mutants have an
inactive TK gene. These TK viruses obtain dTMP by
means of the cellular de novo pathway, and are,
therefore, able to grow in tissue culture (Elion et
+
ad., 1977; Field et al., 1980). TK , acycloguanosine 
resistant mutants, which encode an altered viral DNA 
polymerase that fails to recognise the phosphorylated 
nucleoSide analogue, have also been detected 
(Crumpacker et al., 1980; Darby et al., 1981). Drug 
resistant mutants have been very useful in determining 
the possible effects of antiviral drugs used in vivo. 
Interestingly, as is the case in vitro, most 
acycloguanosine drug resistant mutants isolated in vivo 
have mutations in the TK gene and not the DNA 
polymerase.
16.4 Syncytial (syn) Mutants
At least four loci which can give rise to syncytial 
plaque morphology have been identified in HSV-1 (Figure 
3). Viruses with a syncytial phenotype are known as 
syn mutants. Little and Schaffer (1981) mapped the 
plaque morphology defect (syn 4) in the HSV-1 KOS syn 
mutant, 804, to 0.040-0.064 mu on the genome, and noted 
a reduction in the size of the gB dimer in
mutant virus-infected cells. It was not determined, 
however, whether the syn mutation was responsible for 
this alteration of gB. Later work on the HSV-1 mutant,
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tj3B5, identified a syn locus (syn 3) at the carboxyl 
terminus of gB, separate from the gB ts mutation in 
this mutant (DeLuca et al., 1982). A syn locus (syn 5) 
was also detected to the right of the TK gene (Sanders 
et al., 1982). Ruyechan et al. (1979) claimed that two 
further loci were present at 0.70-0.83 mu (syn 1, syn 
2). However, further analysis of this region 
identified only a single syn gene (syn 1 ) which lies 
within 0.735-0.740 mu. A mutation affecting virus 
plaque size (Bond and Person, 1984; Pogue-Geile et al.,
1984) was also identified in this region, and this 
lesion maps within a gene predicted to encode a 
trans-membrane protein (Debroy et al., 1985).
t
In addition to these loci, gC can also affect plaque 
morphology. There appears to be an as yet undefined 
relationship between gC and the formation of syncytia, 
since many syn mutants are gC , but not all gC 
mutants have the syn plaque morphology.
16.5 Genetic Interactions of HSV
Recombination in HSV was first reported by Wildy (1955)
who used lesion morphology in chick-chorioallantoic
membranes and virulence in mice as markers of
recombination. The ability of HSV to recombine was
confirmed by Subak-Sharpe (1969) who demonstrated the 
+
presence of ts recombinants amongst the progeny virus 
from cells mixedly infected with two different ts
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mutants. Subsequent analyses of recombination 
frequencies from crosses with ts mutants led to the 
construction of linear linkage maps (Brown et al.,
1973; Schaffer et al., 1974; Timbury and Calder, 1976). 
In a later study, the segregation of a variety of 
unselected markers amongst selected recombinant progeny 
was measured to determine the degree of linkage (Honess 
et al., 1980). In contrast to earlier findings, the 
results obtained were consistent with a circular 
genetic map, and it was proposed that recombination 
normally occurred between circular or concatemeric DNA 
molecules. This model was supported by a study on PRV 
recombination in which the appearance of both 
recombinant genomes and virus was monitored (Ben Porat 
et al., 1982). Evidence from this work suggested that 
recombination occurred mainly between parental genomes 
rather than progeny genomes and that it took place 
prior to DNA replication. These findings contrast with 
earlier data of Ritchie et al. (1977), who found that
the frequency of recombination increased with time, 
indicating that both parental and progeny genomes 
participate in the process of recombination. The 
discrepancy between the two sets of data has yet to be 
resolved.
Recombination also occurs between HSV-1 and HSV-2 
(Timbury and Subak-Sharpe, 1973; Esparza et al., 1976), 
and crossover sites have been detected in all regions
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of the genome (Preston et al. , 1978; Ruyechan et al., 
1979). Intertypic recombinants and ts mutations have 
been exploited to map viral polypeptides on the virus 
genome (Marsden et al., 1978; Morse et al. , 1978; 
Preston et al♦, 1978; Ruyechan et al♦, 1979) and this 
approach, together with the technique of marker rescue 
(Stow et al. , 1978; Stow and Wilkie, 1978; Chartrand et 
al., 1979, 1981), has greatly facilitated the location 
of genes on the virus genome, and proved to be much 
more reliable than mapping by recombination analysis.
As well as participating in generalised recombination 
between genomes, HSV also undergoes intramolecular
and TRj^  which
results* in the inversion of Us relative to 1^. It is 
thought that inversion occurs by site-specific 
recombination between inverted copies of the a sequence 
(Mocarski et al., 1980; Mocarski and Roizman, 1981;
Chou and Roizman, 1985), and that this process is 
mediated by as yet unidentified, trans-acting, viral 
gene products (Mocarski and Roizman, 1982b). Although 
the a sequence is particularly active in the inversion 
of Us and UL , recent work (Longnecker and Roizman,
1986) has shown that a second, less active site of 
inversion is present within the b sequence of the Ij 
repeat.
recombination between IRg and TRg or IR^
CHAPTER 2
MATERIALS
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Viruses
+
Seed stocks of wild type HSV-1 strain 17 syn (Brown et al. ,
1973) and wild type HSV-2 strain HG52 (Timbury, 1971) were
provided by Mrs M Murphy. The HG52 mutant, ts2203, was
isolated by Dr V G Preston and contained one of the ts
lesions present in the HG52 multiple mutant tsl3. A cloned
Bglll i fragment from tsl3 was recombined into wild type
HG52 by marker rescue and the mutant ts22Q3 was isolated
from this transfection experiment. Five independently
+
isolated revertants of ts2203, which were ts for growth at 
the NPT, were supplied by Dr V G Preston. These viruses 
were ts2203 rev-1, rev-2, rev-3, rev-4 and rev-5.
Wild type HSV-2 strain HVD25766 was kindly provided by Dr A 
C Minson, Cambridge. The tsl3 mutation in Bglll i fragment 
was transferred to this strain by marker rescue and the
+
resulting ts virus isolate was referred to as ts2204. A ts 
+
virus, ts 2204 (MR-1) was obtained by recombining cloned 
+
ts HG52 Bglll i into ts2204. Since ts2204 was subsequently
shown to have a secondary ts mutation, a second ts mutant,
+ +
ts2205, and ts virus ts 2205(MR-2), were constructed in the
+
same way as ts2204 and ts 2204(MR-1).
The HSV-1 strain 17 mutant tsl201 (Preston et al., 1983) was 
supplied by Dr V G Preston.
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TISSUE CULTURE CELLS AND MEDIUM
BHK C13 cells (Macpherson and Stoker, 1962) were used 
throughout this study.
These cells were grown in lx Glasgow modified Eagle's medium 
(Busby et al., 1964), supplied as a lOx concentrate by Gibco 
Ltd. This medium was supplemented with 100 units/ml 
penicillin, lOOug/ml streptomycin and 0.2ug/ml amphotericin.
The following modified tissue culture media were also used:
ECn Eagle's medium containing n% calf serum
EHUn Eagle's medium containing n% human serum
Agar overlap Eagle's medium containing 5% calf serum
and 0.6% Noble 's agar
PLASMIDS
The plasmids pGZ73 and pGZ74 were constructed by Dr M 
Dalrymple and obtained from Dr V G Preston.
The construct containing HSV-2 HVD25766 BamHI a was kindly 
supplied by Dr A C Minson, Cambridge. pGZl containing HSV-2 
HG52 BamHI g was obtained from Dr V G Preston.
The remaining plasmids, pTKN2 (Cordingley et al., 1983), 
pGX158, pMCl and pMC4 (Campbell et al., 1984) were all 
obtained from Dr C M Preston.
Information about the composition of the above plasmids is 
given in Table 2 and a detailed description of the 
construction of these recombinant clones is given in the 
Results, Sections 3 and 4.
Table 2
Host bacteria and composition of recombinant plasmids 
used in this study
References:
1. Vieira and Messing (1982).
2. Hanahan (1983).
3. Bolivar et al (1977).
4. Brenner (1979).
5. Twigg and Sherratt (1980).
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RADIOCHEMICALS
Radiolabelled compounds were obtained from Amersham 
International pic.
CHEMICALS
Analytical grade reagents were used wherever possible. 
Chemicals were obtained from the following suppliers: BDH
Chemicals, Poole, England; BioRad Laboratories, California, 
USA; Koch-Light Laboratories, Suffolk, England; Pharmacia 
Fine Chemicals, Uppsala, Sweden; Sigma (London) Ltd.
Reagents for electron microscopy were obtained from Agar 
Aids, Stanstead, Essex, and Taab Laboratories, Emmer Green, 
Reading. *
ENZYMES
Restriction endonucleases were obtained from Bethesda 
Research Laboratories (UK) Ltd, Cambridge, England.
OLIGONUCLEOTIDES
Phosphorylated Xbal oligonucleotide linkers were obtained 
from Pharmacia Fine Chemicals.
IMMUNOLOGICAL REAGENTS
Fluorescein isothiocyanate—conjugated rabbit anti—mouse IgG 
and rabbit anti—mouse I9G were purchased from Miles—Yeda 
Laboratories, Israel. Non-immune (pre-immune) rabbit serum 
was obtained from the Scottish Antibody Production Unit, 
Glasgow, Scotland. Protein-A sepharose was supplied by
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Pharmacia Fine Chemicals, Sweden.
The monoclonal antibody LPI, specific for Vmw65 (McLean 
et al., 1982) was obtained from Dr A C Minson.
MISCELLANEOUS
Nitrocellulose membranes were obtained from Schleicher and
Schull, Dassel, West Germany. Photographic film was
2
supplied by Kodak Ltd, London. Plastic 850cm roller 
bottles used for tissue culture were obtained from Becton 
Dickinson, Oxford. Plastic Petri dishes were supplied by 
Nunclon Ltd.
t
-100-
STANDARD SOLUTIONS 
Phosphate buffered 
Saline (PBS)
PBS-calf
Tris-Saline
Versene 
Trypsin * 
Giemsa stain
Reticulocyte soluble 
1.5mM buffer (RSB) 
TSE
NTE
Hepes buffered 
saline (HEBS)
170mM NaCl, 3.4mM KC1, lOmM 
Na2 HP04 , 2mM KH2 P04 pH7 . 2 
(Dulbecco and Vogt, 1954).
PBS, 5% calf serum (v/v).
140mM NaCl, 30mM KC1, 280mM Na2 
HPO^lmg/ml glucose, 0.0015%
(w/v) phenol red, 25mM 
Tris-HCl pH7.4, 100 units/ml 
penicillin, lOOug/ml 
streptomycin.
0.6mM EDTA in PBS containing 
0 .002% (w/v) phenol red.
0.25% (w/v) trypsin in 
tris-saline.
1.5% (w/v) giemsa in glycerol 
o
heated at 56 for 120min and 
diluted with an equal volume 
of methanol.
lOmM Tris-HCl pH7.5, lOmM KC1,
MgCl2•
lOmM Tris-HCl pH8.0, ImM EDTA,
0.25% (w/v) SDS.
lOmM Tris-HCl pH7.5, lOOmM
NaCl, ImM EDTA.
130mM NaCl, 4.9mM KC1, 1.6mM Na2HP04 
5.5mM D-glucose, 21mM HEPES 
(N-2-hydroxyethylpiperazine-N'-2- 
ethane-sulphonic acid) pH7.05.
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Plating medium
Cell lysis buffer
Gel Soak I (lx)
Gel Soak II (lx)
Nick translation 
buffer
T4 DNA polymerase 
»
Denhardt's buffer 
(x5)
Hybridization buffer
SSC buffer (20x)
TE buffer (lx) 
Resolving gel buffer
Stacking gel buffer
SDS-polyacrylamide
50% (conditioned) EC10, 44% (fresh) 
EC10, 10% HEBS, 0.4mM CaCl2 .
0.6% SDS, lOmM EDTA, lOmM 
Tris-HCl pH 7.4.
200mM NaOH, 600mM NaCl.
ImM Tris-HCl pH8.0, 0.59M 
NaCl.
50mM Tris-HCl pH7.5, 5mM MgCl2 , 
50ug/ml BSA, ImM DTT.
330 mM tris acetate pH7.9, 600mM 
buffer potassium acetate, lOOmM 
magnesium acetate, 5mM 
dithiothreitol, lmg/ml BSA.
0.1% (w/v) Ficoll, 0.1% (w/v) 
polyvinyl pyrollidone, 0 .1%
(w/v) BSA.
5 x Denhardt's buffer, 0.1%
(w/v) SDS, 6 x SSC, 30ug/ml 
denatured calf thymus carrier DNA. 
3M NaCl, 0.3m tri-sodium 
citrate.
lOmM Tris-HCl pH7.4, ImM EDTA.
1.5M Tris-HCl pH8 .9, 0.4%
(w/v) SDS.
0.49m Tris-HCl pH6.7, 0.4%
(w/v) SDS.
53mM tris, 53mM glycine, 0.1%
(w/v) gel tank buffer SDS.
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Dye Ficoll
TBE buffer (lOx)
Electro-elution
Zweig's buffer
t
Elution buffer
Washing buffer
TK Lysis buffer
TK reaction buffer
15% (w/v) Ficoll, 0.2% (w/v) 
bromophenol blue, lOOmM EDTA 
(pH8 .0).
8 .9mM Tris-HCl pH8.3, 8 .9mM 
boric acid, 0.3mM EDTA containing 
0.5mg/ml ethidium bromide.
0.05M sodium acetate, 0.01M 
EDTA, buffer (xlO) 0.4M Tris-HCl 
pH7.5.
0.1M Tris-HCl pH8, 10% 
glycerol, 0.5% NP40, 0.5% sodium 
deoxycholate, 0.2mM 
phenylmethylsulphonyl fluoride 
(PMSF).
2% SDS, 20% glycerol, 5% (v/v) 
^-mercapthoethanol, 0.125M Tris-HCl 
pH6.8, 0.004% (w/v%) bromophenol 
blue.
600mM LiCl, lOOmM Tris-HCl pH7.4,
1% (v/v)£$-mercaptoethanol.
20mM Tris-HCl pH7.5, 2mM MgCl2 , 
lOmM NaCl, 0.5% (v/v) NP40, 6 .5mM 
j^-mercaptoethanol (added just 
prior to use).
lOOmM sodium phosphate buffer
(pH6.0), 50um, dTTP, 5mM ATP,
3
lOmM MgCl2 , lOOuCl[ H]-thymidine/ 
ml.
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STET buffer
Ligation buffer 
L-broth
Permeabilization
buffer
Fix solution
8% (w/v) sucrose, 5% (v/v)
NP40, 50mM EDTA, 50mM Tris-HCl, pH 
8.0.
20mM Tris-HCl pH7.5, lOmM MgCl2 , 
lOmM DTT, ImM ATP.
170mM NaCl, 10g/l Difco 
bactotryptone, 5g/l yeast 
extract.
10% (w/v) sucrose, 1% calf serum, 
0.5% buffer (v/v) NP40, (in PBS). 
2% (v/v) formaldehyde, 2%
(w/v) sucrose (in PBS).
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METHODS
1 - Cell Culture
o 2
BHK C13 cells were grown at 37 in rotating 850cm
culture bottles containing 200ml ETC10 in an
atmosphere of 95% air, 5% CO . A confluent
8
monolayer of approximately 3 x 10 cells from one
2
bottle was used to seed five further 850cm 
bottles.
Cells were harvested by washing the monolayers
first with 20ml versene, then with 40ml
trypsin:versene (1:1). The cells were shaken off
the glass and resuspended in culture medium.
*
6
A density of 2 x 10 cells per 50mm petri dish and 
6
1 x 10 cells per 30mm dish was sufficient to
obtain subconfluent monolayers after an overnight
o
incubation at 37 .
2. Virus Culture
2.1 Production of Virus Stocks-  2 
Confluent BHK cell monolayers in 850cm glass
roller bottles were infected with a moi of 0.003
pfu virus per cell in 50ml EC5. After incubation 
o
at 31 for 3-4 days when extensive CPE had
developed, virus-infected cells were shaken into
the medium and pelleted at l,500rpm for 15min at 
o 
4 .
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Cell-released virus in the supernatant was
concentrated by centrifugation at 12,000rpm for 2h 
o
at 4 . The virus pellet was resuspended in
virus-infected cell medium by sonication, and 
o
stored at -70 .
The virus-infected cell pellet was sonicated in a 
small volume of EC5 to release cell-associated 
virus, and the cell debris was removed by
o
centrifugation at 3,000rpm for 15min at 4 . The
sonication step was repeated if necessary and the
cell-associated virus stocks were pooled and
o
stored in aliquots at -70 .
2.2 Sterility Check
Medium from virus-infected cells was streaked onto
o
blood agar plates and incubated at 31 for 3-5 
days. Any virus stocks containing bacteria which 
grew on blood agar were discarded.
2.3 Titration of Virus Stocks
Serial tenfold dilutions of virus stock were made
in PBS-calf. The medium was removed from 75-90%
confluent cell monolayers, and lOOul of diluted
virus was added to each dish. Following virus
o
absorption for 45-60min at either 37 (for plates
o
to be incubated at the PT) or 38.5 (for plates to 
be incubated at the NPT), cells were overlaid with
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4ml EHU5 to prevent the spread of virus plaques. After
°  °  
incubation at 38.5 for 2 days or 31 for 3 days, the
medium was removed from the dishes and the cells
stained with Giemsa for lOmin at RT. The monolayers
were washed with water to remove the stain, and virus
plaques were counted under a dissecting microscope.
2.4 Virus Plaque Purification from Cells Overlaid with Agar 
Medium
A single plaque together with the overlying agar medium
were scraped up into a Pasteur pipette, transferred to
o
500ul PBS-calf, sonicated and stored at -70 prior to 
virus titration.
2.5 Ts Mutant Infections
o
Virus infections were carried out at the PT(31 ) or NPT 
o
(38.5 ). Cell monolayers were incubated at the
required temperature for a minimum of 15min prior to
the addition of virus, and the overlay medium was
o
pre-warmed to 42 before use. All manipulations at the 
NPT were carried out as rapidly as possible to prevent 
any drop in temperature.
+
2.6 Isolation of Spontaneous ts Revertants of ts2203
Single plaques were isolated from a low passage stock
o
of ts2203 titrated on BHK cells at 31 . BHK cell 
monolayers from five 50mm petri dishes were infected 
with virus from a single plaque and a small seed stock
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o
grown up at 31 . The seed stocks were titrated at the 
NPT and any cell monolayers showing CPE after 
incubation for 2 days were harvested. Progeny virus 
from each cell monolayer were tested for the ability to 
form plaques at the NPT. Those which grew at the NPT 
were plaque-purified once at the NPT and twice at the 
PT.
+
Seed stocks from five ts revertants, all derived from 
different plaques of ts2203, were made and each used to 
grow up a larger virus stock.
2.7 Single-step Growth of Virus
Subconf^luent monolayers of BHK cells in 30mm dishes
were infected at a moi of 5pfu virus per cell at the PT
or NPT. After incubation for lh, the cells were washed
3x with PBS-calf to remove unabsorbed virus and
overlaid with 1.5ml EC10. At various times post
absorption, the cells were scraped into medium,
o
sonicated and the virus stored at -70 prior to 
titration at the PT.
2.8 Virion Thermostability Assay
5
Virus stocks at a concentration of 1x10 pfu per ml PBS
containing 0.05% calf serum, in plastic 15ml Falcon
o
tubes, were incubated in a water bath at 40 . At 
various times lOOul aliquots were removed and added to
900ul PBS-calf serum. Samples of virus were stored at
o °
-70 prior to titration on BHK cells at 31 .
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2.9 Recombination Assay
BHK cells in 30mm dishes were infected at a moi of
lOpfu virus per cell (5pfu of each virus in mixed
o
infections). After incubation for lhr at 31 
monolayers were washed twice with PBS-calf to remove 
any unabsorbed virus and incubated in 1.5ml EC10 for 
24h at the PT.
Virus-infected cells were scraped into the growth
o
medium, sonicated and stored at -70 before virus 
titration at the PT and NPT. Recombination could then 
be assessed by growth at the NPT.
3. Preparation of Viral DNA
3.1 Large-Scale Preparation of Virion DNA
Virus-infected cells showing extensive cpe (normally 
2
from 5-10 850cm roller bottles), were harvested into
the medium, pelleted by low speed centrifugation and
resuspended in 20ml RSB containing 0.5% NP40. After
incubation on ice for lOmin, the sample was centrifuged
o
at 2,500rpm for lOmin at 4 to separate the nuclei from
the cytoplasmic fraction. The pellet of nuclei and
cell debris was resuspended in 20ml RSB-NP40 buffer,
left on ice for lOmin and centrifuged again. The
cytoplasmic supernatant fractions were then combined
with the virus-infected cell medium and the virus
o
concentrated by centrifugation for 2-3h at 4 .
The virus pellet was sonicated in 5ml NTE and lysed by
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the addition of SDS to a final concentration of 2%
(w/v). The virus DNA sample was sequentially extracted
three times with phenol saturated with TE, once with
chloroform, incubated overnight at RT with RNase I (10
o
ug/ml), and finally treated with proteinase K at 31 
for l-2h. The solution was then deproteinised with an 
equal volume of phenol:chloroform (1:1 ), followed by 
extraction with chloroform. Sodium acetate was added 
to a concentration of 0.3M and the viral DNA was 
precipitated by the addition of 2 volumes of ethanol. 
The DNA was pelleted by low speed centrifugation, 
lyophilised and resuspended in 2-3ml TE.
3.2 Small-scale Preparation of Virus-infected Cell DNA
6
BHK cell monolayers (4x10 cells per 50mm dish) were 
infected with a moi of 5pfu virus per cell at the 
required temperature. After incubation for 18h, the 
cells were harvested and either total virus-infected 
cell DNA or encapsidated DNA prepared from the samples.
3.3 Total Virus-infected Cell DNA
The medium was removed from the cells and cell-released
virus pelleted by centrifugation at 18,000rpm for lh at 
o
4 in an SS34 rotor. The virus pellet and cells were
incubated in 2ml lysis buffer, containing 500ug/ml
o
pronase for 4h at 37 . NaCl was added to a final 
concentration of 200mM, and the DNA sequentially 
extracted once with phenol:chloroform (1 .1 ), once with
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chloroform, and precipitated in ethanol. The DNA 
pellet was lyophilised and resuspended in 400ul H 0 
containing lOug/ml RNase I.
3 . 4 Encapsidated (DNase resistant) DNA
The medium was removed from the dishes and cell
released virus was concentrated as described for the
total virus DNA. The virus pellet and cells were
incubated in 0.5ml RSB containing 0.5% (v/v) NP40,
o
lOOug/ml DNase I for 2h at 37 . SDS, EDTA and pronase
were then added to concentrations of 0.5%, lOmM and
500ug/ml respectively, and the sample was incubated for
o
a further 2h at 37 .
t
Virus DNA was purified as described previously.
4. Analysis of Viral DNA
4.1 Restriction Endonuclease Digestion of DNA
DNA was digested with restriction endonuclease using 
conditions recommended by the suppliers.
4.2 Separation of Restriction Endonuclease DNA Fragments
4.2.1 Agarose Gel Electrophoresis
Large DNA fragments were separated on horizontal
0.8-1.0% (w/v) agarose gels. DNA samples in 10% (v/v)
dve Ficoll were loaded into wells formed with plastic
2
combs, and the gel was electrophoresed at 2—lOv/cm in 
lx TBE buffer containing 0.5ug/ml EtBr at RT for 
16-24h. The separated fragments were visualised under
UV light.
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4 -2 *2 Polyacrylamide Gel Electrophoresis (PAGE)
DNA fragments in a size range of 70-1,000 bp were
separated by PAGE. Gels were prepared from 80ml 10-16%
polyacrylamide (using a stock solution of
acrylamide/N-N'-methylene bisacrylamide in a ratio of
29:1 (w/w) in 0.55xTBE. Ammonium persulphate and
N,N,NT-N'-tetramethylethylene diamine (TEMED) were
added to a final concentration of 0.006% (w/v) and
0.004% (w/v) respectively to polymerise the gel. DNA
fragments in 10% (v/v) dye Ficoll were loaded on to the
2
gel and separated by electrophoresis at 3v/cm for 
16-24h in 0.55x TBE.
DNA bands were visualized under UV light after the gel 
had been stained in 0.55xTBE containing 0.5ug/ml EtBr 
for 30min.
4. 3 Southern Blot Analysis
4.3.1 Transfer of DNA Fragments to Nitrocellulose
The experimental procedure used was essentially the 
same as the method described by Southern (1975). DNA 
restriction endonuclease fragments were separated by 
agarose gel electrophoresis, and the gel piece 
containing the DNA was shaken gently in 0.2M HC1 at RT 
to depurinate the DNA. After 30min, the gel was washed 
in deionised water and treated with GSI for 60min to 
denature the DNA. This solution was neutralized by 
soaking the gel in GSII for 60min.
-112-
The gel was transferred onto Whatman 3mm filter paper, 
the ends of which were in contact with a reservoir of 
lOxSSC buffer. A sheet of moistened nitrocellulose was 
placed on top of the gel and any air bubbles were 
smoothed out. Four sheets of 3mm filter paper, 
slightly smaller than the gel, were placed over the 
nitrocellulose sheet and a weighted stack of paper 
towels laid on top acted as a wick to draw the lOxSSC 
from the reservoir.
The next day the nitrocellulose paper was removed and
washed in 2xSSC, air dried and baked in a vacuum oven 
o
at 72 for 2hrs. To ensure that efficient transfer of 
DNA fragments from agarose to nitrocellulose had 
occurred, blotted gels were soaked in lxTBE containing 
lmg/ml EtBr for 30min and visualised under shortwave UV 
light.
32
4.3.2 In Vitro [ P]-Labelling of DNA by Nick
Translation (Rigby et al., 1977)
The reaction mixture (50ul), containing plasmid DNA
-6
(0.2-0.6ug), 1x10 mg/ml DNase I, lxNT buffer, 20uM
o
dATP and 20uM dTTP, was placed in a 37 water bath for
32
2-3min prior to the addition of lOuCi each of fcX.- P] 
32
-dCTP and p]-dGTP together with 1 unit of E. coli
o
DNA polymerase I (pol I). After incubation at 16 for 
2hrs, the reaction was terminated by the addition of 
20mM EDTA, and the sample extracted once with 
phenol:chloroform (1:1 ).
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32
Unincorporated [ot- P]-dNTPs were separated from the 
32
[ P]-labelled DNA by fractionation through a Sephadex
column. The DNA was collected in a lOOul volume and
denatured in 0.2M NaOH at RT for lOmin. The solution
was neutralised by the addition of 0.2M HC1. A
7 8
specific activity of 1x10 -1x10 cpm per ug plasmid DNA 
was routinely obtained.
4.3.3 Separation of Deoxyribonucleotide Triphosphates
32
from [ P]-labelled DNA: The Spun Column Technique 
(Maniatis et al., 1982)
A small plug of sterile siliconised glass wool was
inserted into a 1ml disposable syringe and the syringe
was theh placed in a 1.5ml reaction vial. A solution
of fine Sephadex G50 in TE was spun through the syringe
o
at 3,000rpm for 2min at 4 . This procedure was 
repeated until the volume of Sephadex G50 retained in 
the syringe was 0.8-1.0ml. A lOOul volume of TE was 
spun through the column, followed by lOOul of 
nick-translated DNA in TE which was collected into a 
fresh reaction vial.
4.3 ..4 DNA Blot Hybridisation
High stringency conditions of hybridisation based on 
those described by Southern (1975) and Denhardt (1966) 
were used.
Vacuum—dried nitrocellulose filters were incubated in 
20ml of hybridisation buffer in sealed plastic bags
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o
submerged in a shaking water bath at 72 . After 2-3h,
this solution was replaced with fresh hybridisation
7 32
buffer containing 2x10 cpm denatured [ P]-labelled
o
DNA probe, and incubation was continued at 72 for a 
further 16-18hrs. Following hybridisation, the 
nitrocellulose sheets were washed four times in 2xSSC, 
once in lxSSC and once in 0.5xSSC.
All washes contained 0.36% SDS and lOmM sodium
pyrophosphate. Blots were air-dried and placed in
contact with Kodak X-Omat XS-1 film and a DuPont
o
phosphotungstate intensifying screen at -70 for 4-24h.
5. Insertion of Oligonucleotide Linkers into Plasmid DNA
5.1 Production of Linear Partial DNA
Plasmid DNA (2ug) was digested for various times with 2 
units of a multi-cutting restriction endonuclease in 
the presence of decreasing concentrations of EtBr to 
determine the optimal conditions for the production of 
linear partials of the plasmid DNA.
Digested DNA was analysed on a 0.8-1.0% agarose gel and 
. a bulk restriction was carried out under optimal 
conditions. The linear DNA was then eluted from 
agarose gel slices.
5.2 Purification of DNA from Agarose Gels
DNA was eluted from agarose gel by high-voltage
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electrophoresis in elution buffer, and purified by 
sequential extraction in saturated butan-2-ol, 
phenol:chloroform (1:1) and finally chloroform. Sodium 
acetate (pH6 .6 ) was added to a final concentration of 
0.3M and the DNA precipitated with an equal volume of 
isopropanol. After 2h at RT, the DNA was pelleted at 
10,000rpm for 10 min, lyophilised and resuspended in 
TE.
5.3 Ligation of Linear Partial Plasmid DNA with a 6bp 
Oligonucleotide Linker Fragment
Purified linear partial DNA was treated with 5 units of
calf intestinal phosphatase in 50mM Tris-HCl, O.lmM
o
EDTA (pH8.0) for 60min at 37 . The DNA was extracted 
once wi\:h phenol: chloroform (1 :1 ), once with 
chloroform, and precipitated with isopropanol in the 
presence of 0.3M sodium acetate (pH6 .6 ).
o
Plasmid DNA (10-50ng) was incubated overnight at 4 
with a 10-100 x molar excess of Pharmacia Xbal 
(5'TCTAGA 3 1) phosphorylated oligonucleotide linker in 
a total volume of lOul containing 1-2 units of T4 DNA 
ligase in lx ligation buffer.
5 .4 The Production of Competent Bacteria and DNA 
Transfections
The method used was based on that described by Cohen et 
al., (1972). E.coli K12 strain DH-1 was grown in
L-broth to an optical density (OD 590nm) of 
approximately 0.2. The cells were pelleted at 3,000
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o
rpm for 10 min at 4 , and resuspended in 1/4 volume 
ice-cold lOOmM CaCl^. After incubation on ice for 
60min, the cells were concentrated by centrifugation 
and resuspended in 1/10 volume of ice-cold lOOmM CaCl, .
A sample of cells were tested for competence using
uncleaved vector DNA. Plasmid DNA (lOng) was added to
lOOul of the cells and the sample was left on ice for
60min before heat-shock treatment for 90-120sec at 
o
42-45 . The bacteria were then added to 1.5ml L-broth
o
and shaken at 37 . After 60min, lOOul samples were 
plated onto L-broth agar containing lOOug/ml
o
ampicillin, and plates were incubated overnight at 37 .
6
Routinely, more than 1 x 10 colonies per ug plasmid
vector were obtained, and since the competence of DH-1
bacteria increases 5-fold after an overnight incubation 
o
at 4 , competent bacteria were added to the ligation 
reactions 16h after their initial preparation.
5.5 Small-scale Preparation of Plasmid DNA (STET 
Preparations)
(A Modification of the method described by Maniatis et
. al., [1982] )
Bacteria from a single colony were grown in 1.5ml
L-broth containing lOOug/ml ampicillin in an orbital 
o
shaker at 37 for 16-18h. After being pelleted at 
10,000rpm for 90sec, the cells were resuspended in 75ul 
STET buffer, treated with 6ul lOmg/ml lysozyme (Holmes
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and Quigley 1981) and boiled for l-2min before 
centrifugation at 10,000rpm for lOmin. The supernatant 
was retained and extracted sequentially once with 
phenol:chloroform (1 :1 ) and once with chloroform. 
Plasmid DNA in a solution containing 0.3M sodium 
acetate was precipitated with an equal volume of 
isopropanol, pelleted at 10,000rpm for lOmin, 
lyophilised and resuspended in 40-50ul lOmM Tris-HCl 
(pH7.4).
5 .6 Bulk Preparation of Plasmid DNA
This is based on the procedure described by Godson and
Vapnek (1973). A flask containing 11 L-broth
supplemented with lOOug/ml ampicillin (for growth of
E.coli K12 MRC1, 50ug/ml diaminopimelic acid and
200ug/ml N-acetyl glucosamine were also added) was
inoculated in 10ml of an overnight bacterial culture,
o
and incubated at 37 in an orbital shaker for 6-7h.
Chloramphenicol was added to a final concentration of
25ug/ml, and incubation was continued for a further
16h. The bacteria were pelleted by centrifugation at
o
8,000rpm for 5min at 4 , and resuspended in 25ml 25% 
•sucrose on 50mM Tris-HCl pH7.9. The mixture was 
incubated on ice for 30min at which time EDTA (pH7.9) 
was added to a final concentration of 50mM. Five 
minutes later, NaCl and SDS were added to final
concentrations of 750mM and 2.5% (w/v) respectively.
o
After incubation at 4 for 2-3h, the sample was
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o
centrifuged at 20,000rpm for 60min at 0 to remove 
debris and high molecular weight bacterial DNA. The 
resulting supernatant was extracted once with 
phenol:chloroform (1 :1 ), once with chloroform, and the 
DNA was precipitated with 2 volumes of ethanol in the 
presence of 0.3M sodium acetate. The pelleted DNA was 
washed with 70% ethanol, lyophilised and incubated 
overnight in 2-5ml lOmM Tris-HCl pH7.5 containing 
lOug/ml RNase I. The DNA was then further purified by 
equilibrium centrifugation on caesium chloride-ethidium 
bromide gradients.
5.7 Caesium-chloride-ethidium bromide Gradients (CsCl-EtBr)
To eacfi ml of plasmid DNA preparation, lg caesium
chloride was added to give a solution with a final
density of 1.55g/ml. This solution, plus ethidium
bromide (500ug/ml), was centrifuged at 45,000rpm for 
o
18h at 15 in a Beckman TV865 rotor. The tubes were 
examined under long wave UV light, and the lower band 
of DNA, representing supercoiled plasmid DNA, was 
withdrawn through a syringe inserted in the side of the 
tube.
The ethidium bromide was removed by sequential 
extraction of the solution with isopropanol saturated 
with caesium chloride. After overnight dialysis 
against TE buffer to remove the caesium chloride, the 
DNA was concentrated by ethanol precipitation, and 
pelleted by centrifugation.
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5 .8 Storage of Bacterial Stocks
Concentrated bacteria were resuspended in 40% glycerol,
o
1% bactopeptone broth, and stored at -20 .
6 . Expression of TK in Transfected Cells
6 .1 Transfection of Plasmid DNA into BHK Cells
Calcium chloride was added to a solution containing a
total of 3ug DNA (a mixture of test plasmid and carrier
DNA) to a final concentration of 136mM in lx HEBS. The
solution was briefly mixed and left for 30min at RT to
allow the formation of a fine precipitate. The
suspension was added dropwise to drained, 50% confluent
cell monolayers in 30mm dishes and the cells were 
o
incubafed at 37 . After 45min the cells were overlaid
o
with 2ml plating medium and incubation continued at 37
for 3-4h at which time cells were treated with 25% DMSO 
for 4 mins
in lx HEHSJT” After extensive washing to remove DMSO,
o
cells were incubated for 16h at 37 in EC10.
6 .2 Preparation of Cell Extracts
Cells were washed once with ice-cold PBS, scraped into
lml of PBS and pelleted by centrifugation at 10,000rpm
. for 2min. The cell pellet was resuspended in 150ul
ice-cold lysis buffer and samples incubated on ice for
5min. The vials were then briefly vortexed and placed
on ice for a further 5min. After a final vortex, the
samples were centrifuged at 10,000rpm for 2min, and the
supernatant was retained for immediate use, or frozen
o
in dry ice and stored at -70 .
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6 .3 Thymidine Kinase Assay
Routinely, 50ul of reaction mixture containing 5ul of
cell extract, lOOmM sodium phosphate buffer (pH6.0),
lOmM MgCl , 50um dTTP, 5mM ATP and lOOuCi 
3 o
[ H]-thymidine/ml were incubated at 30 for 60min. The
reaction was terminated by the addition of lOul of 2mM
thymidine.
o
The tubes were heated for 3min at 100 in a heating
block, incubated on ice for 5min and centrifuged at
10,000rpm for 2min. A sample (40ul) of the supernatant
was spotted onto DE81 discs, and when dry, the discs
were washed three times in a solution of 4mM ammonium
o
formate*, lOmM thymidine for lOmin at 37 , followed by a 
brief wash in 100% ethanol. Discs were dried under a 
heat lamp, placed in scintillation vials with 5ml 
scintillation fluid (Ecoscint) and counted in a 
scintillation counter for lmin.
7. Marker Rescue Technique
Experiments were performed as described by Stow et al., 
(1978) with the modifications of Preston (1981).
Calcium chloride was added to a final concentration of 
130mM in a 500ul solution containing 0.5ug intact 
mutant virion DNA, a 10-fold molar excess of an HSV DNA 
fragment and lOug/ml calf thymus carrier DNA in HEBS. 
Samples were then left undisturbed for 5min at RT to
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allow the development of a fine suspension which was
added to drained BHK cell monolayers in 50mm dishes.
o
After incubation at 37 for 45min, the monolayers were
o
overlaid with EC5 and incubation was continued at 37 .
At about 4h from the time of addition of DNA to cells,
the transfected cells were washed once with EC5 and
boosted with 1ml 25% (v/v) DMSO in hepes for 4min at
RT. The monolayers were washed three times in EC5 to
remove the DMSO, and cells were incubated in 4mls EC10 
o
at 31 for 3-4 days until extensive CPE had developed. 
Cells were scraped into the growth medium, disrupted by 
sonication and virus yield at both the PT and the NPT 
determined.
8 . Analysis of Virus-induced Polypeptides
8 .1 Preparation of Radiolabelled Cell Extracts
Subconfluent monolayers of BHK cells in 30mm dishes
were infected at a moi of 20 pfu virus per cell. After
o o
incubation for 45min at either 31 or 38.5 , cells were 
washed once with EC5 to remove any unabsorbed virus, 
overlaid with EC10, and incubated at either the PT or 
•NPT until the designated labelling time.
35
8 .2 Labelling Polypeptides with [ S]-methionine 
Virus-infected cells were washed once with pre-warmed
PBS and incubated in pre-warmed PBS containing
35
lOOuCi/ml [ S]-methionine for l-2h. The monolayers
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were washed three times with PBS before harvesting.
8 .3 Harvesting Radiolabelled Infected Cells for Analysis by 
SDS-PAGE
Virus-infected cells were harvested in 300ul disruption
o
buffer and stored at -70 .
8.4 Immunoprecipitation
Radiolabelled virus-infected cells were harvested in
500ul Zweig's buffer, transferred to glass vials and
sonicated. After incubation on ice for 60min, samples
were centrifuged at 10,000rpm for 5min. The
o
supernatant was retained and stored at -70 until 
required.
Routinely, 25ul antigen (equivalent to approximately 1 
6
x 10 cpm) was incubated on ice with lOul rabbit
anti-mouse immunoglobulin and 20ml of a 1/40 dilution
of monoclonal antibody LPI. After 3h, 70ul Protein A
Sepharose (33% w/v suspension) was added and samples 
o
rotated at 4 for 60min.
• Immunoprecipitates bound to Protein A Sepharose were 
washed 6 times by centrifugation at 10,000rpm for 20sec 
followed each time by resuspension in 50ul lithium 
chloride washing buffer. The samples were finally
o
resuspended in 50ul disruption buffer, heated at 100 
for 5min, then centrifuged at 10,000rpm for 5 min. The 
supernatant was analysed by SDS-PAGE.
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8 .5 SDS-PAGE
Polypeptides were separated on 8% polyacrylamide gels 
(acrylamide was crosslinked with 1 part in 40 (w/w)
N,N'-methylenebisacrylamide) in resolving gel buffer. 
Ammonium persulphate (0.006% w/v) and TEMED (0.004% 
v/v) were added to the solution to polymerise the gel. 
After the gel had been poured, it was overlaid with 
1/4-strength resolving gel buffer to ensure a smooth 
gel surface on polymerisation.
A stacking gel, containing 5% polyacrylamide (with the
same ratio of acrylamide to N,N'-methylenebisacrylamide
as above) in stacking gel buffer was poured on top of
the resolving gel and a Teflon comb inserted to form
the wells. Samples were boiled for 5min and loaded
into the wells, and the gels electrophoresed at 0.45 
2
A/cm for 3-4h in fresh tank buffer.
8.6 Fluorography
Gels were fixed in a solution of methanol:water:acetic
acid (50:50:1) for lh, soaked for 18h in a solution of
methanol:water:acetic acid (5:88:17), treated with 
3
. En hance (New England Nuclear, Boston, USA) for lh at
RT, and rehydrated in water for 30min at RT. Gels were
then dried onto a sheet of Whatman (3mm) filter paper 
o
at 80 under vacuum, placed in contact with flashed
o
X-Omat XS-1 film at -70 , and the film exposed for a 
minimum of 18h.
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8 .7 Immunofluorescence Assay
The procedure used was essentially that of Randall
and Dinwoodie (1986). Cells were grown to 25%
confluence on 13mm diameter coverslips, infected with
virus at a moi of 5 pfu per cell, or mock infected
(mi), and incubated at the PT or the NPT. At 8h pi,
the growth medium was removed and the cells were fixed
in a solution of 5% formaldehyde. After lOmin at RT,
the coverslips were washed four times in PBS containing
1% calf serum (wash buffer), immersed in 
e
bilisation buffer for 5min at RT, and then washed 
three more times with wash buffer.
LPI monbclonal antibody (25ul of a 1/40 dilution in 
wash buffer) was added to each coverslip, and the 
samples were left for 60min at RT. Unbound antibody 
was removed by washing the coverslips in wash buffer. 
Cells were incubated at RT for a further 60min in 25ul 
isothiocyanate-conjugate rabbit anti-mouse 
immunoglobulin diluted 1:40 in wash buffer. Coverslips 
were washed lx in permeabilisation buffer, 4x in wash 
buffer and lx in water, then mounted in Gelvatol on 
glass slides. Fluorescence was visualised under a 
Leitz UV microscope with an appropriate filter for 
maximum absorption of fluorescein isothiocyanate 
conjugate.
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9. Electron Microscopy
9.1 Preparation of Samples for Thin Sectioning
Monolayers of BHK cells in 30mm dishes were infected
with a moi of 5 pfu virus per cell, and incubated at 
o o
31 or 38.5 . At various times after infection,
samples were harvested; the growth medium was removed
and the cells were washed three times with ice-cold PBS
before being fixed in l-2ml 2.5% (v/v) glutaraldehyde
o
in PBS. After at least lh at 4 , the cells were 
scraped into the glutaraldehyde-PBS solution and 500ul 
of cell suspension transferred to a soft Beem capsule. 
The cells were centrifuged at 5,000rpm for lOmin and 
the pellet washed three times with ice-cold PBS. Cells 
were subsequently treated with 1% (w/v) osmium 
tetroxide for 60min, washed three times with PBS and 
sequentially dehydrated in solutions of 30%, 50%, 70%, 
90% and 100% (v/v) ethanol in PBS for a minimum of 
90min in each solution.
Cells were left overnight in fresh ethanol (100%) and
embedded, first in 50% (v/v) epon resin in ethanol,
then in 100% epon resin. Finally, samples were
o
incubated in fresh 100% epon resin at 65 for 2 days to 
polymerise the resin.
9.2 Thin Sectioning
Thin sections of virus-infected cells embedded in resin 
were cut with a Rawleyer diamond knife or a glass knife 
on a Reichart-Jung Ultramicrotome and collected on
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parlodium-coated copper grids. The samples were
stained for 60min with saturated uranyl acetate in 50% 
(v/v) ethanol, rinsed in deionized water, counter 
stained with lead citrate for lOmin and examined at 
60-100Kv in a Jeol 100s electron microscope.
9.3 Virus Particle Counts
Virus stock was mixed with an equal volume of a latex 
bead suspension of known concentration and the same 
volume of phosphotungstic acid (1% (v/v) pH6.2). A 
small sample was spotted onto a parlodium coated copper 
grid, air dried, and examined in the electron 
microscbpe.
The numbers of latex beads and virus particles in a 
minimum of 10 fields of the grid were determined, and 
the concentration of particles in the virus stock 
calculated.
CHAPTER 3
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3. CHARACTERISATION OF THE HSV-2 MUTANT, TS2203, WHICH HAS 
A TS DEFECT IN A GENE ENCODING A STRUCTURAL POLYPEPTIDE
Introduction
The mutant, ts2203, was derived from the HG52 multiple
mutant tsl3, one of thirty-three ts mutants isolated
from HG52 virus mutagenised with BUdr (Timbury, 1971).
Thirteen of these mutants (tsl...tsl3) were classified
into different complementation groups (Timbury, 1971;
Halliburton and Timbury, 1976) and analysed
biochemically (Halliburton and Timbury, 1973, 1976).
Tsl3, which produced limited amounts of viral DNA at
the NPT, was the only virus unable to induce 
«
virus-specific alkaline exonuclease activity at the NPT 
(Francke et al., 1978). In addition to this defect, 
tsl3 was shown to have a thermolabile virus particle 
(Halliburton and Timbury, 1976), and this phenotype was 
thought to result from a second ts lesion in the virus, 
within a gene encoding a structural polypeptide (Moss 
et al., 1979 ).
+
This was later confirmed by the isolation of ts
o
: revertants of tsl3 which were thermostable at 39 but
which retained the apparently non-lethal alkaline
exonuclease defect (Moss et al., 1979). The particle
defect was subsequently mapped to a different portion
conditional
of the genome from the exonuclease lesion. Thejn.ethal 
ts mutation was located within the region common to 
EcoRI 1 and Xbal d (mu 0.638 to 0.700) by intra- and
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intertypic marker rescue (Chartrand et al. , 1981), 
whilst the defect in the alkaline exonuclease gene was 
mapped within 0.145-0.185mu using a modified marker 
rescue assay (Moss et al., 1979; Moss, 1986). Further 
work suggested that the structural polypeptide affected 
by the ts lesion in t^sl3 was Vmw65, a major component 
of the tegument; the monoclonal antibody, MA1044, 
specific for Vmw65, failed to react with the tsl3
+
polypeptide, but did recognise Vmw65 induced by a ts
revertant of tsl3 (H Moss and J Palfreyman, personal
communication).
«
More recently, Campbell et al. (1984) demonstrated that 
the HSV-1 Vmw65 virion polypeptide was also the 
trans-inducing factor (TIF) of IE transcription, and 
this aspect is dealt with in Section 4. Vmw65, 
therefore, appears to have a dual role in the growth of 
the virus; it is important at very early times of the 
lytic cycle for accelerating IE transcription and at 
late times it is present as a major component of the 
virion. To study the structural role of Vmw65, the ts 
mutation within mu 0.622 to 0.720 in ts!3 was cloned 
from the virus, recombined into WT HG52, and the mutant 
ts2203 isolated.
3.1 Growth Properties of ts2203- o
As well as the ts phenotype at 38.5 , ts2203 grew
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o
less well than WT HG52 at: 31 , as demonstrated by a
one-step growth experiment (Figure 13), and ts22Q3
virus stocks had titres generally 5-10 fold lower than
o
those of WT HG52. This property at 31 correlated with 
a high number of non-infectious virus particles in 
ts2203 stocks, where the particle: pfu ratio was 
approximately 1^ times higher than that of HG52 (Table 
3).
3.2 Ts2203 has a ts Lesion in the Vmw65 Gene
Evidence that ts2203 has a ts lesion within the Vmw65 
gene was obtained using a variety of experimental 
approaches.
3.2.1 Intratypic Marker Rescue
The marker rescue technique has been extremely useful 
in mapping mutations to very small regions on the HSV 
genome. Using this approach, it has been possible to 
rescue a mutant with a DNA fragment as small as 320bp 
(Preston, 1981), although clearly, marker rescue with a 
fragment of this size is at the limits of the 
technique.
Initially, pGZ74, containing tsl3 Bglll i, was analysed 
for the ability to marker rescue ts2203 (Table 4a). 
pGZ74 failed to do this, suggesting that the ts!3
Figure 13
Growth of ts2203 and HG52
Subconfluent monolayers were infected at a moi of 5pfu
virus per cell with ts2203 or wild type (WT) HG52 and
o
incubated at 31 for 2 to 31h pi. Cells were harvested
o
and virus titrated at 31 .
r 7-
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ts2203
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Table 3
Particle: pfu ratios of HSV-2 HG52 and ts2203 virus 
stocks
Table 3
Particle: pfu ratio
2
3x10
3
5x10
HG52
ts2203
Table 4
Summary of marker rescue results for ts2203
a. Control samples, Bglll i digested pGZ73, and Bglll 
i digested pGZ74,
b. Unseparated Kpnl plus Bglll, digested pGZ73 DNA,
c. Separated Kpnl plus Bglll; Kpnl, Bglll plus
Xbal, digested pGZ73 DNA,
«
d. Unseparated Xhol-, SstI- and BamHI- digested pGZ73 
DNA,
were used in marker rescue experiments. The relative 
efficiency of plating (eop NPT/PT) was calculated from 
the yield of progeny virus from the transfected cells.
Table 4
HSV-2 DNA Fragment eop NPT x 100 Rescue
PT
pGZ73
pGZ74
(HG52 
(tsl3
Bglll
Bglll
i)
i)
ts2203 virus
b. Unseparated Kpnl digested pGZ73
c. Separated Kpnl fragments of pGZ73:
Kpnl c t 
Kpnl i 
Kpnl s 
Kpnl cl 
Kpnl c2
d. pGZ73 (HG52 Bglll i) 
pGZ74 (£$13 Bglll i)
ts2203 virus
Unseparated BamHI digested pGZ73
pGZ73 (HG52 Bglll i) 
pGZ74 (tsl3 Bglll i) 
ts2203 virus
Unseparated Xhol digested pGZ73 
Unseparated SstI digested pGZ73
47.368
0.002
0.0001
9.000
8.700
0.152
0.700
9.600
0.0042
140.000
0.001
0.0002
0.00006
66.670
0.083
0.067
0.001
0.003
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lesion had indeed been transferred to the HG52 virus in 
ts2203.
To fine map the ts mutation within ts2203 Bglll i, 
pGZ73 (HG52 Bglll i) was digested with Kpnl and Bglll 
(Figure 14), and marker rescue performed with the 
unseparated fragments (Table 4b). As the result was 
positive, the fragments were separated by agarose gel 
electrophoresis, and used individually in marker rescue 
(Figure 15, Table 4c). These results suggested that 
the mutation was within the Kpnl c fragment, and the 
map location was further refined using Kpnl, Bglll and 
Xbal digested fragments of pGZ73 in the marker rescue 
experiment. The addition of Xbal to the digestion 
cleaved Kpnl c, producing two smaller fragments, termed 
here Kpnl cl, and Kpnl c2 (Table 4c).
Unseparated fragments of BamHI-, Xhol- or Sstl- 
digested pGZ73 were also assessed for marker rescue of 
ts2203 (Table 4d). However, no rescue was observed, 
and it was concluded that the restriction sites for 
these enzymes lie close to the position of the ts; 
lesion, rendering the fragments incapable of rescue.
Figure 14
Map of restriction endonuclease sites within HG52 
Bglll i fragment (0.622-0.720mu)
Kpnl and Kpnl plus Xbal fragments used in marker rescue 
experiments are given, together with the fragments 
generated by BamHI digestion of Bglll i.
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Figure 15
Restriction fragments of HSV-2 Bglll i (pGZ73)
The restriction endonuclease fragments indicated in 
Figure 14 were generated by digestion of pGZ73 with 
Bglll (track 1); BamHI plus Bglll (track 2); BamHI 
(track 3); Kpnl (track 4); Kpnl plus Bglll (track 5); 
Kpnl,1 Bglll plus Xbal (track 6 ).
Fragments are: (a) Bglll i; (b) BamHI a; (c) Kpnliand 
Kpnl c (track 5)/ Kpnl i (track 6 ); (d) Kpnl cl; (e) 
BamHI k; (f) BamHI w (tracks 2,3); (g) Kpnl c2 (track 
6 ); Ch) pUC9 vector; (i) Kpnl s (tracks 4,5,6).
HSV fragments carrying vector sequences in tracks 3 and 
4 are not labelled.
CO 
CD
1 2 3 4 5 6
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Therefore, the failure of BamHI unseparated fragments, 
and the ability of the Kpnl c fragment, to rescue the 
ts2203 lesion, suggests that it lies close to the BamHI 
site at 0.678 or 0.695mu within Kpnl c (0.676 to 0.790 
mu). This information is summarised in Table 4, and 
the map locations of the fragments are given in Figure 
14.
3.2.2. Intertypic Marker Rescue
The HSV-1 cloned DNA BamHI f fragment (in pGX158) and 
plasmid pMCl, which encode the HSV-1 Vmw65 gene, were 
analysed for the ability to marker rescue ts2203. The 
results (Table 5) suggested that the HSV-1 Vmw65 gene 
had rescued ts2203, indicating that the ts lesion in 
^ts2203 is located within the HSV-2 gene homologous to 
HSV-1 Vmw65.
+
3.2.3. Ts Revertants of ts2203
+
Stocks of five independently isolated ts revertants of 
+
ts2203, (ts revl...rev5), were grown up from seed
stocks supplied by Dr V G Preston, and the eop NPT of
PT
each virus determined (Table 6 ). The fact that the eop
NPT of these viruses is similar to WT virus confirmed 
PT
MR data suggesting that ts2203 contains a single ts 
mutation.
Table 5
Marker rescue of ts2203 with HSV-1 and HSV-2 DNA 
fragments
pGX158 (containing HSV-1 BamHI f), pMCl (containing 
HSV-1 Vmw65), pGZ73 (containing HG52 Bglll i) and pGZ74 
(containing ts;13 Bglll i) DNA, digested with BamHI, 
EcoRI plus -EcoRV, Bglll and Bglll, respectively, were 
tested for the ability to marker rescue ts2203.
The results from *2 independent experiments are shown.
Table 5
HSV DNA Fragment eop NPT (xlOO) (xlOO) Rescue 
PT
ts2203 alone 0.001 0.002
pGZ73 (HG52 Bglll i) 80.000 35.900 +
pGZ74 (tsl3 Bglll i) 0.010 0.250
pGX158 (HSV-1 BamHI f) 9.000 2.700 +
pMCl (HSV-1 Vmw65) 4.800 1.000 +
Table 6
Eop NPT/PT of ts+ revertants of ts2203
Table 6
Eop NPT of ts revertants of ts2203 
PT
Virus eop NPT
PT
2.0
1.6
1.8
0.9
1.2
2.0
HG52
+
ts rev-1 
+
ts rev-2 
+
ts rev-3 
+
ts rev-4 
+
ts rev-5
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3.3 The Location of Vmw65 Gene within HSV-2 Bglll i
The results of the marker rescue experiments showing 
that pMCl, which contains HSV-1 Vmw65, rescues ts2203, 
together with earlier work on tsl3 using a monoclonal 
antibody specific for Vmw65 (Moss and Palfreyman, pc), 
strongly suggested that the ts2203 lesion mapped within 
the Vmw65 gene. In order to determine the location of 
Vmw65 within HSV-2 Bglll i, pMCl was cross-hybridised 
to subfragments of pGZ73, which contains HG52 Bglll i.
3.3.1 Cross-hybridisation of HSV-1 and HSV-2 Vmw65
In orde’r to remove vector sequences, pGZ73 was digested 
with Bglll, and the fragments separated by agarose gel 
electrophoresis. HSV-2 Bglll i DNA was then recovered 
from the larger fragment band by elution of DNA from 
the agarose gel slices (Section 2.5.2). Digestion of 
pMCl with EcoRI and EcoRV similarly removed the pUC9 
(2.7kb) vector together with 5' noncoding sequences 
adjacent to the Vmw65 coding region (Figure 16).
Bglll i DNA was digested with the restriction 
endonucleases BamHI, Kpnl and Kpnl plus Xbal. The 
separated fragments (Figure 17) were transferred from
an agarose gel onto nitrocellulose membrane, and the
32
DNA was then hybridised with [ P]-labelled HSV-1 Vmw65 
DNA under low stringency hybridisation conditions to 
promote annealing between HSV-1 and HSV-2 DNA.
Figure 16
Structure of pMCl
pMCl contains approximately 2.7kb HSV-1 sequences, 
including Vmw65, ligated into pUC9.
Details of the structure of pMCl are given in Section 
4 and Figure 49. :
pUC9 
2.7Kbp
I m
I* 0) o
:= 81 33
 <
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<
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«■
Vmw65 
2.7Kbp
Figure 17
Separation of HSV-2 Bglll i DNA fragments 
32
[ P]-labelled (tracks 1-4) and unlabelled (tracks 5-8) 
HSV-2 Bglll i DNA was digested with Bglll (tracks 1,5); 
BamHI (tracks 2,6); Kpnl (tracks 3,7) and Kpnl plus 
Xbal (tracks 4,8), and fragments separated 
electrophoretically on a 1% agarose gel.
Fragments are: (a) Bglll i; (b) BamHI a (c) Kpnl i,
Kpnl c; (d) Kpnl cl; (e) BamHI k; (f) Kpnl c2 (tracks 
4,8); (g) BamHI w (tracks 2,6) and (h) Kpnl s.
<D 
O
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Where Bglll i DNA was digested with BamHI, the 
fragments BamHI a, BamHI k and BamHI w were produced. 
Digestion with Kpnl resulted in three fragments, Kpnl i 
and Kpnl c, which migrate together, and Kpnl s, a much 
smaller fragment. The addition of Xbal to a Kpnl 
digestion resulted in the separation of Kpnl i, Kpnl cl 
and Kpnl c2 (Figures 17 and 18a).
The results of hybridising unlabelled, digested HSV-2
32
Bglll i DNA with [ P]-labelled HSV-1 Vmw65 are shown 
in Figure 18^. The HSV-2 Bglll i control fragment 
hybridised with HSV-1 Vmw65 (track 1), as did the BamHI 
a fragment (track 2), but not BamHI k or BamHI w. 
Similarly, Kpnl s, which is contained within the BamHI 
a fragment, hybridised with HSV-1 Vmw65, but the 
addition of Xbal to the Kpnl digest of HSV-2 Bglll i 
showed that of the large Kpnl fragments, only Kpnl cl 
hybridised with the HSV-1 sequences.
These results, together with the marker rescue results, 
are summarised in Figure 19. The results suggest that 
in HSV-2 Bglll i the sequences colinear to HSV-1 Vmw65 
extend through Kpnl s into Kpnl c, but are not present 
in BamHI w, or are limited to such a small region that 
they cannot be detected by hybridisation.
Figure 18
Cross-hybridisation of HSV-1 and HSV-2 Vmw65 gene
sequences
32
a. [ P]-labelled HSV-2 Bglll i DNA digested with (1) 
Bglll, (2) BamHI, (3) Kpnl, (4) Kpnl plus Xbal.
b. Unlabelled HSV-2 Bglll i DNA digested as in a. and
32
hybridised with [ P]-labelled HSV-1 Vmw65 DNA.
HSV-2 fragments bfybridising with HSV-1 Vmw65 are 
indicated.
a. is a composite of two exposures of the sample, and
c. represents the exposure for tracks 3 and 4, plus 
overexposure of tracks 1 and 2 .
a) 1 2 3 4 b) 1 2 3 4
Bglll i  ►
♦
4 * ■ BamHI a *
9' • * Kpn I n  ► Kpnl c
■  j k
■J
v [ w Kpnl cl ^* t
t  4 . Kpnl s ►
a
1 2  3 4
c)
j
Figure 19
Summary of marker rescue and cross-hybridisation data 
The map locations of HSV-2 Bglll i restriction 
endonuclease fragments which rescued ts2203, and those 
which hybridised with HSV-1 Vmw65 are given, together 
with the location of Vmw65 on the HSV-2 genome as 
determined by this data.
The proposed location of the ts lesion in ts2203, 
bounded by Kpnl and BamHI at (0.676 and 0.678mu) 
restriction endonuclease sites is also given.
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From the mapping data, the region between the Kpnl site 
at 0.676mu and BamHI site at 0.678mu is approximately 
300bp. HSV-2 Bglll i, pGZ73, was digested with Kpnl, 
BamHI or Kpnl plus BamHI. On separation by agarose gel 
electrophoresis, a unique 600bp fragment was produced, 
indicating that available HSV-2 HG52 restriction maps 
are inaccurate in this region (Figure 20).
The results therefore indicate that the bulk of HSV-2 
Vmw65 lies between the Kpnl site at 0.664mu and BamHI 
site at 0.678mu, approximately 2.17kbp, and that the ts 
lesion*is located towards the 5' terminus of the gene 
in a 600bp subfragment of Kpnl cl. In addition, there 
may be some 5 ’ regulatory sequences of Vmw65 located 
within BamHI w, and 3' sequences within BamHI a.
3.4 Thermolability of ts2203 Virus Particle
Early work on tsl3 (Halliburton and Timbury, 1976)
suggested that one of the ts lesions in this virus was
in a structural polypeptide, since tsl3 virions were 
o
unstable at 39 . Ts2203 was similarly analysed to
determine if the virion instability was due to a lesion 
in the Vmw65 gene, rather than a secondary defect 
present in ts!3.
Samples of HSV-2 HG52, ts2203 or tsl3 virus stocks were
o
incubated in plastic tubes at 40 for 0-8h, and
Figure 20
Restriction endonuclease digestions of pGZ73 (HG52 
Bglll i)
Samples were digested with BamHI (track 3), Kpnl (track 
4) and BamHI plus Kpnl (track 5), and separated on a 1% 
agarose gel. A unique fragment of approximate size, 
600bp, was generated by the BamHI/Kpnl digest. pAT DNA 
digested with Hinfl (track 2) and DNA, digested with 
EcoRI plus Hindlll (track 6 ), were used as size 
markers. *
Track 1 = undigested pGZ73.
Fragments were also separated on a 2% agarose gel, but 
no further fragments were detected.
1 2 3 4 5 6
1.63
0.517
21.8
5.24,
5.05/4.21
3.41
1.98
1.90
1.57
1.32
0.93
0.84
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o
aliquots removed at various times were titrated at 31 
for virus infectivity.
The results (Figure 21) demonstrate that ts2203, like
o
tsl3, was more thermolabile at 40 than wild type HG52 
virus, indicating that a ts lesion in the Vmw65 gene 
affects the stability of the virus particle.
3.5 Analysis of ts2203-infected Cell Polypeptides 
The polypeptide profiles of WT virus- or 
ts2203-infected cells were analysed at the PT and the 
NPT to identify any differences induced by the presence 
of a ts lesion in the Vmw65 gene.
Mock-infected cells or cells infected with HG52 or
o o
ts2203 were incubated at 31 or 38.5 , labelled with 
35
[ S]-methionine for lh at various times pi, harvested, 
and the radiolabelled polypeptides analysed by SDS 
PAGE. Figures 22 and 23 show autodiagrams of the 
electrophoretically separated polypeptides.
The polypeptide profiles of ts2203- and WT HG52 virus- 
infected cells at the PT and NPT were very similar, 
consistent with the suggestion that at the NPT the 
block to ts2203 infection occurs late in the virus 
growth cycle, after DNA replication. One noticeable 
difference, however, was that the Vmw65 induced by
Figure 21
Thermolability of the HSV virion
4
Virus samples containing 1 x 10 pfu per ml of HG52,
o
ts2203 or tsl3 were incubated at 40 . Aliquots were
removed at various times, diluted, and virus titrated
o
on BHK cells at 31 . Results are given as percentage 
(%) of virus infectivity at Oh.
10CH
90
80
70
60
50
40
30
20
10
0
time(h)
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ts13
ts2203
Figure 22
Autoradiogram of electrophoretically separated 
polypeptides from mock-and virus-infected cells 
incubated at the NPT
35
Cells were labelled with [ S]-methionine from 2-3h 
(tracks 1-3) and 6-7h pi (tracks 4-6) and harvested. 
Protein samples were analysed on a 9% single 
concentration SDS-polyacrylamide gel.
mock-infected (MI*) cell polypeptides (tracks 1, 4); 
HG52-infected cell polypeptides (tracks 2, 6 ); 
ts2203-infected cell polypeptides (tracks 3, 5).
MWxIO3 1 2 3 4 5 6
Vmwl57
Vmw65
Vmw45
Figure 23
Autoradiogram of electrophoretically separated 
polypeptides from mock-and virus-infected cells 
incubated at the PT
35
Cells were labelled with [ S]-methionine from 4-5 
(tracks 1-3), 6-7 (tracks 4-6) and 7-8 (tracks 7-9)h pi 
and harvested. Protein samples were analysed on a 9% 
single concentration SDS-polyacrylamide gel (SDS Page).
mock-infected (MI*) cell polypeptides (tracks 1, 4, 7); 
ts2203-infected cell polypeptides (tracks 2 , 5 , 8 ); 
HG52-infected cell polypeptides (tracks 3, 6, 9).
MWxlo3 1 2 3 4 5 6  7 8  9
Vmwl57
Vmw65
Vmw45
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o o
ts2203 at both 31 and 38.5 migrated slightly faster 
than the WT species. This finding is in agreement with
earlier results of Moss and Palfreymanj who also found
/ ’
that tsl3 Vmw65 had a lower apparent MW than HG52 WT 
Vmw65.
3 .6 Analysis of Vmw65 Synthesised by ts2203
Ts2203 Vmw65 is recognised by the monoclonal antibody, 
LPI, specific for Vmw65.
As mentioned earlier, previous work by Moss and
Palfre^man (personal communication) suggested that the
structural defect in tsl3 was located within the Vmw65
gene. This conclusion was based on the finding that
MA1044, the type-common monoclonal antibody to Vmw65
+
immunoprecipitated WT HG52 and tsl3 ts revertant 
Vmw65, but not the Vmw65 synthesised by tsl3 at the PT 
or the NPT. In addition, these workers noted that the 
tsl3 Vmw65 synthesised at both these temperatures had 
an aberrant mobility on SDS PAGE.
Analysis of polypeptides induced by ts2203 (Figures 22 
and 23) demonstrated that the Vmw65 synthesised at both 
the PT and NPT by this virus had an altered mobility on 
SDS PAGE, in agreement with the findings of Moss and 
Palfreyman, suggesting that the production of an
-137-
aberrant polypeptide was due to the presence of a
lesion in Vmw65 gene rather than an alternative
+
location. To further examine this, ts revertants of 
ts2203 were analysed for the synthesis of an altered 
Vmw65.
Immune precipitation experiments using a second
monoclonal antibody to Vmw65, LPI, were carried out on
extracts prepared from cells infected with WT HG52,
+
ts2203 and each of five independently isolated ts 
revertants of ts2203, and incubated at the PT or NPT. 
SDS PA(3e of the immune precipitations revealed that LPI 
recognises Vmw65 synthesised by ts2203 as well as that 
synthesised by each of the revertant viruses (Figures 
24 and 25).
+
Ts rev-1, rev-2 and rev-4 Vmw65 had the same
electrophoretic mobility as the WT polypeptide
indicating that the ts mutation itself is responsible
for the alteration in the apparent MW of Vmw65.
+
However, ts rev-3 and rev-5 Vmw65 retained the
aberrant mobility of the ts2203 species, suggesting
that these viruses retained the original mutation
affecting Vmw65 mobility, and have a second mutation
+
converting the virus to the ts phenotype.
Figure 24
+
Analysis of Vmw65 induced by HG52, ts2203 or ts 
revertants of ts2203
o +
Cells infected at 38.5 with HSV-2 HG52, ts2203 or ts
+
revertants of ts2203, (ts rev-1... rev-5), were 
35
labelled with [ S]-methionine from 5-6h pi, and 
harvested into Zweig's buffer. Immunoprecipitation was 
carried out using monoclonal antibody LPI which is 
specific for Vmw65. Immunoprecipitated polypeptides 
were analysed on 'a 9% SDS polyacrylamide gel.
Tracks 1-8 = whole cell extracts of mock infected (MI)
+
(track 1), HG52 (track 2), ts2203 (track 3), ts 
rev-1... rev-5 (tracks 4-8 respectively) infected cells.
Tracks 9-16 = immunoprecipitations of MI (track 9),
+
HG52 (track 10), ts2203 (track 11), ts rev-1... rev-5 
(tracks 12-16 respectively), virus infected cell 
polypeptides.
cell extracts Immunoprecipitations
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Figure 25
+
Analysis of Vmw65 induced by HG52/ ts2203 or ts 
revertants of ts2203
o +
Cells infected at 31 with HSV-2 HG52, ts2203 or ts
+
revertants of ts2203, (ts rev-1... rev-5), were 
35
labelled with [ S]-methionine from 5-6h pi, and 
harvested into Zweig's buffer. Immunoprecipitation was 
carried out using monoclonal antibody LPI which is 
specific for Vmw65. Immunoprecipitated polypeptides 
were analysed on*a 9% SDS polyacrylamide gel.
Tracks 1-8 = whole cell extracts of mock infected (MI)
+
(track 1), HG52 (track 2), ts2203 (track 3), ts 
rev-1... rev-5 (tracks 4-8 respectively) infected cells.
Tracks 9-15 = immunoprecipitations of MI (track 9),
+
HG52 (track 10), ts2203 (track 11), ts rev-1... rev-5 
(tracks 12-16 respectively), virus infected cell 
polypeptides.
MWxlO cell extracts Immunoprecipitations
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
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It can be concluded, "therefore, since LPI recognises
+
ts2203 Vmw65, as well as the WT and ts revertant 
Vmw65, that the epitope recognised by this antibody is 
not affected by the ts mutation.
3 . 7 Cellular Location of Vmw65
Immunofluorescence assays were performed to determine
the intracellular location of Vmw65 synthesised by
+
HG52, ts2203 and ts revertants of ts2203.
Hfl cells were infected at the PT or NPT for 6-8h, then 
fixed &nd permeabilised, and incubated with monoclonal 
antibody LPI and fluorescein, or control serum. Cells 
were examined for fluorescence under UV light (Figure 
26) .
+
In WT-, ts2203- and ts 2203 revertant-infected cell 
samples, grown at either the PT or NPT, Vmw65 was 
distributed throughout the cell cytoplasm and nucleus, 
although more intense immunofluorescent staining was 
observed in the nucleus. Since Vmw65 is .present in 
the nucleus and is a component of the capsids prior to
envelopment, it is not surprising that it is
predominantly nuclear in location. Moreover, the 
results suggest that the localisation of ts2203 Vmw65
within the cell st the NPT is unaffected by the
Figure 26
+
Localisation of Vmw65 in ts2203, HG52 and ts revertant 
virus-infected cells
o
Immunofluoresence at 38.5 Monolayers of Hfl cells were
mock infected (MI) or infected with 5pfu HSV-2 HG52,
+
ts2203 or ts rev-1, rev-2, rev-3, rev-4 or rev-5.
Cells were harvested at lOh pi and prepared for 
immunofluorescence assay with
a. LPI, a type cdmmon monoclonal antibody specific for 
Vmw65 or
b. rabbit control serum (RCS).
+
ts revertant viruses were indistinguishable in their
+
reactions to the antibodies, and ts rev-1 only is 
shown here.
MI Cells + LPI (1), + RCS (2); HG52-infected cells +
LPI (3), + RCS (4); ts2203-infected cells + LPI (5), + 
+
RCS (6 ); ts 2203 rev-1 infected cells + LPI (7), + RCS
o o
(8 ). Samples were identical at 38.5 and 31 , 
o
therefore 38.5 samples alone are shown here.

5 6
8
x S
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ts lesion. It is, therefore, likely that the lesion in 
the gene directly affects the ability of Vmw65 to 
participate in virion assembly.
3 .8 Ts2203 Bglll i Stimulates IE Gene Transcription at the
PT and NPT
Previous experiments have shown that HSV-1 Vmw65, 
encoded within HSV-1 sequences present in pMCl 
(Campbell et al., 1984) can trans-activate HSV IE gene 
transcription in vitro. From the marker rescue data, 
cross-hybridisation studies and immunological evidence, 
it appears that the ts lesion in ts22Q3 is located 
within the Vmw65 gene. It was, therefore, of interest 
to determine whether the ts2203 defect affected IE gene 
transcription at the NPT.
Preliminary experiments (M Dalrymple, 1986) suggested 
that the ts lesion in tsl3 Bglll i did not impair the 
ability of Vmw65 to stimulate TK expression from 
plasmid pTKN2, a chimaeric plasmid in which the HSV TK 
coding sequences were linked to the IE175 promoter 
sequences (Section 4.1, Figure 44). Using a short term 
cotransfection assay, plasmids pGZ73 (containing WT 
HSV-2 Bglll i) and pGZ74 (containing tsl3 Bglll i) were 
compared with pMCl for the ability to stimulate TK 
activity from pTKN2.
-140-
o
All three DNA clones stimulated TK expression at 31 
o
and 38.5 (Table 7), confirming that the ts lesion in 
ts2203 does not affect the transcriptional function of 
Vmw65.
3.9 Electron Microscope Analysis of ts2203- and HG52- 
infected Cells Grown at the PT and NPT
Defects in capsid assembly or viral DNA encapsidation
can easily be detected using the electron microscope,
since empty, partially cored and dark-staining capsids
containing DNA can be clearly differentiated under the
electron microscope. Therefore, to determine whether
the ts2203 lesion affected virus assembly, samples of 
6HVC
virus-infected\cells grown at the PT or NPT were 
examined under the electron microscope and compared with 
WT virus-infected cell samples.
o
At 31 , in both HG52 and ts2203-infected cells, large 
quantities of capsids, including numerous fully cored 
capsids, and enveloped virus particles, were visible. 
However, although both HG52 and ts2203 synthesised 
numerous capsids at the NPT, very few of the capsids 
had dense cores (Figure 27, Table 12). This suggested
V
that both viruses packaged DNA inefficiently at the 
NPT, and in addition, very few enveloped virus 
particles were observed.
Table 7
Stimulation of IE-TK expression by pGZ73, pGZ74 and 
pMCl
Each of the above 3 plasmids was assayed for the
ability to stimulate TK activity when co-transfected
into cells with pTKN2, containing the IE175 promoter
linked to TK coding sequences.
The results are presented as cpm plasmid
cpm pTKN2
Table 7
Level of Stimulation
o o
Cloned HSV DNA 31 38.5
pMCl 8.65 5.50
pGZ73 8.78 15.83
pGZ74__________________________ 7.81_____ 10.73
Figure 27
Electron microscopic analysis of HG52 and 
ts2203-infected cells
Cells were infected at a moi of 5pfu virus per cell at 
the NPT and uncubated for 18h. They were then 
harvested and embedded in epon resin. Thin section 
preparations of virus-infected cells were examined 
under the electron microscope. The bar representsQ5um.
1,2 = ts2203-inf&cted cells 
3,4 = HG52-infected cells
P = partially cored capsid ; <3
F = dense-cored capsid ;
E = empty capsid ; <
Nu = nucleus; Cy = cytoplasm.
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Therefore, although the results indicated that the 
lesion in ts2203 does not affect the synthesis of 
capsids, it was difficult to ascertain whether there 
were any differences between the mutant and wild type 
virus at the stage of viral DNA encapsidation or capsid 
envelopment.
3.10 Synthesis of DNA in HG52 and ts2203-infected Cells 
The results from electron microscopic analysis 
suggested that both HG52 and ts2203 packaged DNA 
inefficiently at the NPT. One possible explanation for 
this finding is that the viruses synthesise reduced 
amounts of DNA at the NPT.
BHK cells were infected with ts2203 or HG52 at the PT
or NPT and harvested at 18h pi. Serial dilutions of
total virus-infected cell DNA were taken then loaded
onto nitrocellulose membrane using a "slOt-blot"
apparatus. Known amounts of pGZ73 (HSV-2 Bglll i) DNA
were also loaded onto the membrane so that the numbers
of genomes synthesised in WT and ts2203 infected cells
could be determined. The DNA samples were then 
32
hybridised to [ P]-labelled pGZ73 (Figure 28).
It was apparent from these results that HSV—2 and 
ts2203 synthesised similar quantities of DNA at both the
Figure 28
Autodiogram of DNA synthesized by HG52 and ts2203 at
the PT and NPT
-2 -3 -4 ( in
Dilutions (10 , 10 , 10 ) of virus infected cell DNA
and samples of pGZ73 (HG52 Bglll i fragment) equivalent 
2 3
to 10 and 10 copies/cell ie. 10.70ng and 107.00ng
pGZ73, were loaded onto the nitrocellulose membrane
using a slot-blot apparatus. Samples were hybridised 
32
to [ P]-labelled pGZ73.
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5
PT and NPT, equivalent to approximately 10 genome 
copies per cell as assessed by densitrometric analysis 
(Table 8 ). Ts2203 does not, therefore, have a defect
in viral DNA synthesis unlike tsl3, the virus from 
which it was derived (Moss et al, 1979; Moss, 1986).
3.11 Processing of Viral DNA in ts2203- and HG52-infected 
Cells
An analysis of the amount of viral DNA synthesised by
ts2203 and HG52 showed that both viruses made similar
amounts of DNA at the NPT and the PT. It was,
therefore, likely that HG52 and ts2203 were ts for
encapsidation of DNA, and experiments were performed to
assess the ability of ts2203 and HG52 to cleave and
package unit lengths of viral DNA, from concatemers, at 
o
38.5 .
Total virus-infected cell DNA and encapsidated viral
DNA samples were prepared from ts2203- or HG52-infected
cells incubated at the PT or NPT for 18h. The viral
DNA was then analysed by the Southern bloting
technique. DNA samples were digested with BamHI, which
cleaves the long and short repeat sequences as well as
the unique sequences. The fragments were separated on
an agarose gel, transferred onto a nitrocellulose
32
membrane and hybridised to [ P]-labelled pGZl. This
Table 8 
32
Densitometric analysis of [ P]-labelled virus-infected 
cell DNA
Densitometric analysis was made of an autoradiogram of 
DNA extracted from HG52- and ts2203-infected cells 
incubated at the PT and NPT (Figure 28).
The approximate number of genome copies per cell per
50mm dish was determined by a comparison with the
3
equivalent of 10 copies/cell/50mm dish of pGZ73 
(containing HSV-2 Bglll i DNA fragment).
Table 8
Copy number: genomes/cell/50mm plate
o o
31 38.5
4 4
HSV-2 HG52 10 8x10
4 4
ts2203 10 8x10
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contains the joint-spanning fragment of HG52, BamHI g, 
thus giving a measure of the proportion of BamHI g 
joint fragment to the terminal fragments BamHI v and u 
(which also hybridise to BamHI g) (A map of BamHI 
restriction sites in HSV-2 is given in Figure 30). An 
estimate can therefore be made of the amount of viral 
DNA cleavage and packaging.
Figure 29 shows an autoradiogram of a Southern blot of 
BamHI-digested total virus DNA and encapsidated DNA.
As anticipated from the previous "slot-blot" 
hybridisation analysis of viral DNA present in ts2203- 
and HG52-infected cells, HG52 and ts2203 synthesised 
similar amounts of viral DNA at the PT and NPT.
However, it was clear that at the NPT, both HG52 and 
ts2203 DNA samples contained low amounts of the 
terminal fragments BamHI v and u, suggesting that most 
of the viral DNA was "endless".
Analysis of encapsidated viral DNA confirmed that both 
HG52 and ts2203 packaged viral DNA inefficiently at the 
NPT. Although in three independent experiments ts2203 
packaged less DNA than HG52 at the NPT, ts2203 
encapsidated DNA was always detectable. It was, 
therefore, difficult to determine whether the ts2203 
lesion within Vmw65 affected this stage of capsid 
maturation or a later stage such as envelopment.
Alternatively, ts2203 Vmw65 may simply be "leaky" at
o
38.5 , and able to function to a limited extent.
Figure 29
The processing of viral DNA in ts2203- and 
HG52-infected cells
Total virus-infected cell DNA and DNase-resistant 
(packaged) DNA were purified from virus-infected cells 
incubated at the PT or NPT for 18h.
1/20 total virus-infected cell DNA and 1/10
DNase-resistant DNA samples were digested with BamHI
and the fragment^ separated by agarose gel
electrophoresis. The fragments were transferred to
32
nitrocellulose and hybridised to [ P]-labelled pGZl 
which contains HG52 BamHI g. An autoradiogram was made 
of the Southern blot.
a. HG52- and ts2203-infected cell DNA (PT) [tracks
1,2 respectively]; HG52- and ts2203 encapsidated 
DNA (PT) [tracks 3,4]; HG52- and ts2203-infected
cell DNA (NPT) [tracks 5,6]; HG52- and ts2203
encapsidated DNA (NPT) [tracks 7,8].
b. represents a longer exposure of the tracks shown
in a.
1 2pr3 4 i 5 W  8
t V  6 ^  ,
wf- fj Wf ft «  WK fct
^  *  W *
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BamHI g
BamHI u 
BamHI v
BamHI g
BamHI u 
BamHI v
Figure 30
Physical map of HSV-2 for restriction endonuclease
32
BamHI, and an autoradiogram of [ P]-labelled HSV-2 DNA
disgested with BamHI
32
(a) [ P]-labelled DNA samples were digested with 
BamHI and separated on a 1% agarose gel. The 
letters refer to specific HSV-2 DNA fragments, and 
the physical map locations of these are shown in 
(b). The autoradiogram was supplied by Dr V.G. 
Preston.
(b) Physical map of HSV-2 DNA for restriction 
endonuclease BamHI, taken from Davison (1981).
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3.12 Temperature Sensitivity of HSV-2 HG52 and ts2203
Since HG52 and ts2203 packaged DNA inefficiently at the
NPT, it was important to determine whether the NPT
could be lowered to a temperature at which ts2203 was
still ts, but at which HG52 packaged DNA efficiently.
Therefore, an assessment was made of virus growth at
o
various temperatures below 38.5 .
Stocks of HG52 and ts2203 were titrated at various
o o
temperatures ranging from 31 to 38.5 (Table 9). The
results demonstrate that although the titre of. ts2203 
o
below 38.5 was reduced in comparison with WT virus,
the defect was not entirely ts. However, it should
o
also be noted that at temperatures of 36.4 and above, 
the plaques produced by ts2203 were smaller and more 
difficult to count than the WT plaques, presumably due 
to an effect of the ts defect on virus encapsidation 
and/or envelopment.
As a consequence of this result, the NPT could not be 
reduced in order to increase the amount of DNA 
encapsidation and the yield of HG52 virus.
3.13 Transfer of the ts!3 Mutation into HSV-2 Strain 
HVD25766
One possible way of overcoming the problem described 
above was to recombine tsl3 Bglll i into a different
Table 9
Plaque-formation of HG52 and ts2203 at various 
temperatures
Virus stocks were titrated at temperatures ranging from 
o o
31 (PT) to 38.5 (NPT).
Table 9
Incubation Temperature________ HG52______ ts2203
o 8 8
31 8.0x10 1.0x10
o 9 7
35.6 * 1.0x10 9.0x10
o 8 7
36.4 9.0x10 6.0x10
o 9 5
37.5 2.0x10 2.3x10
o 9 5
38.0 1.0x10 2.0x10
o 8 3
38.5 5.0x10 <10
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HSV-2 strain. The strain HVD25766 was reported to grow 
o
well at 38.5 , and to produce large quantities of
cell-released infectious virions. Preliminary results
confirmed this: electron microscopic analysis of thin
section preparations of HVD-infected cells, grown at 
o
38.5 for 18h, showed that HVD synthesised large
quantities of dense-cored capsids and enveloped
particles. In contrast, samples of HG52-infected cells
grown under the same conditions contained few
dense-cored capsids, and very little enveloped virus
(Figure 31, Table 12). Single step growth of HVD
o
confirmed that the virus grew well at 38.5 (Figure
32). In addition, the HVD virus produced large amounts
_st_ low moi
of cell released (CR) and cell associated (CA) virus;at 
o ^
31 , which had equivalent titres. The CA Virus had a
titre 5 to 10 fold higher than an HG52 CA stock grown 
o
at 31 .
In view of these results the tsl3 mutation in the 
Bglll i DNA fragment was transferred into HVD25766 
virus.
Intact HVD25766 WT virus DNA and pGZ74 (containing ts!3
Bglll i) cleaved with Bglll, were cotransfected into
BHK cells, and the resulting virus progeny titrated at 
o °
31 under agar. Well isolated plaques formed at 31
o o
were picked, and the virus assayed at 31 and 38.5 for
temperature-sensitivity. Potential ts; virus isolates
Figure 31
Electron microscopic analysis of HG52 and HVD infected 
cells
BHK cells were infected at a moi of 5pfu virus per cell
and incubated at the NPT for 18h. Cells were
harvested, fixed and dehydrated, then embedded in epon
resin. Thin sections of infected cells were stained
and examined under the electron microscope. The bar
represents 0.5um.
«
HG52-infected cells at 18h pi (1); HVD-infected cells 
at 18h pi (2 ).
Dense-cored capsids:
—  '-*1
Partially-cored capsids:
Empty capsids: ^
Virions: ---
Nu; nucleus; Cy; cytoplasm

Figure 32
Single cycle growth of HG52 and HVD 25766 at the PT and 
NPT
Subconfluent monolayers of cells in 30mm dishes were 
infected at the PT and NPT with CA stocks of virus at a 
moi of 5pfu per cell. Cells were then harvested at 
various times pi and the virus yield was titrated on 
BHK cells at the PT (Section 2).
Log. _pfu 
per 
10 
cells
HVD25766
HG52
20 3228
time(h)
L
o
g
10 
p*u 
per 
10 
ee,*s
NPT
HVD25766
HG52
3228
time(h)
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were plaque-purified 3 times and stocks screened for 
the ability to recombine with ts2203.
One of the 3 ts isolates which failed to recombine with
ts2203, No.171, was renamed ts2204, and a high titre 
stock of this virus was prepared. To confirm that 
ts2204 contained the tsl3 lesion, the virus was 
re-checked for recombination with ts2203. Ts2201, an
HG52 ts mutant which recombined well with ts2203, was 
also included in the recombination assay (Table 10).
3.14 Processing of Viral DNA in ts2204-infected Cells
Ts2204 was compared with WT HVD25766 for the ability to
cleave and package viral DNA at the PT and NPT.
BamHI-digested total virus-infected cell DNA and
packaged DNA samples were separated on agarose gels,
transferred to a nitrocellulose filter, and hybridised 
32
to [ P]-labelled pGZl (which contains HG52 BamHI g), 
and a plasmid containing HVD BamHI a.
Figure 33 shows an autoradiogram of the Southern blot 
obtained from this experiment. Both WT HVD and ts2204 
synthesised large quantities of viral DNA at the PT and 
NPT, and at the PT packaged similar amounts of viral 
DNA. At the NPT, in contrast, terminal BamHI fragments  ^
were barely detectable in the ts2204-total virus DNA 
sample digested with BamHI, and almost no encapsidated
Table 10
Recombination analysis of ts2204
ts2204 was assayed for the ability to recombine with 
ts2203 or ts2201 at the PT.
The recombination frequency R(f) was calculated using 
the formula given in Brown et al., (1973).
Table 10
Virus Titre of Virus (pfu per ml) R(f)
31 38.5
ts2204(CA) 2 .0x10 <10 /
ts2204(CR) 2 .0x10 <10 /
ts2203 3.5x10 <10 /
ts2201 1 .0x10 <10 /
ts2204(CA)/ts2203 1.0x10 <10 0
ts2204(CR)/ts2203 2.0x10 <10 0
ts2204(CA)/ts2201 2.0x10 9.5x10
3
8.45
ts2203 /ts2201 9.0x10 3x10 5.37
Figure 33
The processing of viral DNA in ts2204-and HVD-infected 
Cells
Total virus-infected cell DNA and DNase-resistant 
(packaged) DNA were purified from virus-infected cells 
incubated at the PT or NPT for 18h.
1/20 total virus infected cell DNA and 1/10
DNase-resistant DNA samples were digested with BamHI,
and the fragments* separated by agarose gel
electrophoresis. The fragments were transferred to
32
nitrocellulose and hybridised to [ P]-labelled pGZl
32
which contains HG52 BamHI g, and [ P]-labelled HVD 
p(BamHI a ).
Tracks 1-4: samples infected at the PT
HVD-infected cell DNA, (track 1); HVD encapsidated DNA 
(track 2); ts2204-infected cell DNA (track 3); ts2204 
encapsidated DNA (track 4).
Tracks 5-8: samples infected at the NPT 
HVD-infected cell DNA (track 5); HVD encapsidated DNA 
(track 6 ); ts2204-infected cell DNA (track 7); ts2204 
encapsidated DNA (track 8 ).
BamHI
BamHI
BamHI
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DNA at all could be seen in the ts2204 encapsidated DNA 
o
sample at 38.5 . Ts2204, therefore, appeared to have a 
defect in cleavage and packaging of viral DNA at the 
NPT.
3.15 Densitometric Analysis of Total Viral and Encapsidated 
DNA
Since the joint-spanning fragment, BamHI g, contains 
sequences from the long and short repeats, it will 
hybridise not only to itself but also to the terminal 
BamHI fragments, v and u. In virion DNA digested with
BamHI, BamHI g, v and u are in equimolar amounts.» — —
However, in the Southern blot analysis described here,
the probe pGZl containing BamHI g was treated with
32
DNase I prior to in vitro labelling with [ P]-dNTP by 
nick translation. This means that the size of the 
denatured probe should be small, and therefore the 
proportion annealing to BamHI g = BamHI v + u. That 
is, the amount of hybridisation depends on the size and 
molarity of the fragment.
At late times in infection, unpackaged, replicated DNA 
is present as concatemers, and as a consequence BamHI g 
increases relative to the terminal fragments u and v, 
so that the number of BamHI g fragments per concatemer 
ie. the molarity of BamHI g = 2n-l (where n is the 
number of unit length genomes in the concatemer), and
-148-
the molarity of BamHI v = u = 1.
Thus the molar ratio of BamHI g = 2n-l.
v + u 2
This assumes that the ends of the concatemers are the 
same as in virion DNA. However, this may not be so 
since plasmids containing oris but not the a sequence, 
will form concatemers in presence of helper virus. It 
is, therefore, likely that in WT virus-infected cells, 
virus concatemers contain a mixture of ends, some 
terminating in the a sequence as in virion DNA, (if one 
or more cleavage steps have taken place from this end 
of the concatemer), and some terminating elsewhere in 
the genome, possibly near an origin of replication.
A better measurement of packaging can be made by
comparing the amount of a unique fragment in total
virus DNA with the amount present in encapsidated DNA. 
In these experiments BamHI a, which occurs in the UL , 
was used.
Thus, % packaging = BamHI a (encapsidated DNA)
2 x BamHI a (total virus-infected cell DNA)
since twice the amount of BamHI-digested, encapsidated
DNA samples was loaded onto agarose gels compared to
the amount of BamHI-digested total virus-infected cell
DNA used in the experiments.
-149-
+
3.16 Construction of Marker Rescued Virus, ts 2204 (MR-1)
To confirm that the ts2204 lesion in Vmw65 was
responsible for the packaging defect at the NPT, a
recombinant virus was constructed by co-transfecting 
o
cells at 31 with intact ts2204 DNA and pGZ73 
(containing HG52 Bglll i), cleaved with Bglll.
+
Ts virus amongst the progeny was plaque purified once
at the NPT and twice at the PT, and one isolate was
grown to a high titre virus stock. This virus, termed 
+
HVD ts 2204 (MR-1) appeared to have a similar eop NPT
PT
to WT £[VD.
3.17 Ts2204 has a Second ts Lesion
The synthesis and maturation of WT HVD, ts2204 and HVD 
+
ts 2204 (MR-1) at the PT and NPT was analysed by the
Southern blot technique as described in the previous
section. The results (Figure 34) showed that at the
NPT, in contrast to the WT HVD sample, both ts2204 and 
+
HVD ts 2204 (MR-1) DNA samples contained a low
proportion of terminal BamHI fragments, indicating that 
+
HVDts 2204 (MR-1) had a defect in the processing of
viral DNA at this temperature. This suggested that HVD 
+
ts 2204 (MR-1) and possibly ts2204 had a ts mutation 
which mapped outside the Vmw65 gene.
Figure 34
Processing of viral DNA in ts2204, WT HVD and 
+
HVDts 2204(MR-1) infected cells
Total virus-infected cell DNA was purified from 
virus-infected cells incubated at the PT and NPT for 
18h.
1/20 total virus-infected cell DNA samples were
digested with BamHI, and the fragments separated by
agarose gel electrophoresis. The fragments were
transferred to nitrocellulose and hybridised to 
32
[ P]-labelled pGZl containing HG52 BamHI c[ and 
32 '
[ P]-labelled HVD p(BamHI a).
+
a. HVD WT, HVD ts 2204 (MR-1) and ts2204 infected 
cell DNA at the PT (tracks 1-3 respectively) and 
NPT (tracks 4-6 respectively).
b. represents a longer exposure of the blots 
presented in a .
4 5 6 N
BamHI a 
BamHI g
BamHI u]
4 5 6
BamHI a 
BamHI g
BamHI u
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Preliminary experiments revealed that the defect in HVD 
+
ts 2204 (MR-1) was also in ts2204, since at
o +
temperatures above 38.5 its progeny from cells
o
cotransfected at 31 with ts2204 and pGZ73 (containing 
WT HG52 Bglll i), formed small plaques in comparison 
with those formed by WT HVD (V G Preston, personal 
communication). As a consequence of this finding, the 
process of recombination between HVD WT DNA and ts!3 
Bglll i (pGZ74) was repeated in order to isolate a 
recombinant virus which had a single ts lesion.
3.18 Isolation of ts2205 and ts 2205(MR-2)
o
Cells were cotransfected at 31 with intact WT HVD DNA
and pGZ74 cleaved with Bglll as described in Section
3.13. A ts virus which failed to recombine with ts2203
was isolated, and designated ts2205. The HG52 Bglll i
+
fragment was recombined into ts2205, and a ts virus,
+
HVD ts 2205 (MR-2) which had a similar eop NPT to WT
+ PT
HVD, was isolated. Unlike HVD ts 2204 (MR-1), plaques
o
formed by this virus at temperatures greater than 38.5 
were found to be similar in size to those of WT HVD.
3.19 Processing of Viral DNA
Figure 35 shows an autoradiogram of a Southern blot in
which BamHI-digested DNA samples, prepared from BHK
+
cells infected with ts2205, HVD or ts 2205 (MR-2), were
Figure 35
Processing of viral DNA in ts2205, WT HVD and HVD 
+
ts 2205 (MR-2)-infected cells
o o
Cells were infected at the PT (31 ) or NPT (38.7 ) with
+
ts2205, WT HVD or HVD ts 2205(MR-2) at a moi of 5pfu 
per cell, and harvested at 18h pi; alternatively cells 
were infected at the NPT and at 12h pi transferred to 
the PT in the presence of cycloheximide (200ug/ml).
1/20 total DNA and 1/10 encapsidated (DNase-resistant)
DNA samples were digested with BamHI and the fragments
separated by agarose gel electrophoresis. The DNA was
transferred onto *a nitrocellulose membrane and 
32
hybridised to [ P]-labelled HVD pBamHI a and pGZl 
(HG52 BamHI g) . An autoradiagram was then made of the 
Southern blot.
ts2205, HVD WT, HVD ts 2205(MR-2) total cell DNA (PT),
tracks 1-3 respectively; ts2205, HVD WT, HVD 
+
ts 2205(MR-2) total cell DNA (NPT) tracks 4-6
+
respectively; ts2205, HVD WT, HVD ts 2205(MR-2)
encapsidated DNA (PT) tracks 7-9 respectively; ts2205, 
+
HVD WT, HVD ts 2205(MR-2) encapsidated DNA (NPT) tracks
+
10-12 respectively; ts2205, HVD WT, HVD ts 2205(MR-2) 
CHX-treated cell DNA tracks 13-15 respectively; 
ts2205, HVD WT, HVD ts 2205 (MR-2) CHX- treated 
encapsidated DNA, tracks 14-16 respectively. Tracks 
13-16 were transferred to a separate nitrocellulose 
membrane, and are shown at a longer exposure than 
tracks 1-12.
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32
hybridised to [ P]-labelled HVD p (BamHI a) and pGZl.
+
Both HVD WT and ;ts 2205 (MR-2) viruses produced large
o
quantities of viral DNA at the PT (31 ) and NPT 
o
(38.7 ), and by densitometric analysis 15.3% WT HVD and 
+
22.6% ts 2205 (MR-2) DNA, synthesised at the NPT, was 
encapsidated. In contrast, ts2205 failed to package 
significant quantities of viral DNA at the NPT, and 
almost all of the ts2205 total-infected cell DNA 
synthesised at the NPT was in the form of "endless 
DNA". This information in summarised in Table 11.
To determine whether the effect of the mutation could 
be reversed upon temperature downshift, virus-infected 
cells incubated at the NPT, were transferred to the PT 
at 12h pi, with the addition of cycloheximide to 
prevent any further protein synthesis. Cells were 
incubated for a further 6h at the PT, and harvested.
The viral DNA was then examined as described above.
Only background levels of packaged ts2205 DNA were 
detectable on extended exposures of film to the blot 
(Figure 35), less than 2% of ts2205 DNA packaged at the 
PT (Table 11), suggesting that the ts defect in ts2205 
is not reversible.
3.20 Analysis of ts2205-infected Cell Polypeptides
+
Polypeptide profiles of WT HVD-, ts 2205 (MR-2)- and 
ts2205-infected cells incubated at the PT or NPT were
Table 11
Densitometric analysis of Southern blots of total
virus-infected cell DNA and encapsidated (DNase- 
resistant DNA)
The amount of DNA synthesised or encapsidated by each
32
virus is represented by the amount of [ P]-labelled 
probe hybridising to the BamHI a fragment.
Total virus DNA is presented as a percentage of the DNA 
synthesised by hVd WT virus at the PT (1), NPT (2) or 
following shiftdown from the NPT to the PT in the 
presence of cycloheximide (3). In each case synthesis 
of HVD DNA is taken as 100%.
Encapsidated DNA at the PT or NPT is presented as a
percentage of the total virus-infected cell DNA
synthesised at the PT (4) or NPT (5) or on shiftdown
from the NPT to the PT in the presence of cycloheximide
+
(6), for HVD WT, ts 2205 and ts2205.
Table 11
+
HVD % ts 2205 % ts2205 %
i. PT 100.0 76.1 186.5
0  2 . N W 100.0 67.1 50.3
3 . a * 100.0 57.0 28.7
4.PT 29.9 36.4 10.3
V  s.Nfr 15.3 22.6 <1.0
6. ft 6.1
*
4.7 <2.0.
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analysed to determine if Vmw65 was synthesised by
ts2205 at the NPT, and to determine, from the mobility
of Vmw65, if HG52 Bglll i and tsl3 DNA fragments
carrying the Vmw65 gene had been recombined into the 
+
ts 2205 (MR-2) and ts2205 viruses respectively.
Mock-infected cells, or cells infected with the WT HVD, 
+
ts 2205 (MR-2) or ts2205 were incubated, as described
o o
previously, at 31 or 38.7 , labelled with 
35
[ S]-methionine for lh at various times pi, harvested, 
and the radiolabelled polypeptides analysed by SDS 
PAGE. *
The polypeptide profiles of all three viruses were very
similar, but at the PT and the NPT ts2205 synthesised a
Vmw65 polypeptide which migrated slightly faster than
+
the WT HVD or ts 2205 (MR-2) species (Figures 36 and 
37).
+
3.21 Electron Microscopic Analysis of ts2205~, ts 2205
o
(MR-2)- and WT HVD-infected cells grown at the PT (31 ) 
o
and NPT (38.7 )
To confirm that ts2205 had a lesion affecting 
encapsidation of viral DNA at the NPT, thin section 
preparations were made of ts2205-infected cells grown
Figure 36
Autoradiogram of electrophoretically separated 
polypeptides from mock- and virus-infected cells 
incubated at the PT
35
Cells were labelled with [ S]-methionine from 4-5 
(tracks 1-4), 6-7 (tracks 5-8) and 7-8 (tracks 9-12)h 
pi and harvested. Protein samples were analysed on a 
9% single concentration SDS-polyacrylamide gel 
(SDS-PAGE).
*
mock-infected (MI) cell polypeptides (tracks 1,5,9);
HVD-infected cell polypeptides (tracks 2,6,10);
ts2205-infected cell polypeptides (tracks 3,7,11);
+
ts 2205-infected cell polypeptides (tracks 4,8,12).
MWxIO3
Vmwl57
V mw65
Vmw45
Figure 37
Autoradiogram of electrophoretically separated 
polypeptides from mock- and virus-infected cells 
incubated at the NPT
35
Cells were labelled with [ S]-methionine from 2-3h 
(tracks 1-4) and 6-7h pi (tracks 5-8) and harvested. 
Protein samples were analysed on a 9% single 
concentration SDS-polyacrylamide gel.
mock-infected (M]f) cell polypeptides (tracks 1,5);
HVD-infected cell polypeptides (tracks 2,6);
ts22_05-infected cell polypeptides (tracks 3,7);
+
ts 2205(MR-2)-infected cell polypeptides (tracks 4,8).
MWxIO3
Vmwl57.
Vmw65-
Vmw 42.5
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at the PT and NPT, and compared under the electron
+
microscope with WT- or ts 2205 (MR-2)- infected cell 
samples.
At the PT, similar number of capsids were made by all
three viruses, and large quantities of full capsids and
virions were observed (Figure 38). At the NPT, WT HVD 
+
and ts 2205 (MR-2) virus-infected cell nuclei contained
similar numbers of dense-cored, partially cored and
empty capsids. Larger amounts of enveloped virus
particles were identified at later times ih cells
infecte'd with these viruses (18-22h pi), compared with
samples harvested at 12h pi. In contrast, very few
full capsids (approximately 1 full capsid per 10-15
infected cell nuclei) and only one enveloped particle
(in 30 infected cells examined), were found in
ts2205-infected cells, even at 22h pi, and nearly all
the capsids produced by ts2205 were partially cored.
toJo
(Figure 39). There are explanations for the
presence of low numbers of full capsids in
ts2205-infected cells at the NPT: the mutation, which
clearly affects virus DNA encapsidation, could be
slightly leaky, and permit a low level of DNA
encapsidation. Alternatively, the full capsids could
+
be due to low numbers of ts revertants in 
ts2205-infected cells.
Figure 38
Electron microscopic analysis of virus-infected cells
grown at the PT
Cells were mock infected (MI) or infected at a moi of
+
5pfu virus per cell with WT HVD, ts 2205(MR-2), ts2205
and incubated for 18h at the PT. Cells were then
harvested and embedded in epon resin. Thin section
preparations of infected cells were examined under the
electron microscope. The bar represents 0.5um
*
1, ts2205-infected cells; 2, HVD-infected cells;
+
3, ts 2205(MR-2)-infected cells; 4, MI cells.
Empty capsids 
Partially cored capsids 
Dense-cored capsids 
Virions
Nu: nucleus; Cy: cytoplasm
1m
0
*
4 V
Figure 39
Electron microscope analysis of virus-infected cells
grown at the NPT
.+
Cells were infected with WT HVD, ts 2205(MR-2) or
ts2205 at a moi of 5pfu virus per cell, and incubated
at the NPT for 18h. Cells were then harvested, and
embedded-in epon resin. This section preparations of
virus-infected cells were examined under the electron
microscope. The bar represents 0.5um
*
1,2 ts2205-infected cells; 3, HVD-infected cells;
+
4, ts 2205-infected cells.
Empty capsids ^
Partially-cored capsids *===^
Dense-cored capsids 
Virions
Nu: nucleus; Cy: cytoplasm
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Virus-infected cells incubated at the NPT were also 
transferred to the PT in the presence of cycloheximide, 
at 12h pi, to determine if the defect was reversible. 
These cells were incubated for a further 6h at the PT, 
harvested, and then embedded in epon resin.
Examination of thin sections of virus-infected cells 
confirmed that the lesion in ts2205 was not reversible 
(Figure 40), and that the lesion affected encapsidation 
of virus DNA.
The proportion of full, partially cored and empty 
capsid^, and virions was determined from thin section 
preparations of infected cells under the electron 
microscope. Thirty cells were examined, and the 
results (Table 12) confirmed observations that ts2205 
fails to encapsidate significant quantities of viral 
DNA at the NPT.
3.22 DISCUSSION
The tegument of HSV has been described as amorphous 
structure which interfaces with the virus capsid and 
envelope. Whilst some tegument proteins have been 
identified, the function of this structure as a whole, 
and the role of its component polypeptides have 
remained elusive.
Figure 40
Reversibility of the encapsidation defect of ts2205
Cells were infected at the NPT with WT HVD,
+
ts 2205(MR-2) or ts2205 at a moi of 5pfu virus per 
cell, and incubated for 12h. Infected cells were then 
transferred to the PT in the presence of 200ug/ml 
cycloheximide to prevent further protein synthesis, and 
incubated for 6h. Cells were harvested at 18h pi and 
embedded in epon resin. Thin section preparations of 
virus-infected c^lls were examined under the electron 
microscope. The bar represents 0.5um
1,2 ts2205-infected cells; 3, HVD-infected cells;
+
4, ts 2205-infected cells.
Empty capsids 
Partially-cored capsids 
Dense-cored capsids 
Virions
Nu: nucleus; Cy: Cytoplasm
<1

4
Table 12
Estimation of the proportion of each capsid type in 
virus-infected cells
The proportion of dense-cored, partially-cored and
empty capsids in the nuclei of cells infected at the PT
+
or NPT with WT HVD, ts2205 or ts 2205(MR-2) was 
determined from examination of thin section 
preparations of cells under the electron microscope.
30 cells were screened. The results are presented as
(1 ) average number of each capsid type per nucleus, and
(2 ) % capsid type per nucleus.
Samples were examined at 16, 18 and 22h pi at the NPT, 
and at 18h pi at the PT.
Samples were also examined at 18h pi, following a 
temperature shift from the NPT to the PT at 12h pi in 
the presence of cycloheximide (CHX).
The proportion of capsids in the nuclei of cells
infected at the NPT with HG52 or ts2203 is also shown.
Capsids per nucleus
Table 12(1)
Partially Empty Dense Virions Av. No. 
Cored Cored particles/
__________ nucleus
PT 18h pi
ts2205
+
25.06 4.72 34.39 5.0 59.17
ts 2205(MR-2) 28.12 5.50 27.50 8.1 69.72
HVD 30.10 10.24 27.0 9.8 77.14
NPT 16h pi
ts2205
_i_
9.60 0.33 0.13 0.00 10.07
T
ts 2205(MR-2) 
HVD *
8.00
8.63
0.70
1.00
2.50
2.83
0.17 
0.23
11.37 
12.70
NPT 18h pi
ts2205
i
12.73 0.26 0.40 0.00 13.40
~r
ts 2205(MR-2)
HVD
HG52
ts2203
7.50
15.60
77.20
53.00
0.40
1.00
1.50
0.90
1.20
9.10
3.50
1.60
4.00
2.70
0.50
0.20
13.10 
28.40 
82.67 
85.70
NPT 22h pi
ts2205 23.90 1.80 0.20 0.00 25.90
+
ts 2205(MR-2) 
HVD
16.17
15.60
0.40
0.50
5.67
6.30
2.83
2.30
25.07
24.70
CHX:(18h pi)
ts2203 29.10 1.80 0.70 0.10 32. 50
+
ts 2205(MR-2) 
HVD
19.50
9.60
1.60
0.70
4.70
2.70
2.80
2.70
28.60
15.70
Table 12(2)
% capsids/nucleus
0
Partially
Cored
Empty Dense
Cored
Virions
PT 31 18h pi
ts2205 42.32
+
ts 2205(MR-2) 40.62
HVD 38.94
7.98
7.95
13.45
41.22
39.33
34.93
8.45
11.70
12.68
NPT 16h pi
ts2205 95.36
+
ts 2205(MR-2) 70.26
HVD * 67.98
3.31
6.14
7.87
1.32
21.93
22.31
0.00
1.46
1.84
18h pi
ts2205 95.02
+
ts 2205(MR-2) 57.25
HVD 54.93
HG52 93.39
ts2203 95.15
1.99
3.05
3.52
1.81
1.62
2.99
30.53
32.04
4.23
2.87
0.00
9.16
9.50
0.60
0.36
22h pi
ts2205 92.28
+
ts 2205(MR-2) 64.49
HVD 63.16
6.95
1.60
2.02
0.77
22.61
25.51
0.00
11.30
9.31
CHX(18h pi)
ts2205 89.54
+
ts 2205(MR-2) 68.18
HVD 61.15
8.00
5.59
4.46
2.15
16.43
17.20
0.31
9.79
17.20
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The results from characterisation of ts2205 showed that
a major structural component of the tegument, Vmw65,
has an essential role in the encapsidation of viral
DNA. Although initial work on the HG52 mutant, ts2203,
failed to determine whether Vmw65 was important for
nucleocapsid formation or virus envelopment, the 
+
analysis of ts revertants of ts2203 was extremely 
useful for providing information about the mutation in 
the Vmw65 gene.
+
3.22.1 Ts Revertants of ts2203 '
The five independently isolated revertants of ts2203,
+
ts 2203revl....rev5, fell into two categories.
1. Those that induced a Vmw65 which retained the 
altered electrophoretic mobility of ts:2203 Vmw65 
on SDS polyacrylamide gels.
2. Those that synthesised Vmw65 which comigrated with 
the WT polypeptide on an SDS polyacrylamide gel.
The conclusion, therefore, is that there is a single 
mutation in the Vmw65 gene of ts2203 which is 
responsible for the ts phenotype and altered 
electrophoretic mobility of Vmw65.
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The reason for the alteration in apparent MW of the
polypeptide specified by ts2203 is not known. There
may be a defect in the processing of Vmw65 although the
results of H.Moss (personal communication) suggest that
the mutant polypeptide is still phosphorylated. It is
also not clear whether the aberrant electrophoretic
mobility of the mutant Vmw65 is responsible for the
temperature-sensitive phenotype, or whether it is a
secondary effect of the amino acid substitution. Since
0 o
ts2203 induced an altered Vmw65 at both 31 and 38.5 , 
the aberrant polypeptide does not appear to 
significantly affect virus growth at the PT.
The ts lesion may cause a change to the tertiary 
structure of Vmw65 which affects the ability of the 
polypeptide to interact with other tegument or capsid 
proteins. Alternatively, ts2203 may synthesise a Vmw65 
which is unstable at the NPT. Although this is an 
unusual situation, some ts mutations have been found to 
introduce instability into virus polypeptides, for 
example, there is a ts lesion in the PRV mutant tsl 
which affects the stability of the major capsid protein 
(Ladin et al., 1980, 1982). Nevertheless, as will be 
discussed later, this is unlikely to be the case with 
ts2203 Vmw65.
-157-
+
There are several explanations for the isolation of ts 
revertants with an aberrant Vmw65 ability. A change in 
the DNA sequence at the site of the ts lesion would 
convert the amino acid back to the WT, or substitute a 
similar type of amino acid. In the latter situation, 
such a revertant may or may not regain the 
electrophoretic mobility of WT Vmw65. It is also 
possible that a "second-site" reversion or mutation, 
either elsewhere in the Vmw65 gene, or in another gene 
could also allow the mutant to grow as well as WT virus 
at the NPT. In this case, since the virus would retain 
the original ts lesion, it would still produce a Vmw65 
with an altered electrophoretic mobility at the PT and 
NPT. If such a mutation was present in another gene, 
then this would suggest that WT Vmw65 interacts with 
this gene product.
3.22.2 Analysis of the Defect in ts2205
■or'
The defect in ts2205 was ^ reversible on temperature 
shift-down of infected cells from the NPT to the PT in 
the presence of cycloheximide. This could be due to an 
instability of the mutant protein produced at the NPT 
making it susceptible to degradation. However, as the 
mutant Vmw65 was detectable at late times in infection 
at the NPT by SDS PAGE of tj32205-infected cell 
extracts, and by immunoprecipitation of ts2203-infected
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cell extracts with a Vmw65-specific antibody, any
degradation of the polypeptide at this temperature must
be minimal, suggesting that the gene product is stable 
o
at 38.5 . A more likely alternative is that the
polypeptide produced at the NPT has an altered,
non-functional conformation which fails to resume the
WT conformation upon temperature shift-down to the PT
in the presence of cycloheximide, a protein synthesis
inhibitor. Thus, the ts virus would fail to cleave and
encapsidate^ DNA under these conditions unless the
block in protein synthesis was removed.
«
3.22.3 Temperature-sensitivity of HSV-1 and HSV-2 DNA
Encapsidation
From the analyses of viral DNA encapsidation, it is
clear that HSV-2 strain HG52 packaged less DNA than
o
HSV-2 strain HVD25766 at 38.5 and that both viruses
o
encapsidated less DNA at this temperature than at 31 .
Addison (1986) found that HSV-1 strain 17 was also
o
slightly ts at 38.5 for DNA encapsidation, and that at 
higher temperatures the ts effect was increased. These 
results suggest that HSV-1 and HSV-2 both have 
thermolabile polypeptide(s ) involved in packaging virus 
DNA, and that this effect can vary between strains of 
HSV.
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3.22.4 Ts Lesions in other Herpesvirus Genes which Effect 
Encapsidation of Viral DNA 
A number of HSV-1 ts mutants which have defects in the 
packaging of viral DNA have been isolated (Figure 41), 
and these fall into at least 5 different 
complementation groups. These mutants include ts!204 
and tsl208, which each have a defect in the gene (UL
25) specifying a 62,000 MW polypeptide (Addison et al., 
1984; D.J.McGeoch, personal communication), ts!201, 
which has a mutation in the gene encoding ICP35 (U^
26)(Preston et al., 1983), tsl203 which has a lesion in 
a gene‘specifying an 85,000 MW (Ul28) polypeptide 
(Addison, 1986), and tsl233 which has a mutation in a 
gene encoding a 14,000 MW polypeptide (0^33)
(M.Al.Kobasai, personal communication). In addition, 
two other mutants, tsN2Q (Schaffer et al., 1973), and
ts247 (Pancake et al., 1983) which probably have 
defects in encapsidation of DNA have also been 
described. These viruses, however, have not been well 
characterised. Recent results (M.A1 Kobasai, personal 
communication) suggest that the lesion in tsN20 maps in 
a different gene to the one in which the tsl233 lesion 
lies, probably within Ul32.
PRV packaging mutants have been identified in at least
-160-
8 different complementation groups (Ladin et al., 1980;
Ben Porat et al., 1982; Ihara et al., 1982; Ladin et
al., 1982) (Figure 41). Little is known about the 
products of the genes in which these mutants have 
defects. The PRV mutants tsl09, tsJ and tsl fail to 
accumulate the 35,000 MW assembly protein at the NPT, 
but it is not clear whether these viruses have 
mutations in this polypeptide. It should be noted that 
although these viruses have essentially colinear 
genomes, the region between mu 0.1 and 0.4 is inverted 
(Davison and Wilkie, 1983) so that some of the HSV and 
PRV mutants will probably have lesions in analogous 
genes.
Although it is likely that both PRV and HSV-1 mutants 
have lesions in capsid or tegument proteins, with the 
exception of ICP35, the gene products in which the 
mutations lie have not been assigned to components of 
the virion. Interestingly, whilst the HSV Vmw65 
tegument protein is clearly involved in packaging viral 
DNA, there is no evidence to suggest that the high MW 
tegument protein, Vmw273, is required for viral DNA 
packaging. Instead, information from analyses of ts 
mutants indicates that this polypeptide is involved in 
uncoating of viral DNA, and possibly in envelopment 
(Batterson et al., 1983; Batterson and Roizman, 1983;
Figure 41
Map locations of ts mutations of HSV-1 and PRV which 
affect the ability of virus to package DNA at the NPT
Also included is the map location of the lesion in 
tsB7, which lies within Vmw273 tegument protein and 
prevents the virus from being uncoated at the NPT.
Further details and references are given in the text.
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V.Preston, personal communication).
3.22.5 Methods of Encapsidation of Viral Nucleic Acid
Two general models for encapsidation of viral nucleic 
acids have previously been described in Chapter 1.
That is (a) a capsid forms about the replicated DNA or 
RNA and (b) the genome is inserted into a preformed 
capsid shell. Whilst the weight of evidence suggests 
that HSV DNA is packaged into a preformed capsid 
(Perdue et al., 1976; Ladin et al♦, 1980; Preston et 
al., 1983) this is not the case for all viruses. In 
analysing the role of Vmw65 and the virus tegument in 
HSV DNA encapsidation, it is perhaps worthwhile 
examining the means by which other viruses package 
nucleic acid.
The ds DNA bacteriophages have been extensively 
analysed for their pathways of capsid assembly, DNA 
cleavage, and encapsidation, and these processes are 
analogous to those of HSV in many ways. These viruses 
include lambda ( \  ), Tl, T4, P22, 0X174 and 029, all 
of which produce concatemers of DNA either by rolling 
circle DNA replication, or by recombination (Takahashi, 
1974; Tye et al., 1974; Bastia et al♦, 1975; Ritchie 
and Joicey, 1978); the head to tail multimers are
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cleaved to approximately unit-length monomers and 
packaged. A number of packaging models have been 
proposed for these viruses. Whilst it was initially 
suggested that the DNA condensed and a protein shell 
was built around it (Kellenberger et al., 1958).
Luftig et al, (1971) carried out in vivo density shift 
experiments on T4 phage which indicated that in fact, 
preformed proheads packaged the DNA. This was shown 
conclusively in an in vitro packaging system using X 
(Kaiser et al., 1975, 1976). Furthermore, empty 
capsids were shown to be precursors of full capsids
(Laemmli
and Favre, 1973; Hohn and Hohn, 1974; Kerr and 
Sadowski, 1974; Kaiser et al♦, 1975). Similar 
proposals have been made for packaging of herpesvirus 
DNA. Perdue et al. 1976 suggested that DNA was 
packaged into a preformed capsid on the basis of a 
study of different capsid types in EHV infected cells. 
This model was shown to be in agreement with results 
from the analysis of ts mutants of PRV and HSV (Ladin 
et al., 1980; Preston et al., 1983) which failed to 
package DNA.
Phage X initiates cleavage and packaging of DNA by 
means of a specific recognition step, and a virus 
encoded enzyme, the terminase, plays a major role in 
the overall process. The terminase recognises a cos
nicking and binding sites
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site on the genome, which is composed of the two 
regionsj^cosN and cosb')^  and binds both to cosB and to a 
preformed phage prohead, initiating a site specific 
single strand nick on the DNA to begin packaging. The 
terminase then scans the genome and completes the 
packaging process by a second site specific cleavage at 
a cosN site (Emmons, 1974; Becker et al. , 1977; Feiss 
et al., 1983) (Figure 42). Cos cleavage terminating 
packaging of one genome can also serve as an initial 
cos site for packaging of the next genome (Emmons,
1974) and during this process the terminase remains
bound to the genome (Feiss et al., 1985).
In some phages, for example, T1 and P22, packaging is 
initiated by a site-specific ds cleavage event at a 
unique pac site on the genome (Tye et al., 1974). 
Packaging then proceeds, without further sequence 
specifity, by sequential excisions of headfuls of the 
DNA of variable size, producing permutations of the 
genome (Jackson et al., 1978; Ramsay and Ritchie,
1983).
On the HSV genome certain sequences and processes are 
analogous to parts of these phage packaging systems.
The a sequence plays a role similar to that of the pac
or cos sequences and there is such a region in the a
Figure 42
Schematic representation of the phage X  DNA packaging
system 
see text for details
■ B
cosN cosB
_ . ."XDNA 
concatemer
Cos
terminase
Phage prohead plus scaffolding 
proteins and terminase bind to 
concatemer at cosB.st.tc. oi^CoS.
Cleavage and initiation of packaging; 
packaging continues for a genome's 
length. Second cleavage at cosN^ IfejL 
site.
cosN cosB.
Terminase remains attached to DNA. 
New prohead is bound and processive 
action continues.
Full prohead stabilised; loss of 
scaffolding proteins.
Mature phage particle,
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sequence of HSV-1 which has homology to HSV-2, EBV and 
VZV sequences, and is thought to represent a pac 
sequence (Deiss et al., 1986), although the evidence 
suggests that in HSV this is not the cleavage site, and 
thus it differs from the pac site of phage.
Site-specific ds cleavage mechanism, the theft and 
modified theft models (Varmuza and Smiley, 1985; Deiss 
et al., 1986) have been proposed for HSV. Indeed, in 
the simplest possible HSV cleavage system direct ds 
cleavage of viral DNA at a double a sequence, followed 
by a repeat cleavage at a similar double a sequence a 
genome’s length from the initial cleavage site would 
fit the known packaging requirements. In addition, the 
staggered nick repair mechanism which is similar to the 
cleavage system has been suggested for HSV (Varmuza and 
Smiley, 1985). In this model ss cleavage is induced by 
a packaging complex which might be composed of immature 
capsids.
Studies on X  have also shown that phage DNA passes 
through, or makes contact with, a "connector structure" 
at the base of the prohead (Serwar, 1976; Coombs and 
Eiserling, 1977), and in vitro analyses of phage 
packaging have suggested that it is an active process
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since ATP is required as a form of energy (Syvanen and 
Yin, 1978; Poteete et al., 1979).
Phage DNA makes contact at, and may interact with, the 
inner wall of the capsid, then coils inwards due to its 
stiffness and charged nature (Earnshaw and Harrison, 
1977), becoming packaged as a superhelical toroid (King 
et al. , 1973; Earnshaw et al., 1976). Following 
packaging, phage DNA is stabilised within the capsid by 
the addition of polyamines(Earnshaw and Casjens, 1980). 
The loss of "scaffolding proteins" from the unstable 
intermediate structure results in the formation of a 
mature phage head (Bjornsti et al., 1983, Guo et al., 
1986).
HSV DNA encapsidation has many parallel aspects to 
these stages of encapsidation and maturation of phage 
DNA. p40, a low processed form of the ICP35 family may 
be analogous in some ways to the scaffolding proteins. 
This polypeptide appears to be intrinsically involved 
in DNA packaging, but whilst it is closely associated 
with empty capsids, it is absent from full capsids 
(F.J.Rixon, personal communication). The reasons for 
the alteration in p40-capsid association are unknown, 
but stabilisation of a mature full HSV capsid through 
the dis-association of p40 cannot be excluded.
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However, p40 is again detectable in the mature virion. 
In addition, polyamines are found in the HSV capsid 
(Gibson and Roizman, 1971), and these may stabilise the 
newly packaged viral DNA which is wound about a 
cylindrical core. Finally, the core undergoes 
condensation to produce the toroidal HSV DNA structure 
(Furlong et al., 1972; Perdue et al., 1976).
Despite the similarities in packaging models, there is 
clearly a limit to the comparisons that can be made 
between HSV and the ds DNA bacteriophages since the 
viruses* differ in many ways apart from that of the host 
cell which they infect. For example, structurally, the 
ds DNA phages have tails and tail fibres, and lack an 
envelope or tegument structure comparable to that of 
HSV. However, it is interesting that these viruses 
follow the same basic mechanisms of DNA encapsidation; 
that is, the site-specific cleavage of DNA, and the 
packaging of a genome into a preformed prohead or 
capsid shell. In contrast, a number of animal viruses 
have been shown, or are believed, to form a capsid 
shell about replicated DNA or RNA.
This may be the case with adenovirus, a non-enveloped 
DNA virus. It was originally proposed that insertion 
of adenovirus DNA and core proteins into preformed
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capsids was by means of a specific recognition signal 
290-330bp from the left hand end of the genome (Weber, 
1976; Hammerskjold and Winberg, 1980; Philipson, 1984). 
Weber et al. (1985), however, found that virion 
assembly was dependent on concurrent DNA synthesis and 
Nicolas et al. (1983) have shown that inhibitors of DNA 
synthesis also inhibited adenovirus assembly, 
suggesting that virions arise from assembly of capsids 
around replicated virus genomes. A similar mechanism 
is believed to be employed by SV40. SV40 replicated 
DNA is present as nucleoprotein complexes (NPCs), and 
is theiA processed to form young, and mature virions, 
although the mechanism for this maturation remains 
unknown (Cosa Prados and Hsu, 1979; Garber et al.,
1980; Blasquez et al♦, 1983).
The Rhabdoviruses are a group of non-segmented, 
negative strand RNA viruses, which include the animal 
pathogens, rabies and vesicular stomatitis virus 
(VSV)(Wagner, 1975). The replicated RNA in these 
viruses is encapsidated by a single major structural 
protein, termed N, which becomes associated with the 
RNA strand as a single molecule by means of a 
recognition signal sequence in the first 18 bases of 
the 5' leader. N protein molecules then coat the
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genome 3' to the initiation point forming the 
ribonucleoprotein (RNP)(Emerson, 1985). Processed 
proteins L and NS enter the RNP, and a matrix (M) 
protein becomes externally associated with the RNP.
The M protein may be thought of a structurally 
analogous to the HSV tegument, and is believed to 
interact with the glycosylated protein (G) to promote 
envelopment (Newcomb and Brown, 1981). A similar 
matrix is present in the influenza virion between the 
lipid envelope and nucleoprotein (Schule, 1972) and 
again the M protein has been suggested to be involved
t
in the process of envelopment rather than 
encapsidation. It is interesting, however, that in 
some preparations of influenza-infected cells a space 
can be observed between the matrix and envelope 
(Nermut, 1972), perhaps indicating that the matrix may 
not be exclusively associated with envelopment, 
although other data suggests that the M protein may 
penetrate into the lipid bilayer (Lenard et al., 1974).
An alternative system of replication and encapsidation 
is found on examination of the poxviruses, which 
include vaccinia. These are large ds DNA viruses that 
multiply exclusively in the cell cytoplasm, and are 
therefore in a very different situation to that of DNA 
viruses such as the herpesviruses which replicate in 
the nucleus.
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The immature pox virion is composed of a nucleoprotein 
fibrous matrix inserted into a spherical lipoprotein 
bilayer, or envelope, synthesised de novo in the cell 
cytoplasm, whose curvature is controlled by the precise 
attachment of spiracles (Peters, 1956; Westwood et al., 
1964; Dales and Pogo, 1981). The virion is then 
matured by an internal reorganisation resulting in a 
dumbell-shaped core containing DNA, and an outer region 
containing two lateral bodies, surrounded by the 
envelope, where external spiracles are lost or replaced 
by surface tubular elements. Thus the immature 
spheridal particle is converted to a brick-shaped 
mature virion (Sarov and Joklik, 1973).
3.22.6 The Location and Role of the Tegument in Herpes 
Simplex Virus 
The tegument, possible because it is difficult to 
isolate, and is an ill-defined structure, has not been 
studied in detail for any herpesviruses. Information 
on the structural composition of the tegument of HSV 
has been reported only in a review by Roizman and 
Furlong (1974) and from this report Vmw65 cannot be 
exclusively associated with either the virus capsid or 
the envelope.
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In one set of experiments described in this article, 
the envelope and tegument proteins were removed from 
HSV-l(F) virions by treatment either with the non-ionic 
detergent NP40 or with a solution of NP40, 
deoxycholate, and urea. A measurement of the 
attachment of residual proteins to the capsid was then 
made on the assumption that the relative recovery of 
proteins reflected their proximity and strength of 
binding to the capsid. In a second series of 
experiments, virions were externally labelled by means 
of tritiated borohydride reduction of Schiff's bases 
formed*between pyricJox al phosphate and the protein 
amino group in the surface of the virions. The basis 
of this work was that extent of labelling should be 
inversely proportional to the distance from the surface 
of the virion (Roizman and Furlong, 1974). The results 
from these experiments are shown diagrammatically in 
Figure 43. The data derived from treatment of virions 
with NP40 suggests that Vmw65 is associated with the 
envelope, whereas results from experiments in which the 
extrinsic labelling technique was used indicate that 
Vmw65 is more closely associated with the capsid 
(Figure 43).
Gibson (1981) examined CMV Colburn strain capsids, 
purified from virus-infected cells, treated with NP40
Figure 43
Schematic diagram of the HSV-1 strain F herpesvirion
(a) Possible order of polypeptides in envelope and 
tegument of the virion based on the relative 
efficiency of stripping from the virion by the 
nonionic detergent NP-40. Polypeptide number is 
plotted in terms of percentage remaining attached 
to virion after extraction with detergent.
(b) Possible order of polypeptides in the envelope and
tegument of the virion based on relative
accessibility of polypeptides to labelling by
tritiated borohydride reduction of the Schiff's
base formed between the polypeptide and pyridoxal
phosphate. Polypeptide number is plotted from the 
3
ratio of H-external label donated by tritiated
14 14
borohydrate and C-label from C-amino acid
mixture added to the culture medium.
Taken from Roizman and Furlong (1974).
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and dounce homogenised. In the most complex of three 
capsid forms he identified a 205,000 MW polypeptide 
analogous to the HSV Vmw273 tegument polypeptide (Spear 
and Roizman, 1972; Gibson and Roizman, 1972), and a 
phosphorylated 66,000 MW protein which was thought to 
interface the viral nucleocapsid and envelope, and 
therefore is probably equivalent to HSV Vmw65. The 
data indicates that the CMV counterpart to Vmw65 is 
associated with the capsid rather than the envelope, 
although Gibson (1981) had suggested that the tegument 
structure interacts with glycoprotein to promote virus 
envelopment.
The results presented in this thesis do not exclude the 
possibility that the tegument, or indeed Vmw65, has a 
role in envelopment, but on the basis of this work, a 
model for the involvement of Vmw65 in the packaging of 
HSV DNA is proposed in which Vmw65 binds to the virus 
capsid prior to packaging of DNA.
This model makes the assumption that a capsid-tegument 
complex must be formed in order for cleavage and 
packaging of viral DNA to proceed. A ts lesion in 
Vmw65 would prevent the production of such a complex at 
the NPT, and viral DNA would be neither cleaved nor 
packaged until synthesis of functional Vmw65 was
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allowed to proceed at the PT. The model does not 
anticipate direct involvement of Vmw65 in the 
encapsidation of DNA, since the protein has been 
definitively shown to lack any DNA binding properties, 
but it does not preclude the involvement of other 
tegument proteins in such a role. Whilst this 
mechanism does not exclude the possibility that Vmw65 
or the tegument as a whole can promote envelopment of 
the capsid, perhaps by an attraction between certain
glycoproteins and the tegument, the possibility that 
multiple functional forms of Vmw65 exist in the virion 
cannot be excluded at this stage. In this case, 
differently processed forms of the proteins might 
function in encapsidation, and in envelopment and the 
trans-induction of HSV IE gene expression during the 
next round of infection.
3.23 FUTURE DIRECTIONS
The work on ts2205 strongly suggests that the tegument 
protein Vmw65 is important for viral DNA encapsidation. 
To prove conclusively that the ts lesion in ts2205 lies 
within the Vmw65 gene, it will be necessary to sequence 
the region in the ts2205 genome where the mutation has 
been mapped by marker rescue, and to compare it with 
the WT sequence. It will also be interesting to
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analyse the Vmw65 gene in each of the five
+
independently isolated ts revertants to find out 
whether the base pair change has occurred at the site 
of the ts mutation or elsewhere, and to determine the 
nature of the amino acid substitution; such a study may 
identify interacting regions of Vmw65.
The immunofluorescence study indicated that Vmw65 was 
located in the nucleus of both WT- and mutant 
virus-infected cells. It is important to find out 
whether Vmw65 is present at the inner nuclear membrane 
or if i*t is associated with a particular type of 
capsid. This information would be of great value in 
elucidating the role of Vmw65 in encapsidation of viral 
DNA and in determining the reason for the defect in 
ts2205-infected cells at the NPT.
Vmw65 can be located by immune electron microscopy, 
using either the available monoclonal antibodies, which 
recognise different epitopes on Vmw65, or an antiserum 
raised against an oligopeptide specific to a portion of 
Vmw65.
The development of a cell-line expressing WT HSV Vmw65 
would allow the isolation of host range mutants with 
defects in Vmw65. The advantage of this method of
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mutant isolation is that a range of defined mutations 
in Vmw65 can be introduced into the virus. The 
phenotype of any mutant can thus be examined to 
determine the function of Vmw65. It will be 
interesting to find out whether, as suggested by Gibson 
(1981), this polypeptide is required for virus 
envelopment as well as for the encapsidation of viral 
DNA, and trans-activation of IE gene expression.
«
CHAPTER 4
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4. ANALYSIS OF HSV-1 Vmw65: A STRATEGY TO IDENTIFY THE 
FUNCTIONAL DOMAINS OF AN HSV GENE
4 .1 Introduction
Post et al (1981) and Batterson and Roizman (1983) 
showed that HSV IE transcription is strongly stimulated 
by a trans-acting structural component of the virion 
located outside the nucleocapsid, since trans­
activation of IE gene transcription was detectable i-n 
infections at the NPT with tsB7 (a ts mutant which 
fails to uncoat at the NPT). Subsequently, Campbell et 
al. (1984) identified this polypeptide component using 
a novel application of the cotransfection and transient 
expression assay.
In the experiments of Campbell et al. (1984), cloned
DNA fragments, spanning the HSV-1 genome, were 
transfected into cells together with an HSV-1 IE-TK 
chimaeric plasmid. The plasmid pTKN2 (Figure 44) 
consisted of the TK gene under the control of 5' 
upstream regulatory regions of IE175; these included 
the target sequences for stimulation by the virion 
component, the TAATGARATTC consensus, represented in 
IE175 by TAATGAGATGC (Murchie and McGeoch, 1982;
Mackem and Roizman, 1982a, 1982b; Whitton and Clements, 
1984a), and GA-rich flanking regions (Preston et al., 
1984; Bzik and Preston, 1986), extending to 331bp 
upstream from the IE175 mRNA start site. Cells were 
harvested at 16h post-transfection, and cell extracts 
assayed for stimulation of TK expression from pTKN2.
The gene sequences encoding the trans-inducing factor
Figure 44
Location of trans-activating sequences in HSV-1 
Transient expression assays were used to locate 
trans-acting stimulatory sequences in HSV-1 to the 
EcoRI i fragment. Sequences were isolated to 
BamHI f (pGX158), and shown to be contained within 
pMCl, which contains a Sall-Xhol fragment of BamHI 
f cloned into pUC9.
pMC4 is pGXl*58 (BamHI f), with an EcoRI 8bp 
insertion at a PvuII site outside the stimulatory 
sequences of pMCl.
pTKN2 is a chimaeric plasmid containing the 
upstream sequences of the gene encoding IE175 
responding to Vmw65 stimulation, to -331bp. These 
were linked to the coding sequences of the HSV-1 
TK gene. The data are taken from Campbell et al. 
(1984). -
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were thus mapped to a portion of BamHI f, and subcloned 
into the pUC9 vector as a 2.7kb Sall-Xhol DNA fragment 
(pMCl) (Campbell et al., 1984), Figure 44.
pMCl contains sequences which encode a 1.9kb mRNA, 
flanked by noncoding regions from adjacent genes whose 
polypeptide products have approximate MWs of 33,000 and
72.000 (Dalrymple, 1986). The 1.9kb mRNA encoded a
65.000 MW polypeptide (Hall et al., 1982) and hybrid 
arrested translation experiments and immune 
precipitations, using a monoclonal antibody, MA1044, 
identified this as the tegument protein, Vmw65 
(Campbell et al., 1984). Subsequent sequencing of 
BamHI f confirmed that only a single complete open 
reading frame existed within pMCl (M Dalrymple, 1986), 
and a MW of 54,342 was predicted for the HSV-1 strain 
17 Vmw65 protein (Dalrymple et al., 1985). The HSV-1 
strain F gene encoding Vmw65 has also been sequenced 
(Pellet et al., 1985).
In order to demonstrate that in vitro stimulation of TK 
expression from an IE-TK chimaeric plasmid was due to 
the expression of the Vmw65 polypeptide, the Vmw65 gene 
coding sequences were interrupted by the insertion of 
an 8 base pair EcoRI DNA oligonucleotide linker 
(GGAATTCC) at a PvuII site. This procedure disrupted 
the normal reading frame, and no stimulation of TK 
expression could be detected on cotransfection of this 
altered plasmid into cells with pTKN2. Similarly, an 
EcoRI DNA oligonucleotide linker was inserted into the
-177-
cloned HSV-1 BamHI f fragment at a PvuII restriction
endonuclease site outside the pMCl (Vmw65) region,
producing a plasmid termed pMC4. This insertion had no
effect on stimulation of IE transcription in vitro. 
Campbell et al. (1984)
4.2 Analysis of Vmw65
The tegument polypeptide, Vmw65, has a dual role in the 
virion; as a structural polypeptide which is required 
for packaging of viral DNA, and as a trans-inducing 
factor for IE gene transcription. To study the 
relationship between structure and function, the gene 
was analysed for functional domains within the coding 
sequences of Vmw65.
t
This process involved the mutagenesis of cloned HSV-1 
Vmw65 (pMCl) by the insertion of 6 base pair Xbal 
oligonucleotide linkers, at positions throughout the 
DNA coding sequence of the gene. Thus, in frame 
insertion mutants would be produced. Mutagenised 
plasmids could be analysed for: (1). The ability to 
stimulate IE gene transcription, by assaying for 
stimulation of expression from an IE-TK chimaeric 
plasmid in a transient expression assay (2). The 
ability to rescue the ts lesion in ts2203 (intertypic 
marker rescue). The failure to perform either function 
could then be interpreted as the disruption of an 
essential function domain. However, the retention by a 
mutagenised plasmid, of the normal ability to rescue 
ts2203, could also be indicative of recombination 
events between the site of the insertion in pMCl, and
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the site of the ts lesion in ts2203, resulting in the 
production of a WT recombinant virus. Therefore, the 
ability to rescue ts>2203 did not exclude the 
possibility of a disrupted functional domain within the 
plasmid.
4.3 Strategy for Insertional Mutagenesis
The procedure is summarised in Figure 45.
4.3.1. Preparation of Linear pMCl DNA
pMCl DNA was restricted with a restriction endonuclease 
which cleaves at multiple sites within pMCl, in the 
presence of ethidium bromide (EtBr), an intercalating 
agent &hich preferentially binds to linear molecules 
rather than to supercoiled DNA, preventing further 
digestion of DNA. Preliminary experiments determined 
the optimal concentrations of EtBr and enzyme required 
for partial digestion to give maximal recovery of 
linear pMCl DNA (Figure 46), and a bulk preparation of 
linear DNA was then made.
DNA fragments were separated by agarose gel 
electrophoresis, and linear molecules eluted from the 
gel slices (Section 2.5.2). DNA was extracted with 
saturated butan-2-ol to remove any EtBr and then 
purified.
4.3.2. Insertion of Xball Oligonucleotide Linkers
In order to define discrete functional domains of
Figure 45
Flow chart of the procedure for insertional mutagenesis
of pMCl
Figure 45
Flow Chart: The Procedure for Insertional
Mutagenesis of pMCl
pMCl DNA
(EtBr) linear partial DNA produced
Purified linear partial DNA
o
Ligated to Xbal linker DNA 4 /18h
DNA transfected into competent DHI bacteria
amp clones isolated
DNA isolated and restricted with
a. Xbal (single insert) b. Bglll (tandem Xbal inserts)
Bglll digestion of DNA
Purification of DNA: Religate
Transfect into non-methylating 
bacteria (GM48)
i
r
amp clones isolated
Plasmid DNA can be restricted 
with Xbal,
and- Bglll.
V
Plasmid is restricted with 
Xbal, and religated
4/
A 6bp Xbal linker is now retained in all plasmids
"V
Insertion located within Vmw65 sequences (Figure 47)
v
Precise location of insert (Figure 48)
Transient expression assay 
(Table 14)
Marker rescue assay 
(Table 15)
Figure 46
Preparation of linear pMCl DNA
Track 1: undigested pMCl DNA; track 2: Hindlll digested
pMCl, linear DNA. pMCl DNA (2ug) was digested with 2u
o
Haelll endonuclease at 37 for 120min (tracks 3-7) or 
60min (tracks 8-12) in the presence of 2.0ug EtBr 
{tracks 3,8); l.Oug EtBr (tracks 4, 9); 0.5ug EtBr 
(tracks 5, 10); 0.25ug EtBr (tracks 6, 11); 0.125ug 
EtBr (tracks 7, 12). Samples were separated by agarose 
gel electrophoresis (1% agarose gel) and linear partial 
DNA identified against pMCl linear DNA (arrowed).
1 2 3 4 5 6 7 8 9 10 11 12
m U M M  M  It mi Ml
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the gene, it was essential to limit disruption to the 
Vmw65 sequence, so in these experiments 2 amino acid 
codons were inserted into the sequence. Synthetic 6bp 
oligonucleotide linkers used for this purpose were 
blunt-ended and phosphorylated, and were composed of 
the nucleotides (5'-TCTAGA-3’), a sequence which is 
recognised by Xball restriction endonuclease and does 
not occur in pMCl. All mutagenised plasmids could, 
therefore, be screened for the presence of a unique 
Xbal site.
Insertions were made into blunt-ended sites generated
by restriction endonucleases (Rsal, Alul, Thai or
HaeIII)*but insertion of oligonucleotide linkers was
only achieved at Haelll endonuclease sites (GG'CC).
Purified linear partial DNA was treated with
phosphatase, and then ligated to Xbal 6bp linkers (at a
molar ratio of 10-100 times that of the plasmid DNA) in
o
a lOul volume at 4 for 16-18h in the presence of T4
DNA ligase. Following ligation, the DNA was
transfected into competent E .coli DHI bacteria (Section
2.5.4), plated onto L-broth agar plus ampicillin, and 
o s
incubated at 37 . Ampicillin resijjtant clones were
harvested and plasmid DNA extracted (Section 2.5.5).
4.3.3 Analysis of Xbal Insertions
Because the ratio of linker to plasmid DNA was
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very high in the ligation mix, it was anticipated that 
multiple tandem linkers would become ligated into the 
Haelll site. Under these conditions adenine residues 
in the sequence 5'-GATC-3', which is formed by tandem 
Xbal linkers (5'-TCTAGATCTAGA-31), would become 
methylated by the bacterial host (dam methylation), and 
rendered insensitive to Xbal endonuclease digestion.
All plasmids were, therefore, screened with Xbal (for 
any single linker insertions), and Bglll, which 
recognises the sequence in a double Xbal insertion 
Bglll
(5'-TCTAGATCTAGA-31) but which is not affected by 
Xbal Xbal
dam methylation of adenine residues.
All plasmids isolated by this method contained at least
2 Xbal 6bp insertions, since they were digested by
Bglll alone. The DNA was, therefore, linearised with
Bglll, and purified with ethanol to remove the small
fragments. DNA was then religated and transfected into
non-methylating E coli GM48 bacteria (Marinus, 1973).
r
Plasmid DNA was harvested from the amp bacterial 
clones, and could be restricted with Xbal enzyme. 
Plasmids were then digested with Xbal and religated, to 
produce samples with 6bp insertions.
4.3.4 Location of Xbal Oligonucleotides in the pMCl
Sequence
An Ec o RI/Ec oBv digestion separates the plasmid
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vector and Vmw65 sequences present in pMCl (Figure 
47) and the further addition of Xbal to the digestion 
of mutagenised plasmids showed whether the insertion 
was in vector or coding sequences (Figure 47) .
Plasmids with gross deletions, or an insertion at a 
Haelll site in the vector were discarded.
The location of the inserts was determined by digestion 
with pairs of restriction enzymes (Apal and Xbal, PvuII 
and Xbal, Sail and Xbal or Smal and Xbal), followed by 
separation of the fragments on a 16% polyacrylamide 
gel. The size of the fragment produced by a Xbal 
insertion was determined (Figure 48), and Xbal inserts 
were th\is identified at Haelll positions 5, 6, 11, 15 
and 17 (Figure 49). These will be referred to as p5, 
p6 , pll, pl5 and pl7. In addition, an Xbal 
oligonucleotide was inserted into pMC4 (Figure 44), at 
a unique PvuII site within the Vmw65 gene.
pMC4 was restricted with PvuII, and Xbal linkers 
ligated to the DNA as previously described. On 
analysis, a single Xbal linker was found to be inserted 
into pMC4, thus destroying the remaining PvuII site 
(Figure 48). This plasmid was termed pP2. The 
location of all the insertions are given in the map of 
pMCl in Figure 49.
Figure 47
Location of Xbal inserts in Mutagenised pMCl Plasmid
DNA
Track 1 pMCl DNA digested with EcoRI plus EcoRV:
(larger fragment represents vector DNA and 5' 
non-coding flanking sequences of Vmw65, smaller 
-fragment is Vmw65 plus 3' non-coding flanking 
sequences); Tracks 2-7, mutagenised plasmids digested 
with EcoRI/EcoRV/Xbal; Track 8 , pTKl digested with 
BamHI plus Smal to provide size markers.
In plasmids 2-6 the Vmw65 fragment is reduced in size 
as Xbal insert is in Vmw65 coding sequences. Tracks 3, 
4 location of smaller fragment is indicated by an 
arrow. Track 7, the insert has been made in the 
vector: this plasmid was therefore discarded.
1 2 3 4 5 6 7 8
Figure 48
Location of Xbal oligonucleotide insertions in Vmw65 
mutagenised plasmids
Mutagenised pMCl DNA was digested with Apal plus Xbal, 
PvuII plus Xbal, Sail plus Xbal or Smal plus Xbal, and 
fragments separated on a 16% polyacrylamide gel. The 
presence of an Xbal site resulted in the production of 
a novel fragment, and the location of the insert could 
be determined from the size of this fragment relative 
to Apal and PvuII sites, or Smal and Sail sites in 
pMCl. The location of insertions is given in Figure 
49.
1. U : undigested pMCl DNA
L : linearised pMCl DNA
1,2: insert at Haelll site 17 [1: Sail, Xbal. 2:
Smal, Xbal]
4,5: Insert at Haelll site 15 [4-: Sail, Xbal,
(where no novel fragment is produced) 5:
Smal, Xbal]
3: pAT size markers (Hinfl, EcoRI]
An Xbal insertion was made into pMC4 at a PvuII 
site in the Vmw65 coding region.
6 : undigested pMC4 DNA
7: pP2 [Xbal]
8 : pMC4 [linearised with PvuII]
9: pMCl [linearised with Hindlll]
Fragments were separated on a 1% agarose gel.
2. 1,2: Insert at Haelll site 11 [1: Apal, Xbal. 2:
PvuII, Xbal]
4,5: Insert at Haelll site 6 [4: Apal, Xbal. 5:
PvuII, Xbal]
7,8: Insert at Haelll site 5 [7: Apal, Xbal; 8 :
PvuII, Xbal]
3,6,9: PAT size markers [Hinfl, EcoRI].
1 6 3 1
517
396
298
221
220
154 /45
75
2.  1 2  3  4  5 6 7 8 9
■  m
n
1631
517
396
298
221
220
154
145
75
1631
517
396
298
220 221
154
145
75
Figure 49
DNA Sequence and Amino Acid Sequence of pMCl 
Haelll'sites are underlined, and numbered; Haelll 
sites where an Xbal insertion was made are 5, 6 , 11, 15 
and 17. PvuII site where an Xbal insertion was made in 
pMC4 is P2.
»
HaellK 1—17)
T r a n o > „ 11 o n of: PM Cl.K EV
OAGCCCCAGCOCGCTCCGCTTCTCGCCCCAGACGGCCCGTCGAGTCAAAACTTCCGTACCCACACAATAAAGCAC 7 5 
CA ACAGGGCTTCATTCGGTGTTGGCGTTGCGTGCCTTTGTTTCCCAATCCGA CGGGGA CCGGGACTGGGTGGCGG 1 5 0  
GGGGTGGGTTGGACAGCCGCCCTCGGTTCGCCTTCACGTGACAGGAGCCA ATGTGGGGGGA AGTCACGAGGTACG 2 25 
GGGCGGCCCGTGCGGGTTGCTTAA ATGCGTGGTGGCGACCACGGGCTGTCATTCCTCGGGA ACGGACGGGGTTCC 3 00  
CGCTGCCCACTTCCCCCCATAAGGTCCGTCCGGTCCTCTAACGCGTTTGGGGGTTTTCTCTTCCCGCGCCGTCGG 3 75  
GCGTCCCACACTCTCTGGGCGGGCGGGGACGATCGCATCA A AAG CCCG ATATCGTCTTTCCCGTATCAACCCCAC 4 5 0
M 0 L L V D E L F A D M N A D G A S 18
CCA ATG GAC CTC TTG GTC GAC GAG CTG T T T GCC GAC ATG AAC GCG GAC GGC GCT TCG 5 0 7
P P P P R P1 A G G P K N T P A 2 A P P L 37
CCA CCG CCC CCC CGC CCG GCC GGG GGT CCC AAA AAC ACC CCG GCG GCC CCC CCG CTG 5 6 4
Y A T G R L S Q 3 A 0 L M P S P P H P V 56
TAC GCA ACG GGG CGC CTG AGC CAG GCC CAG CTC ATG CCC TCC CCA CCC ATG CCC GTC 6 2 1
P P A A L F N R L L 0 D L G F S A c4 P 75
CCC CCC GCC GCC CTC T T T AAC CGT CTC CTC GAC GAC TTG GGC TT T AGC GCG GGC CCC 6 7 8
A L C T M L D T w N E D L F S A L 9 4
GCG c t a TG T ACC ATG CTC GAT ACC TGG AAC GAG GAT CTG TT T TCG GCG CTA CCG ACC 7 3 5
N A 0 L Y R E C K F L S T L P S D V V 1 13
AAC GCC GAC CTG TAC CGG GAG TGT AAA TTC CTA TCA ACG CTG CCC AGC GAT GTG GTG 79 2
E w C 0 A Y V P E R T 0 I D I R A H G 1 32
GA A TGG GCG GAC GCG TAC GTC CCC GA A CGC ACC CAA ATC GAC ATT CGC GCC CAC GGC 8 4 9
0 V 5  a F P T L P 6  A T R D G7 L G L Y Y E 1 5 1
GAC GTG GCC TTC CCT ACG CTT CCG GCC ACC CGC GAC GGC CTC GGG CTC TAC TAC GAA 9 0 6
A L S R F F H A E L R A R E E S Y R T 1 7 0
GCG CTC TC T CGT TTC TTC CAC GCC GAG CTA CGG GCG CGG GAG GAG AGC TAT CGA ACC 9 6 3
V t * A N F C S '9 A L Y R Y L R A S V R Q 1 89
GTG TTG GCC AAC TTC TGC TCG GCC CTG TAC CGG TAC CTG CGC GCC AGC GTC CGG CAG 1 0 2 0
L H R 0 A H M R G R D R 0 L G E M L R 2 0 8
CTG CAC CGC CAG GCG CAC ATG CGC GGA CGC GAT CGC GAC CTG GGA GAA ATG CTG CGC 1 0 7 7
A T I A D R Y Y R E T A R L A R V L F 2 2 7
GCC ACG A TC GCG GAC AGG TAC TAC CGA GAG ACC GCT CGT CTG GCG CGT G TT TTG T T T 1 1 3 4
L H L v L F L T R E I L w10A A Y A E 0 2 4 6
TTG CAT TTG T A T CTA T T T TTG ACC CGC GAG ATC CTA TGG GCC GCG TAC GCC GAG CAG 1 1 9 1
M M D L F D C L C C 0 L E S W R Q 2 6 5
ATG ATG CGG CCC CAC CTG T T T  GAC TGC CTC TGT TGC GAC CTG GAG AGC TGG CGT CAG 1 2 4 8
L A G L  F Q  P F M F V  N G A L T V  R G 2 8 4
TTG  GCG GGT CTG TTC  CAG CCC TTC ATG TTC  GTC A AC GGA GCG CTC ACC GTC CGG GGA 1 3 0 5
12
V P I E A R R L R
GTG CCA ATC GAG GCC CGC CGG CTG CGG
L P L V R S A A T
CTC CCG CTG GTG CGC AGC GCG GCT
13
ACG
P T L P G N Q- -'  A R
CCC ACC CTG CAT GGC AAC CAG GCC CGC
A K L 0 S Y S S F
GCG AAG TTG GAC TCG TAT TCC AGC TTC
E H A Y S R A R T
GAA CAC GCG TAC AGC CGC GCG CGT ACG
L L 0 L P D D 0 A
CTG CTC GAT CTC CCG GAC GAC GAC GCC
L S F L P A G H T
CTG TCC T T T CTC CCC GCG GGA CAC ACG
V s L G 0 E L H L
GTC AGC CTG GGG GAC GAG CTC CAC TTA
D A L 0 0 F D L D
GAC GCG CTA GAC GAT TTC GAT CTG GAC
G F T P H D S A P
GGA T T T ACC CCC CAC GAC TCC GCC CCC
F E 0 M F T D A L
T T T GAG CAG ATG T T T ACC GAT GCC CTT
N H I R E H L N 3 0 3
AAC CAC ATT CGC GAG CAC C TT AAC 1 3 6 2
P G A P L T T P 322
CCA GGG GCG CCG TTG ACG ACC CCT 1 4 1 9
G Y F M V L I R 341
GGG TAC TTT ATG GTG TTG A T T CGG 1 4 7 6
S P S E A V M R 360
TCG CCC TCC GAG GCG GTC ATG CGG 1 5 3 3
14
N Y G S T I E’ • G 379
AAT TAC GGG TCT ACC ATC GAG GGC 1 5 9 0
E A G L A A P R 3 9 8
GAG GCG GGG CTG GCG GCT CCG CGC 1 6 4 7
§a lt A P P T D 4 1 7
CTG TCG ACG GCC CCC CCG ACC GAT 1 7 0 4
E 0 V A M A H A 4 3 6
GAG GAC GTG GCG ATG GCG CAT GCC 1 7 6 1
G D G 0 sSipal 16P 4 5 5
GGG GAC GGG GAT TCC CCG GGG CCG 1 8 1 8
A L 0 H A D F E 4 7 4
GCT CTG GAT ATG GCC GAC TTC GAG 1 8 7 5
0 E Y G G _ 4 9 0
GAC GAG TAC GGT GGG TAG GGGGCGC 1 9 3 3
i^T!
GA CCGGA CCCGCATCCCCCGTCTGGGTTTTCCCCTCCCGTCACCGGTTCGTATCCACAATAAACACGAGCACATA 2 0 0 8  
CATTACAAAACCTGCGGTTGTCGTCTGATTATTTGGTGGTGGGGGAAAGAACTAGCCAGGAGACGGGACCGCGCA 2 0 8  3 
ACCAACCCACTGGGGTCTGGGTTGCCGGCGTGTGTGTTAGCCGCGTCTGCGGGCCTGTCGTGTAGATTCGAAACC 2 1 5 8  
ACGGACGGGTGATTGTGTCGCAGGGCGGCCCGCGTATAAAGGCGAGAGCGCGGGACCGTTTCCGCATTTGGCCGG 2 23  3 
GGGCTGGGGCGGCGGGTAGCCTTCGCGGGAGATACTGCGTTTTTTTGCGCCGGCCCCGTCGCTCCCGTCCATTCC 2 3 0 8  
CATCGCGAGGGGGTCCGGCGGCACCTACCCCGGCCTCCATCCGCGCTGTGGGGTCTTTTTCTTTTTTGGGGGGTA 2 3 8 3 
GCGGACATCCGATAACCCGCGTCTATCGCCACCATGTCGGCTCGCGAACCCGCGGGGCGCAGGAGGCGCGCATCC 2 4 58  
ACCCGCCCCCGCGCCTCGCCCGTGGCGGACGAGCCAGCGGGCGATGGGGTGGGGTTCATGGGGTACCTGCGTGCG 2 5 3 3 
GTGTTCCGCGGGGATGACGACAGCGAGCTAGAGGCTCTGGAGGAGATGGCGGGCGACGAGCCGCCCGTGCGCCGT 2 6 0  8
PvuII
c 2 6 0 9
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4.4 Insertion of Amino Acid Codons
The insertion of the Xbal linker (TCTAGA) into the 
Vmw65 reading frame can result either in the addition 
of the amino acids serine and argine, leucine and 
asparate, -• or in the production
of an amber termination codon (TAG) (Table 13). The 
insertions at positions 5, 6, 15 and 17 produced 
termination codons, which would generally preclude the 
synthesis of any functional polypeptide. However, 
there is a possibility that the insertion of such a 
codon close to the normal termination site would have a 
limited effect on polypeptide function. Interestingly, 
therefore, the Xbal insert at pl7 is just 59bp upstream 
of the'normal 'stop-codon'.
4.5 Functional Analysis of pMCl
Plasmids were analysed for the disruption of 
functionally essential domains within Vmw65.
4.5a.Analysis of domains of Vmw65 Important for 
Transcription Activation
WT pMCl or mutagenised plasmid DNA was transfected into
cells together with the chimaeric plasmid pTKN2, at 
o
37 . Cells were incubated, and harvested after 24h; 
cell extracts were then assayed for TK activity 
(Section 2.6, Table 14). The results show that only 
pl7 retained the WT Vmw65 ability to stimulate IE-TK 
expression. This suggests that pP2 affects an 
essential functional domain of Vmw65 which is
Table 13
Codon Changes in pMCl Following Insertion of an Xbal 
Linker
Changes are described for plasmids p5, p6, pll, pl5, 
pl7 and pP2. Valine: V; alanine: A; threonine: T; 
glutamine: Q; leucine: L; serine: S; arginine: R; 
tryptophan: W; proline: P; phenylalanine: F; glutamate 
E; methionine: M; stop codon:-
Locations of insetts are shown in Figure 49 (pMCl 
sequence).
Table 13
Plasmid pMCl Sequence Mutagenised Sequence
V A V V - T
p5 GTG GCC GTG GTC TAG ACC
P A  P V - T
p6 CCG GCC CCG GTC TAG ACC
Q L Q S R L
pP2 * CAG CTG CAG TCT AGA CTG
R P R S R P
pll CGG CCC CGG TCT AGA CCC
T A T V - T
pi 5 ACG GCC ACG GTC TAG ACC
M A M V - T
pi 7 ATG GCC ATG GTC TAG ACC
Table 14
Stimulation of pTKN2 Expression by Cotransfection with 
pMCl or Mutagenised Plasmids
Cells were transfected with l.Oug pTKN2, l.Oug test 
plasmid and l.Oug carrier DNA.
Stimulation represents the increase in expression of TK 
relative to pTKN2 (pTKN2 stimulation = 1.0).
The results of 2 experiments are given, and the value 
relative to pMCl (where pMCl stimulation = 100%) is 
also given.
Table 14
Plasmid TK Stimulation from pTKN2
________________ 1^ ______ 2._____ Mean Value_____ % of pMCl
pMCl 8.77 9.77 9.27 100
p5 0.68 0.75 0.715 7.7
p6 0.65 0.85 0.750 8.1
pll 1.25 1.09 1.170 12.6
pl5 0.70 0.86 0.780 8.4
p!7 5. £7 4.40 4.935 53.2
pP2 0.88 0.79 0.835 9.0
required for transcriptional stimulation, and that the 
sequences 3 ’ to site 17 are not required for this 
function. The results obtained with pll were less 
conclusive. Although Vmw65 activity was clearly 
diminished, some stimulation (approximately 13% of pMCl 
levels) of IE-TK expression was consistently observed.
5b.Analysis of Structural Domains of Vmw65
The effects of the ts lesion in ts2203, which is 
located at the 5' end of the HSV-2 Vmw65 gene, and the 
marker rescue of this lesion by pGX158 (containing 
HSV-1 BamHI f DNA fragment) or pMCl, have been 
described in detail in Section 3.
t
Marker rescue of ts2£Q3 was carried out, as previously
o
described, at 31 and virus progeny were screened at
+
the PT and NPT for ts virus.
The eop NPT of progeny virus is given in Table 15.
PT
From the results, p5, p6 and pl5, all of which contain
termination codons, failed to rescue ts2203. pll also
failed to rescue the lesion, suggesting that the Xbal
linker in this plasmid is present within a functional
domain for this property. Plasmids pl7 and pP2 were
both able to rescue the lesion. However, as described
+
before, the recovery of ts progeny is not complete 
proof that these inserts do not affect an essential 
domain, since WT recombinant viruses may have been 
produced without insertion of the oligonucleotide.
Table 15
Summary of Marker Rescue Experiments
ts2203 DNA and a 10 times molar excess of plasmid DNA
was cotransfected into BHK cells, and progeny virus
+
were titrated at the PT and NPT for ts recombinant 
virus.
o
Rescue is calculated as eop (38.5 ) x 100, and
o
31
is indicated by + = rescue of lesion; - = no rescue.
t
This result is representative of a number of 
experiments.
Table 15
DNA Fragment 
or Plasmid
Eop x 100 Rescue
ts2203 (alone) 
Bglll i (HG52) 
Bglll i (ts!3) 
BamHI f (pGX158) 
pMCl
0.001
30.770
0.001
0.200
0.080
5
6
P2
11
15
17
0.0040
0.0100
0.1890
0.0006
0.0070
0.1500
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Therefore, failure to rescue ts2203 is more significant 
at this stage than the apparent ability to rescue the 
lesion.
4.5c.Hydropathicity Plot of Vmw65
Previous work (Dalrymple, 1986) demonstrated that the 
HSV-1 Vmw65 was highly charged and acidic, with 
significant proportions of p-pleated sheets, but that 
it had no extensive regions of hydrophobicity or 
hydrophilicity.
A graphical analysis of hydropathicity of Vmw65 and the 
mutagenised plasmids was carried out using the 
programme of Kyte and Doolittle (1982) to study the 
effects of newly inserted amino acids (Figure 50). 
Little change in hydropathicity was evident for any 
plasmid.
4 .6 Functional Domains of HSV-1 Vmw65
The results of this analysis are given in Table lj&, 
together with those obtained from a similar study in 
which 12bp BamHI insertions were made into Haelll 
endonuclease sites of pMCl, resulting in addition of 4 
amino acids (C.I.Ace, personal communication).In these 
experiments IE trans-activation by Vmw65 was assessed 
by cotransfection of plasmid plus an IE-CAT chimaeric 
plasmid, and subsequent CAT-assays. However, in all 
other respects, the procedures were the same as those 
described for Xbal insertional mutants.
Figure 50
Comparison of hydropathic profiles of pMCl and
mutagenised plasmids
!
Hydropathic profiles were predicted by the program of 
Kyte and Doolittle (1982).
Degree of hydrophobicity increases with distance above
i<* I
the mid-line; degree of hydrophilicity decreases with 
distance below the mid-line. Letters beneath the plots 
refer to amino acid residues.
Parameters: group length = 9
shift = 1
pMCl samples are given as representatives of the WT 
protein.
Hydropathicity
1. pMCl, 2. pP2 amino acids 169-250
3. pMCl, 4. pll amino acids 226-281
5. pMCl, 6 . pl7 amino acids 449-490
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Table 16
Summary of insertional mutagenesis of Vmw65 (pMCl) 
Insertions of 12bp (BamHI) or 6bp (Xbal) linkers were 
made at Haelll sites (1-17 see Figure 49), and assessed 
for
1. Stimulation of TK or CAT expression from IE-TK or 
IE-CAT constructs and
2. For the marker rescue of ts2203.
(P2 insertion was* made into pMC4, which encodes all of 
BamHI f).
Plasmids containing BamHI-linker insertions were suonlied 
by Mr C I Ace.
Table 16
Insertions at 
Haelll sites (1-17) 
within pMCl________
Transcriptional Marker Rescue
Stimulation Xbal BamHI
IE-TK(Xbal) IE-CAT(BamHI)
pMCl
2
4
5
6
7
8 
9
PvuII
11
12
14
15 
17
+ / -
+ / -
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4.7 Predicted Secondary Structure of Vmw65
The insertion of amino acids and their effect upon the 
function of the Vmw65 protein can be related to their 
effect on the secondary structure of the protein. A 
prediction of the HSV-1 Vmw65 secondary structure was 
made using the Chou and Fasman computer program (Chou 
and Fasman, 1973), accepting only strongly predicted 
structures (Figure 51).
As expected, Vmw65 structure can be seen to have 
regions of hydrophilicity and hydrophobicity throughout 
the protein stucture. Also evident through the protein 
are strongly predicted ^ — helices and ^-structures, as 
well a£ a number of reverse turns. In the majority of 
cases the insertion ofXbal and BamHI inserts had 
little effect on the predicted stucture of Vmw65.
At pll, a 2 codon Xbal insertion altered the 
hydropathicity, whereas a 4 codon BamHI insert appeared 
to reduce the length of a strongly predicted C<.-helix 
(Figure 52).
At pP2, both inserts added hydrophilic sites to a 
region of weakly predicted structure.
At p!7, a BamHI insert increased the hydrophilicity, 
however the Xbal insertion, producing a termination 
codon, eliminated a 3'- -helical prediction (Figure 
52 ) .
Figure 51
Predicted secondary structure of pMCl 
The predicted secondary structure of Vmw65 was 
determined using the Chou and Fasman computer program. 
Only strongly predicted structures were accepted:
Predicted -helices, p-structures and reverse turns
Hydrophobic and hydrophilic regions are indicated by
are indicated bu /S and r,
reverse 
turns(t)
ooo
CD
o
o
CD
CD
®  i
o
CD r
CD
l/2— 8
TD
o
NH2
oC-helical structures
Figure 52
Predicted secondary structures of mutagenised pMCl 
Structures predicted by the Chou and Fasman computer 
program for (1) p4 (BamHI); (2) p9 (BamHI); (3) pll 
(BamHI) and (4) pl7 (Xbal) are shown, and the 
approximate site of the insertion is indicated for each 
plasmid.
Hydrophobic and hydrophilic regions are indicated by Q .
Predicted o^-helical regions, ^S-structures and reverse turns are 
indicated by /5, and r, respectively. ____ — —— —
Plasmids containing B a m H I — linker insertions were generously supplied 
by. Mr C I Ace.___________________________________________________________
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Of the remaining plasmids, BamHI insertions at p9 
n
converted a region of weakly predicted p-structures to 
strongly predicted p-forms, and at site 4 a turn was 
predicted to be introduced into the secondary strcuture 
by the addition of a BamHI linker (Figure 52).
4.8 DISCUSSION
The section of work described here was undertaken in
order to demonstrate the identification of essential
functional domains in an HSV-1 gene encoding Vmw65, a
tegument structural and transcriptional trans-activator
of HSV IE gene expression.
»
4.8.1 Strategy for Mutagenesis
Early methods of DNA mutagenesis involved the 
essentially random action of chemicals to produce base 
changes in a specific DNA fragment. These methods have 
been superceded by advances in recombinant DNA 
technology, and site specific mutagenesis of cloned DNA 
is now well established as a method of manipulating 
gene structure and protein function (Shortle et al., 
1981).
For relatively small regions of DNA, gap misrepair 
mutagenesis (Shortle et al., 1982),
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oligonucleotide-directed mutagenesis (Hutchinson et 
ad., 1978; Dalbadic McFarland et ad., 1982) and linker 
scanning mutagenesis, whereby lObp oligonucleotides 
containing a BamHI site were substituted for 10 
nucleotides in the HSV TK promoter (McKnight and 
Kingsbury, 1982), are all methods that have been 
successfully applied to the analysis of DNA sequence 
and function. For mutagenesis of larger sequences, 
such an entire gene, these methods become unsuitable, 
as they are very labour intensive, and require the 
sequencing of large region of DNA. In such cases, 
synthetic oligonucleotides specifying a novel 
restriction enzyme site can be inserted into a 
restridtion site, producing insertional mutations 
across the gene that may be identified by the presence 
of a unique restriction enzyme recognition site. 
However, in doing this a frameshift mutation or a 
termination codon may arise within the DNA sequence, 
thus resulting in the synthesis of a truncated protein 
(Heffron et al., 1978).
A refinement of this technique is the direct insertion 
of a known number of amino acid codons (2-4 codons) 
into a restriction enzyme recognition site, thus 
retaining the reading frame, and adding a new 
restriction site for screening and identification of 
the site of insertion. Defined regions within a gene 
can then be related to the function of the gene 
product.
The insertion of 3 or 4 amino acids can be disruptive 
to overall protein structure (Lobel and Goff, 1984). 
However, this can be remedied by minimising the size of 
the insertion, and using, for example, a 2-codon 
oligonucleotide linker (Boeke, 1981; Stone et al.,
1984; Barany, 1985), as was done in the experiments 
described in this thesis.
Two and four codon insertions have now been made into 
pMCl DNA at Haelll-restriction endonuclease sites 
across the coding sequence of the gene, and no overall 
disruption was detected using the larger insertion.
Xbal linkers were also ligated to Alul or 
Thai-restricted linear partial pMCl, but no 
Xbal-positive clones could be recovered. The reason 
for this observation remains unclear.
In addition, the frequency of plasmids containing an
r
Xbal insertion recovered from amp bacterial clones was 
never greater than 30% of the total number of extracted 
plasmids. Interestingly, under similar conditions, 
Lobel and Goff (1984) recovered 9 and 12bp insertions 
at frequencies varying from 10-50%, and C.I.Ace 
(personal communication) has also noted a similar 
frequency for BamHI linker insertions into pMCl DNA.
The possibility that this low frequency was caused by
r
the presence of an amp background of spontaneously
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religated pMCl was excluded by experimental controls, 
and DNA purification and ligation conditions were 
varied, but the frequency of recovery of plasmid DNA 
containing Xbal recognition sites was not increased. It 
is possible that the small size and high A+T content of 
the 6bp oligonucleotides makes them very susceptible to 
denaturation, and thus unavailable to DNA ligase.
The work presented in the previous section is a 
preliminary assessment of Vmw65 functional domains, 
since for a full analysis of this protein a greater 
number of mutants with insertions scattered throughout 
the coding sequence of the gene would be required. It 
should*also be noted that this work was begun before 
the sequencing of Vmw65 was completed, and 
unfortunately it could not be anticipated that the 
insertion of Xbal linkers into Haelll sites would 
result in the termination codon (TAG) being inserted 
into the reading frame at such a high frequency (11 out 
of a total of 17 Haelll sites compared with an expected 
frequency of 1 in 3 sites). This situation was 
reflected in the recovery of plasmids, where 4 out of 6 
successful insertions generated a termination codon.
4.8.2 Polypeptide Structure and Mutagenesis
An important point that has emerged from this study is 
that whilst Vmw65 has several domains affecting only 
one of its functions (at Haelll sites, 4, 12 and 14), a
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central region extending from Haelll site 8 to the 
PvuII site, and possibly as far as Haelll site 11, is 
required for the maintenance of both functions of 
Vmw65.
However, this analysis of Vmw65 gives no information as 
to the impact of such mutations on the spatial 
conformation, or tertiary structure of the protein 
which might alter the ability of Vmw65 to interact with 
other polypeptides. Whilst the determination of 
protein tertiary structure requires X-ray 
crystallography studies, the native conformation of the 
polypeptide is dependent upon the primary amino acid 
sequence, and numerous efforts have been made to 
predict the protein structure from the sequence, using 
computer programs designed for this purpose. Early 
predictive studies concentrated on the proteins, 
myoglobin and haemoglobin, which are composed of 80% 
0*C-helices and 0% ^-structures. As a consequence, the 
presence of oC-helices was overestimated in subsequent 
predictions. In later work, Chou and Fasman (1978) 
made a statistical survey of 15 proteins, and 
identified the potential for oC-helix or ^-sheet 
conformation of all 20 amino acids, arranging them in a 
hierarchical order. In addition, these workers 
formulated rules for the folding of secondary 
structures with an estimated accuracy of 70-80% (Chou 
and Fasman, 1978).
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Using this method, amino acids can be predicted to be 
strong, weak or indifferent "formers" of ^-helices or 
p-sheets, or alternatively, "breakers" of these 
conformations. For example, glutamate has a 
particularly high potential to form an cxi-helix, whilst 
its p-sheet potential is as a strong "p-sheet breaker". 
Using this information, the potential of a particular 
region to form a helix or p-sheet can be estimated by 
averaging the potential of residues in this portion of 
sequence. The predicted conformations of the secondary 
structure of a protein are:
1. -helical structures, which are initiated by 4
out of 6 residues having a high potential for 
helix formation, and which have characteristic 
intra-chain hydrogen bonding.
2. p-sheet structures, where 3 p-former residues can 
initiate a parallel or antiparallel chain of 
p-sheets, and inter-chain hydrogen bonds are 
formed.
3. Coil regions and p-turns (or reverse turns). Coil
regions are made up of groups of residues which
are not predicted to form cyL -helices or a
B-sheet, and may be composed of p-turns. p-turns
are structures in which the polypeptide chain
o
folds back on itself by nearly 180 , giving a 
protein, such as Vmw65, its globularity.
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It must be remembered, however, that these predications 
are limited in their application, and that in a given 
protein the true secondary structure, rather than a 
predicted one may not conform to the "rules" governing 
conformational structures.
However, within these limitations, the formation of 
predicted secondary structures are a useful and 
interesting means of analysing the possible effects of 
mutations on protein structure, in conjunction with 
their effects on protein function.
It might be expected that the regions most susceptible 
to mutation would be those where the inserted amino 
acids disrupt intra- or inter-chain interactions, such 
as hydrogen bonding. In pMCl, the only insertion to 
make a strong alteration to the predicted structure of 
the sensitive central domain was a BamHI insertion at 
Haelll site 9, where the addition of [arginine: 
isoleucine: arginine: alanine] enhanced a weakly 
predicted B-structure over a region of approximately 30 
residues (Figure 52), thus resulting in a strong 
computer prediction of two regions of p-sheets.
Another small alteration was evident at Haelll site 11, 
where a BamHI insert reduced the predicted length of a 
region of (X -helices. Interestingly, however, the Xbal 
insert at this site had no apparent effect on the 
predicted structure of pMCl, but unlike the larger
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BamHI insert, affected the ability of Vmw65 to
stimulate IE expression. Perhaps this is an indication
of the sensitivity of this domain to mutations, since
although no strongly predicted changes to the secondary
structure were evident from the Xbal insertions at
PvuII or Haelll 11 sites, or from the BamHI insertions
at Haelll 8 and PvuII sites, there were significant
changes to the functioning of the polypeptide. This
suggests that the conformation of this region is
directly essential for Vmw65 function, or
alternatively, that a change in this domain affects the
configuration of other regions of the polypeptide, such
that normal protein functions cannot be fulfilled.
*
Other functional domains were identified at Haelll 
sites 4 and 12, where the marker rescue ability was 
affected, and at Haelll site 14, where Vmw65 
stimulation of IE gene expression was lost. Haelll 
site 4 is in a weakly predicted region of p-turns, and 
the BamHI insertion resulted in the stronger prediction 
of a p-turn. Haelll site 14 is in a region of reverse 
turns, and Haelll site 12 is in a weakly predicted 
OC -helix structure: neither of these regions was
detectably altered in structure by a BamHI insertion.
Finally, the insertion of a BamHI linker or a 
termination codon (Xbal insert) at Haelll site 17 had 
no effect on protein function, although the latter
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insertion resulted in the loss of the predicted 
cxL -helix at the 3' terminus of the protein (Figure 
52). This, plus the fact that a BamHI insertion at 
Haelll site 2 had no effect on function suggests that 
the 3' terminus, and possibly the 5' terminus may be of 
little functional significance. It is interesting to 
speculate that regions of increasing functional 
importance may be retained towards the centre of the 
structure, and perhaps the protein folds itself to 
conserve such areas, which by these results would lie 
approximately between amino acids 150 and 250 in Vmw65.
4.8.3 CONCLUSIONS
Vmw65:Summary and Future Developments
Recent advances in the study of Vmw65 have contributed 
significantly towards understanding the function of 
this protein. Firstly, in addition to its role as a 
structural component of the virus tegument, functional 
Vmw65 has been shown to be essential for encapsidation 
of viral DNA (this have been discussed in detail in 
Section 3). Secondly, Vmw65 is now known to be the HSV 
trans-activator of IE gene expression, increasing IE 
mRNA synthesis by 5-10 fold in vitro.
This transcriptional aspect of Vmw65 function, which 
appears to be unique for an HSV polypeptide, is not 
retained by all other herpesviruses. Campbell and 
Preston (1987) have analysed the upstream sequences of
-1 9 5
the PRV major IE gene, and whilst expression was 
stimulated by HSV Vmw65, no increase in expression was 
observed in cells transfected with PRV IE or HSV IE 
genes or upon addition of, UV-irradated PRV, suggesting 
that PRV does not contain a functional TIF. However, 
in comparison, the evidence suggests that the 
betaherpesvirus, HCMV, encodes a TIF which stimulates 
HCMV but not HSV IE transcription, and that the HCMV 
major IE gene may be induced by the HSV 
trans-activator, Vmw65 (Spaete and Mocarski, 1985; 
Stinski and Roehr, 1985). Whilst these viruses lack 
the TAATGARATTC sequence in IE upstream sequences, they 
share versions of a small repeated element which has 
homology to the TAATGARATTC consensus.
In contrast to these viruses, VZV IE upstream regions 
lack any obvious sequences to TAATGARATTC, but this 
virus encodes a 46,000 MW polypeptide, which apart from 
lacking the final 80 amino acids, has an almost 
colinear ’ amino acid structure to HSV Vmw65.
Vmw65. Whilst their removal (as in pl5), resulted in 
the loss of any protein function, the removal of the 
final 20 amino acids (in pl7) had no discernible effect 
on Vmw65 function. It would be interesting, therefore, 
to determine the minimal amino acid requirement for
This raises the question as to the functional
carboxyl
significance of the 80 terminal amino acids in HSV
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Vmw65 function, and compare its predicted secondary 
structure with that of the VZV 46K polypeptide, thus 
identifying any predicted structural differences which 
might be related to the ability of Vmw65 to interact 
with the TAATGARATTC sequences of IE regulatory 
sequences.
Further work is also required to analyse VZV IE 
upstream sequences for trans-activation by VZV 46K 
and/or HSV Vmw65, and also to determine the effect of 
VZV 46K on HSV IE gene expression. If VZV does 
trans-activate IE gene expression, it probably does so 
via sequences differing from the TAATGARATTC motif, and 
theref6re the introduction of mutations into the VZV 
46K sequence at equivalent points to essential 
functional domains of Vmw65, might provide further 
evidence concerning functional differences between these 
proteins.
Preston et al. (in press) have already begun to 
elucidate the means by which HSV-1 Vmw65 stimulates HSV 
IE gene expression, despite the inability of this 
protein to bind to DNA (Marsden et al., 1987). It has 
been shown that purified Vmw65 or HSV-infected cell 
extracts form a novel complex with cellular 
polypeptides, and that this complex interacts 
specifically with DNA fragments containing the 
TAATGARATTC consensus element. The binding of cellular
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components to TAATGARATTC has also been noted by Pruijn 
et al. (1986), who identified the adenovirus
replication factor, nuclear factor 3 (NF-3) binding 
site, and demonstrated its similarity to the 
TAATGARATTC consensus sequence. Kristie and Roizman 
(1987) have shown that cell polypeptides from both 
infected and uninfected cells bind to TAATGARATTC. 
However, the protected region identified by DNasel 
protection studies differed from that identified by 
Preston et al. (in press). The evidence suggests that 
whilst a number of cellular proteins, or different 
protein complexes have the ability to bind to 
TAATGARATTC, Vmw65 forms a complex with polypeptides 
which are not normally bound to DNA. This novel 
complex can then act at the TAATGARATTC sequence to 
stimulate IE gene expression.
The availability of the insertional mutants of pMCl may 
be of significant use in the further analysis of Vmw65 
function, once the location and sequence composition of 
the mutations is confirmed. A particularly interesting 
aspect will be the study of mutants which partially 
retain the trans-activating properties of Vmw65 [pll 
(Xbal); pPvuII (BamHI)]. The fact these mutants retain 
some trans-activating properties suggests that the 
protein cannot fully interact with the cellular 
component, or that the complex does not efficiently 
interact with the TAATGARATTC sequence. This might be
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detectable, either as a decrease in the production of 
IEC, or, if Vmw65 interacts with a number of proteins, 
by a change in size of the IEC. Alternatively, the 
location of the insertion may result in the protein 
complex binding to DNA, but prevent efficient binding 
of, for example, the polymerase to the IEC.
These proposals could also be applied to tr mutants, 
since complete failure to trans-activate IE genes may 
not necessarily preclude formation of the IEC, but may 
result in the production of a non-functional complex.
In addition, this experimental approach may be 
applicable to those herpes viruses such as HCMV which 
perhapd encode a trans-activating protein, but do not 
appear to act on HSV IE genes. Further study using the 
above methods might demonstrate (1). whether a complex 
of some sort is formed with a TIF produced, for 
example, by HCMV or VZV and (2). where this might act 
other than at the TAATGARATTC element.
In conclusion, therefore, although a number of 
important advances have been made, the means by which 
Vmw65 acts on the DNA sequence is far from clear, and 
this, and the method by which Vmw65 associates with 
cellular polypeptides, represents an interesting and 
expanding area of study. A more complete analysis of 
the functional domains of Vmw65 will be important in 
elucidating the means by which this gene control system 
operates.
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